All 3,091 WHO Global Health Observatory indicators, each as a free REST/MCP call (endpoint who-indicator), no API key.
| Title | Code |
|---|
| 13-15-years old any alcoholic beverage consumed in past 30 days, (%) | SA_0000001786 |
| 13-15-years old any alcoholic beverage consumed in past 30 days, (%) | SA_0000001786_ARCHIVED |
| 13-15-years old first drink before age 14, (%) | SA_0000001787 |
| 13-15-years old first drink before age 14, (%) | SA_0000001787_ARCHIVED |
| 15-19 years old abstainers, lifetime (%) | SA_0000001757 |
| 15-19 years old abstainers, lifetime (%) | SA_0000001757_ARCHIVED |
| 15-19 years old former drinkers (%) | SA_0000001758 |
| 15-19 years old former drinkers (%) | SA_0000001758_ARCHIVED |
| 15-19 years old heavy episodic drinkers (drinkers only), % | SA_0000001756 |
| 15-19 years old heavy episodic drinkers (drinkers only), % | SA_0000001756_ARCHIVED |
| 15-19 years old heavy episodic drinkers (population), % with 95%CI | SA_0000001755 |
| 15-19 years old heavy episodic drinkers (population), % with 95%CI | SA_0000001755_ARCHIVED |
| 15-19 years old total alcohol consumption in litres of pure alcohol | SA_0000001760 |
| 15-19 years old total alcohol consumption in litres of pure alcohol | SA_0000001760_ARCHIVED |
| 15-19 years old, current drinkers (%) | SA_0000001759 |
| 15-19 years old, current drinkers (%) | SA_0000001759_ARCHIVED |
| 15-years old any alcoholic beverage consumed in past 12 months, (%) | SA_0000001781 |
| 15-years old any alcoholic beverage consumed in past 12 months, (%) | SA_0000001781_ARCHIVED |
| 15-years old any alcoholic beverage consumed in past 30 days, (%) | SA_0000001783 |
| 15-years old any alcoholic beverage consumed in past 30 days, (%) | SA_0000001783_ARCHIVED |
| 15-years old first drink at 13 years or younger, (%) | SA_0000001782 |
| 15-years old first drink at 13 years or younger, (%) | SA_0000001782_ARCHIVED |
| 15-years old, any alcoholic beverage consumed at least once a week, (%) | SA_0000001784 |
| 15-years old, any alcoholic beverage consumed at least once a week, (%) | SA_0000001784_ARCHIVED |
| Abortion admissions per 1000 women of reproductive age | ABORTION_ADMISSIONS |
| Abortion rate (model-estimated) | SRH_ABORTION_RATE |
| Abstainers (15-19 years), lifetime (%) | SA_0000001410 |
| Abstainers (15-19 years), past 12 months (%) | SA_0000001412 |
| Access restrictions | SUNBEDREG_ACCESS |
| Access restrictions to maintenance treatment | RSUD_460 |
| Access to a toll-free quit line | O_Quitline |
| Access to a toll-free quit line | TOBACCO_0000000361 |
| Accessibility of activities of daily living support services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q8x3_4 |
| Accessibility of behaviour and psychological management in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q8x3_2 |
| Accessibility of dementia carer training and education [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q12x2x1x1_1 |
| Accessibility of diagnostic services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q8x3_1 |
| Accessibility of financial benefits/social protection for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q12x2x1x1_5 |
| Accessibility of information on legal rights for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q12x2x1x1_4 |
| Accessibility of palliative and end-of-life care services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q8x3_5 |
| Accessibility of psycho-social supports for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q12x2x1x1_2 |
| Accessibility of psychosocial and rehabilitation services in community for dementia [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q8x3_3 |
| Accessibility of respite care for dementia carers [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q12x2x1x1_3 |
| Accessibility of social and financial protection for dementia [Capital/capital and main cities/capital, main cities, rural areas] | GDO_q8x3_6 |
| Action Plan for implementation of alcohol policy | SA_0000001736 |
| Action Plan for implementation of alcohol policy | SA_0000001736_ARCHIVED |
| Adolescent birth rate (per 1000 women) | MDG_0000000003 |
| Adolescent fertility rate (per 1000 women aged 15-19 years) | asfr1 |
| Adolescent mortality rate (per 1 000 age specific cohort) | CHILDMORT10TO19 |
| Adolescent mortality rate (per 1 000 age specific cohort) | MORTADO |
| Adopted written national policy on alcohol | SA_0000001502 |
| Adopted written national policy on alcohol | SA_0000001502_ARCHIVED |
| Adopted written national policy on alcohol, year adopted | SA_0000001697 |
| Adopted written national policy on alcohol, year adopted | SA_0000001697_ARCHIVED |
| Adopted written national policy on alcohol, year revised | SA_0000001698 |
| Adopted written national policy on alcohol, year revised | SA_0000001698_ARCHIVED |
| Adult day centre places (per 10,000 population) | GDO_q9x4_2 |
| Adult day centres | GDO_q9_4 |
| Adult indicator 1 definition | M_def_1_text_adult |
| Adult indicator 1 rate | M_def_1_prev_adult |
| Adult indicator 2 definition | M_def_2_text_adult |
| Adult indicator 2 rate | M_def_2_prev_adult |
| Adult mortality rate (probability of dying between 15 and 60 years per 1000 population) | WHOSIS_000004 |
| Adult smokeless tobacco use indicator definition | M_smkless_def_text_adult |
| Adult smokeless tobacco use indicator rate | M_smkless_prev_adult |
| Adult survey age range | M_svy_age_adult |
| Adult survey age range - smokeless | M_smkless_age_range_adult |
| Adults aged ≥ 20 years who are obese (%) | WHOSIS_000010 |
| Advertising restrictions at cinemas | SA_0000001512 |
| Advertising restrictions at cinemas | SA_0000001512_ARCHIVED |
| Advertising restrictions at point-of-sale | SA_0000001514 |
| Advertising restrictions at point-of-sale | SA_0000001514_ARCHIVED |
| Advertising restrictions in e-sports | SA_0000001846 |
| Advertising restrictions in print media | SA_0000001511 |
| Advertising restrictions in print media | SA_0000001511_ARCHIVED |
| Advertising restrictions on billboards | SA_0000001513 |
| Advertising restrictions on billboards | SA_0000001513_ARCHIVED |
| Advertising restrictions on cable television | SA_0000001508 |
| Advertising restrictions on cable television | SA_0000001508_ARCHIVED |
| Advertising restrictions on local radio | SA_0000001510 |
| Advertising restrictions on local radio | SA_0000001510_ARCHIVED |
| Advertising restrictions on national radio | SA_0000001509 |
| Advertising restrictions on national radio | SA_0000001509_ARCHIVED |
| Advertising restrictions on national television | SA_0000001507 |
| Advertising restrictions on national television | SA_0000001507_ARCHIVED |
| Advertising restrictions on social media | SA_0000001719 |
| Advertising restrictions on social media | SA_0000001719_ARCHIVED |
| Advertising restrictions on the internet | SA_0000001515 |
| Advertising restrictions on the internet | SA_0000001515_ARCHIVED |
| Affordability - percentage of GDP per capita required to purchase 2000 cigarettes of the most sold brand | R_afford_gdp |
| Affordability - trend growth rate | R_afford_trend_growth_rate |
| Affordability of cigarettes: category of change in the last 10 years (Yes (less affordable), No (more affordable), No change) | R_afford_cat |
| Affordability of cigarettes: category of change over past 2 years | R_afford_cat_2 |
| Affordability of fluoride toothpaste | ORALHEALTH_AFFORDABILITY_FLUORIDETOOTHPASTE |
| Age limits off-premise sales | SA_0000001699 |
| Age limits off-premise sales | SA_0000001699_ARCHIVED |
| Age limits on-premise service | SA_0000001518 |
| Age limits on-premise service | SA_0000001518_ARCHIVED |
| Age range of latest youth prevalence survey (nonsmoked) | Yth_nonsmoked_age_grp |
| Age range of most recent adolescent survey | Youth_svy_age_range |
| Age-standardized DALYs (per 100,000) | GBD_DALYRTAGE |
| Age-standardized DALYs attributable to the environment (per 100 000 population) | TOTENV_4 |
| Age-standardized DALYs, alcohol and drug use disorders, per 100 000 | RSUD_5 |
| Age-standardized DALYs, alcohol use disorders, per 100,000 | SA_0000001418 |
| Age-standardized DALYs, breast cancer, per 100,000 | SA_0000001419 |
| Age-standardized DALYs, cerebrovascular disease, per 100,000 | SA_0000001689 |
| Age-standardized DALYs, colon and rectum cancers, per 100,000 | SA_0000001420 |
| Age-standardized DALYs, diabetes mellitus, per 100,000 | SA_0000001421 |
| Age-standardized DALYs, drownings, per 100,000 | SA_0000001422 |
| Age-standardized DALYs, falls, per 100,000 | SA_0000001423 |
| Age-standardized DALYs, fires, per 100,000 | SA_0000001424 |
| Age-standardized DALYs, ischaemic heart disease, per 100,000 | SA_0000001425 |
| Age-standardized DALYs, liver cancer, per 100,000 | SA_0000001426 |
| Age-standardized DALYs, liver cirrhosis, per 100,000 | SA_0000001427 |
| Age-standardized DALYs, mouth and oropharynx cancer, per 100,000 | SA_0000001429 |
| Age-standardized DALYs, oesophagus cancer, per 100,000 | SA_0000001430 |
| Age-standardized DALYs, other unintentional injuries, per 100,000 | SA_0000001435 |
| Age-standardized DALYs, poisoning, per 100,000 | SA_0000001431 |
| Age-standardized DALYs, prematurity and low birth rate, per 100,000 | SA_0000001432 |
| Age-standardized DALYs, road traffic accidents, per 100,000 | SA_0000001433 |
| Age-standardized DALYs, self-inflicted injury, per 100,000 | SA_0000001434 |
| Age-standardized DALYs, violence, per 100,000 | SA_0000001436 |
| Age-standardized NCD mortality rate (per 100 000 population) | WHS2_131 |
| Age-standardized death rates (15+ years), alcoholic liver disease, per 100,000 | SA_0000001456 |
| Age-standardized death rates (15+ years), poisoning, per 100,000 | SA_0000001458 |
| Age-standardized death rates (15+ years), violence, per 100,000 | SA_0000001460 |
| Age-standardized death rates, alcohol and drug use disorders, per 100 000 | RSUD_3 |
| Age-standardized death rates, alcohol use disorders, per 100,000 | SA_0000001437 |
| Age-standardized death rates, breast cancer, per 100,000 | SA_0000001438 |
| Age-standardized death rates, cerebrovascular disease, per 100,000 | SA_0000001690 |
| Age-standardized death rates, colon and rectum cancers, per 100,000 | SA_0000001439 |
| Age-standardized death rates, diabetes mellitus, per 100,000 | SA_0000001440 |
| Age-standardized death rates, drownings, per 100,000 | SA_0000001441 |
| Age-standardized death rates, falls, per 100,000 | SA_0000001442 |
| Age-standardized death rates, fires, per 100,000 | SA_0000001443 |
| Age-standardized death rates, ischaemic heart disease, per 100,000 | SA_0000001444 |
| Age-standardized death rates, liver cancer, per 100,000 | SA_0000001445 |
| Age-standardized death rates, liver cirrhosis, per 100,000 | SA_0000001446 |
| Age-standardized death rates, mouth and oropharynx cancer, per 100,000 | SA_0000001448 |
| Age-standardized death rates, oesophagus cancer, per 100,000 | SA_0000001449 |
| Age-standardized death rates, other unintentional injuries, per 100,000 | SA_0000001454 |
| Age-standardized death rates, poisoning, per 100,000 | SA_0000001450 |
| Age-standardized death rates, prematurity and low birth rate, per 100,000 | SA_0000001451 |
| Age-standardized death rates, road traffic accidents, per 100,000 | SA_0000001452 |
| Age-standardized death rates, self-inflicted injury, per 100,000 | SA_0000001453 |
| Age-standardized death rates, violence, per 100,000 | SA_0000001455 |
| Age-standardized deaths attributable to the environment (per 100 000 population) | TOTENV_2 |
| Age-standardized mortality rate by cause (per 100 000 population) - Cancer | WHS2_160 |
| Age-standardized mortality rate by cause (per 100 000 population) - Cardiovascular | WHS2_161 |
| Age-standardized prevalence of current tobacco smoking among persons aged 15 years and older | SDGTOBACCO |
| Age-standardized road traffic mortality (per 100 000 population) | SDGROADAGE |
| Age-standardized suicide rates (per 100 000 population) | MH_12 |
| Agencies responsible for delivering prison healthcare | PRISON_B3_DELIVHEALTHCARE |
| Agreement in place between the Ministry of Health and other sector(s) in relation to health and climate change policy or programs | CCH_SURVEY_AGREEMENT_MOH_OTHERSECTORS |
| Alcohol content displayed on containers | SA_0000001735 |
| Alcohol content displayed on containers | SA_0000001735_ARCHIVED |
| Alcohol content in beverage in percent of volume, (alcohol by volume) (ABV %) | TAXBEV_ABV |
| Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI | SA_0000001461 |
| Alcohol dependence (15+ ), 12-month prevalence (%) with 95%CI | SA_0000001461_ARCHIVED |
| Alcohol expenditure as a per cent of total household expenditure | SA_0000001476 |
| Alcohol expenditure as a per cent of total household expenditure | SA_0000001476_ARCHIVED |
| Alcohol poisoning deaths, per 100,000 population | SA_0000001837 |
| Alcohol use disorders (15+), 12 month prevalence (%) with 95% | SA_0000001462 |
| Alcohol use disorders (15+), 12 month prevalence (%) with 95% | SA_0000001462_ARCHIVED |
| Alcohol use disorders (15+), 12 month prevalence (%), age standardized, with 95%CI | SA_0000001753_ARCHIVED |
| Alcohol use is banned | SA_0000001504 |
| Alcohol use is banned | SA_0000001504_ARCHIVED |
| Alcohol, 15-19 years heavy continuous drinkers past year (%) | SA_0000001841 |
| Alcohol, 15-19 years heavy continuous drinkers, drinkers only, past year (%) | SA_0000001842 |
| Alcohol, abstainers lifetime (%) | SA_0000001409_ARCHIVED |
| Alcohol, abstainers lifetime (%), age-standardized | SA_0000001409 |
| Alcohol, abstainers past 12 months (%) | SA_0000001411_ARCHIVED |
| Alcohol, abstainers past 12 months (%), age-standardized | SA_0000001411 |
| Alcohol, average daily intake in grams among drinkers with 95%CI | SA_0000001751_ARCHIVED |
| Alcohol, average daily intake in grams among drinkers, three-year average | SA_0000001751 |
| Alcohol, consumers past 12 months (%) | SA_0000001413_ARCHIVED |
| Alcohol, consumers past 12 months (%), age-standardized | SA_0000001413 |
| Alcohol, consumption of pure alcohol by type of beverage (%) | SA_0000001398 |
| Alcohol, consumption of pure alcohol by type of beverage (%) | SA_0000001398_ARCHIVED |
| Alcohol, drinkers only per capita (15+) consumption in litres of pure alcohol, three-year average | SA_0000001404 |
| Alcohol, drinkers only per capita (15+)consumption in litres of pure alcohol | SA_0000001404_ARCHIVED |
| Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 | SA_0000001402 |
| Alcohol, estimate of five-year change in recorded per capita (15+) consumption 2006-2010 | SA_0000001402_ARCHIVED |
| Alcohol, former drinkers (%) | SA_0000001414_ARCHIVED |
| Alcohol, former drinkers (%), age-standardized | SA_0000001414 |
| Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI | SA_0000001754 |
| Alcohol, harmful use (15+), 12 month prevalence (%) with 95%CI | SA_0000001754_ARCHIVED |
| Alcohol, heavy continuous drinkers past year (%) | SA_0000001839 |
| Alcohol, heavy continuous drinkers, drinkers only, past year (%) | SA_0000001840 |
| Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized | SA_0000001739 |
| Alcohol, heavy episodic drinking (15+) past 30 days (%), age-standardized with 95%CI | SA_0000001739_ARCHIVED |
| Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%) | SA_0000001416_ARCHIVED |
| Alcohol, heavy episodic drinking (15+), drinkers only, past 30 days (%), age-standardized | SA_0000001416 |
| Alcohol, heavy episodic drinking (population) past 30 days (%) | SA_0000001415_ARCHIVED |
| Alcohol, patterns of drinking score | SA_0000001417 |
| Alcohol, patterns of drinking score | SA_0000001417_ARCHIVED |
| Alcohol, product placement restrictions in digital media | SA_0000001847 |
| Alcohol, product placement restrictions in e-sports | SA_0000001848 |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol) | SA_0000001400_ARCHIVED |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), by beverage type | SA_0000001400 |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average | SA_0000001401 |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average | SA_0000001401_ARCHIVED |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average | SA_0000001747 |
| Alcohol, recorded per capita (15+) consumption (in litres of pure alcohol), three-year average with 95%CI | SA_0000001747_ARCHIVED |
| Alcohol, regional alcohol per capita (15+) consumption (in litres of pure alcohol) | SA_0000001824 |
| Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) | SA_0000001737 |
| Alcohol, regional per capita (15+) consumption (in litres of pure alcohol) | SA_0000001737_ARCHIVED |
| Alcohol, regional prevalence of alcohol dependence (%) | SA_0000001744 |
| Alcohol, regional prevalence of alcohol dependence (%) | SA_0000001744_ARCHIVED |
| Alcohol, regional prevalence of alcohol use disorders (%) | SA_0000001745 |
| Alcohol, regional prevalence of alcohol use disorders (%) | SA_0000001745_ARCHIVED |
| Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 | SA_0000001746 |
| Alcohol, total (recorded + unrecorded) per capita (15+) consumption with 95%CI, projections to 2025 | SA_0000001746_ARCHIVED |
| Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 | SA_0000001752 |
| Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projected estimates for 2016 | SA_0000001752_ARCHIVED |
| Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) | SA_0000001403 |
| Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) | SA_0000001403_ARCHIVED |
| Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001749 |
| Alcohol, total (recorded 3 year average + unrecorded) per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001749_ARCHIVED |
| Alcohol, total per capita (15+) consumption (in litres of pure alcohol) (SDG Indicator 3.5.2), three-year average | SA_0000001688 |
| Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001822 |
| Alcohol, total per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001822_ARCHIVED |
| Alcohol, total (recorded + unrecorded) per capita (15+) consumption, projections | SA_0000001818 |
| Alcohol, tourist consumption (in litres of pure alcohol) | SA_0000001405 |
| Alcohol, tourist consumption (in litres of pure alcohol) | SA_0000001405_ARCHIVED |
| Alcohol, tourist consumption (in litres of pure alcohol) | SA_0000001823_ARCHIVED |
| Alcohol, tourist consumption (in litres of pure alcohol), three-year average | SA_0000001823 |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) | SA_0000001406 |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) | SA_0000001406_ARCHIVED |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001748 |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001748_ARCHIVED |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol) with 95%CI | SA_0000001821_ARCHIVED |
| Alcohol, unrecorded per capita (15+) consumption (in litres of pure alcohol), three-year average | SA_0000001821 |
| Alcohol-attributable DALYs lost from all causes (all ages), (number) | SA_0000001843 |
| Alcohol-attributable DALYs per 100,000 people (age standardized) | SA_0000001833 |
| Alcohol-attributable Years of Life Lost (YLL) score | SA_0000001740 |
| Alcohol-attributable Years of Life Lost (YLL) score | SA_0000001740_ARCHIVED |
| Alcohol-attributable all-cause deaths (all ages), (number) | SA_0000001844 |
| Alcohol-attributable all-cause deaths per 100,000, age standardized | SA_0000001832 |
| Alcohol-attributable fractions (15+), cancer deaths | SA_0000001808 |
| Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) | SA_0000001741 |
| Alcohol-attributable fractions (15+), liver cirrhosis deaths (%) | SA_0000001741_ARCHIVED |
| Alcohol-attributable fractions (15+), road traffic crash deaths (%) | SA_0000001742 |
| Alcohol-attributable fractions (15+), road traffic crash deaths (%) | SA_0000001742_ARCHIVED |
| Alcohol-attributable fractions, all-cause deaths (%) | SA_0000001743 |
| Alcohol-attributable fractions, all-cause deaths (%) | SA_0000001743_ARCHIVED |
| Alcohol-related cardiomyopathy deaths (% of all cardiomyopathy deaths) | SA_0000001838 |
| Alcohol-related crimes (% of all crimes) | SA_0000001789 |
| Alcohol-related crimes (% of all crimes) | SA_0000001789_ARCHIVED |
| Alcohol-related disease mortality, per 100,000 (15+ years) | SA_0000001473 |
| Alcohol-related injury mortality, per 1,000 | SA_0000001472 |
| Alcohol-related road traffic crashes (% of all traffic crashes) | SA_0000001471 |
| Alcohol-related road traffic crashes (% of all traffic crashes) | SA_0000001471_ARCHIVED |
| Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) | SA_0000001696 |
| Alcohol-related road traffic crashes with fatalities (% of all road traffic crashes with fatalities) | SA_0000001696_ARCHIVED |
| Alcohol-related road traffic crashes with fatalities, per 100,000 population | SA_0000001788 |
| Alcohol-related road traffic crashes with fatalities, per 100,000 population | SA_0000001788_ARCHIVED |
| Alcohol-related road traffic crashes, per 100,000 population | SA_0000001470 |
| Alcohol-related road traffic crashes, per 100,000 population | SA_0000001470_ARCHIVED |
| Alcohol-related road traffic deaths (% of all road traffic deaths) | SA_0000001836 |
| Alcohol-related road traffic deaths, per 100,000 population | SA_0000001835 |
| Alcoholic beverage legally defined | SA_0000001503 |
| Alcoholic beverage legally defined | SA_0000001503_ARCHIVED |
| Alcoholic excise tax revenue as a per cent of government revenue | SA_0000001474 |
| Alcoholic excise tax revenue as a per cent of government revenue | SA_0000001474_ARCHIVED |
| Alcoholic psychosis, incidence, per 100,000 | SA_0000001463 |
| Alcoholic psychosis, incidence, per 100,000 | SA_0000001463_ARCHIVED |
| Ambient air pollution attributable DALYs per 100'000 children under 5 years | AIR_10 |
| Ambient air pollution attributable deaths per 100'000 children under 5 years | AIR_6 |
| Ambient air pollution attributable DALYs | AIR_43 |
| Ambient air pollution attributable DALYs | AIR_7 |
| Ambient air pollution attributable DALYs (per 100 000 population) | AIR_9 |
| Ambient air pollution attributable DALYs (per 100 000 population, age-standardized) | AIR_90 |
| Ambient air pollution attributable DALYs in children under 5 years | AIR_8 |
| Ambient air pollution attributable YLLs | AIR_45 |
| Ambient air pollution attributable death rate (per 100 000 population) | AIR_5 |
| Ambient air pollution attributable death rate (per 100 000 population, age-standardized) | AIR_42 |
| Ambient air pollution attributable deaths | AIR_41 |
| Ambient air pollution attributable deaths (per 100 000 population, age-standardized) | AIR_50 |
| Ambient air pollution attributable deaths in children under 5 years | AIR_4 |
| Ambient and household air pollution attributable death rate (per 100 000 population) | SDGAIRBOD |
| Ambient and household air pollution attributable death rate (per 100 000 population, age-standardized) | SDGAIRBODA |
| Amount of water- and sanitation-related official development assistance that is part of a government-coordinated spending plan (constant 2024 US$ millions) | SDGODAWS |
| Annual budget for tobacco control in currency reported | NTCP_govt_exp |
| Annual incidence of dracunculiasis cases | NTD_3 |
| Annual number of condoms distributed | HIV_CONDOMSDIST_NUM |
| Annual revenues from alcohol excise tax in millions US$ | SA_0000001475 |
| Annual revenues from alcohol excise tax in millions US$ | SA_0000001475_ARCHIVED |
| Annual tax revenues - currency | Rev_curr |
| Annual tax revenues - import duties and all other taxes (excluding corporate taxes on tobacco companies) | Rev_imp_other |
| Annual tax revenues - tobacco products included | Rev_type |
| Annual tax revenues - total excise (specific and ad valorem) | Rev_excise |
| Annual tax revenues - total revenues | Rev_govt_total |
| Annual tax revenues - value added tax (vat) and other sales taxes | Rev_VAT |
| Annual tax revenues - year | Rev_year |
| Antenatal care attendees positive for syphilis who received treatment (%), reported | PerctreatedANC |
| Antenatal care attendees who were positive for syphilis (%), reported | PercposANC |
| Antenatal care coverage - at least four visits (%) | WHS4_154 |
| Antenatal care coverage - at least four visits (in the five years preceding the survey) (%) | anc45 |
| Antenatal care coverage - at least four visits (in the two or three years preceding the survey) (%) | anc4 |
| Antenatal care coverage - at least one visit (%) | WHS4_111 |
| Antenatal care coverage - at least one visit (in the five years preceding the survey) (%) | anc15 |
| Antenatal care coverage - at least one visit (percent) | ANC_ATLEAST1VISIT_PERCENT |
| Antenatal care coverage - at least one visit, among girls aged 15-19 (%) | WHS4_111_AGE1519 |
| Anti-tobacco mass media campaigns | W-MM_Group |
| Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion) | GASP_ISOLATESDSR_PROPORTION |
| Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials testing in Neisseria gonorrhoea isolates (WHO-GASP) (number) | GASP_ISOLATESTESTED_NUMBER |
| Antiretroviral therapy coverage among HIV-infected pregnant women for PMTCT (%) | WHS4_99 |
| Antiretroviral therapy coverage among people with HIV infection eligible for ART according to 2010 guidelines (%) | MDG_0000000033 |
| Antiretroviral therapy coverage among people with advanced HIV infection (%), WHO 2006 guidelines | MDG_0000000034 |
| Appearance of tobacco products in TV and/or films | E14_prod_tv_films |
| Applicability of national motorcycle helmet law to all occupants | RS_219 |
| Applicability of seat-belt law to all occupants | RS_210 |
| Archived, see AP_BOD_HIST mart | AIR_71 |
| Archived, see AP_BOD_HIST mart | AIR_72 |
| Archived, see AP_BOD_HIST mart | AIR_73 |
| Archived, see AP_BOD_HIST mart | AIR_74 |
| Archived, see AP_BOD_HIST mart | AIR_75 |
| Archived, see TOBACCO_INDICATOR | Adult_curr_cig_smoking |
| Archived, see TOBACCO_INDICATOR | Adult_curr_e-cig |
| Archived, see TOBACCO_INDICATOR | Adult_curr_smokeless |
| Archived, see TOBACCO_INDICATOR | Adult_curr_tob_smoking |
| Archived, see TOBACCO_INDICATOR | Adult_curr_tob_use |
| Archived, see TOBACCO_INDICATOR | Adult_daily_cig_smoking |
| Archived, see TOBACCO_INDICATOR | Adult_daily_e-cig |
| Archived, see TOBACCO_INDICATOR | Adult_daily_smokeless |
| Archived, see TOBACCO_INDICATOR | Adult_daily_tob_smoking |
| Archived, see TOBACCO_INDICATOR | Adult_daily_tob_use |
| Archived, see TOBACCO_INDICATOR | Adult_nonsmoked_age_grp |
| Archived, see TOBACCO_INDICATOR | Adult_nonsmoked_national |
| Archived, see TOBACCO_INDICATOR | Adult_nonsmoked_svy_title |
| Archived, see TOBACCO_INDICATOR | Adult_nonsmoked_svy_yr |
| Archived, see TOBACCO_INDICATOR | Adult_survey_title |
| Archived, see TOBACCO_INDICATOR | Adult_svy_age_range |
| Archived, see TOBACCO_INDICATOR | Adult_svy_national |
| Archived, see TOBACCO_INDICATOR | Adult_svy_yr |
| Archived, see health inequality website | bmi30wm |
| Archived, see health inequality website | cpmowho |
| Archived, see health inequality website | fpsmowho |
| Archived, see health inequality website | sevwast5 |
| Archived, see health inequality website | uwgt5 |
| Archived, see health inequality website | vbcg |
| Archived, see health inequality website | vdpt |
| Archived, see health inequality website | vfull |
| Archived, see health inequality website | vmsl |
| Archived, see health inequality website | vpolio |
| Archived, see health inequality website | vzdpt |
| Are the health warnings on cigarette packaging rotating? | W7_rotation_A |
| Are the health warnings on cigarette packaging written in the principal language(s) of the country? | W8_princ_langs_A |
| Are the health warnings on other smoked tobacco packaging rotating? | W7_rotation_B |
| Are the health warnings on other smoked tobacco packaging written in the principal language(s) of the country? | W8_princ_langs_B |
| Are the health warnings on smokeless tobacco packaging rotating? | W7_rotation_C |
| Are the health warnings on smokeless tobacco packaging written in the principal language(s) of the country? | W8_princ_langs_C |
| At least one national mass media campaign ran during the survey period | Camp_nat |
| Attributable fraction of diarrhoea to inadequate hygiene | WSH_20_HYG |
| Attributable fraction of diarrhoea to inadequate sanitation | WSH_20_SAN |
| Attributable fraction of diarrhoea to inadequate water | WSH_20_WAT |
| Attributable fraction of diarrhoea to inadequate water, sanitation and hygiene | WSH_20 |
| Attribution of road traffic deaths to alcohol (%) | RS_208 |
| Authorization/accreditation required for official radon measurement providers | RADON_Q604 |
| Authorization/accreditation required for official radon measurement providers | RADON_Q605 |
| Authorization/accreditation required for prevention/mitigation service providers | RADON_Q704 |
| Automatic adjustment of specific excise on beverage | TAXBEV_EXCISE_AUTOADJUST |
| Availability and status of dementia reporting in the past two years | GDO_q16x3 |
| Availability of atleast one assistive technology for people with dementia | GDO_q10x2_TECH |
| Availability of activities of daily living support services in community for dementia | GDO_q8x2_4 |
| Availability of at least one anti-dementia medication approved for on-label use reimbursement | GDO_q10x1x2 |
| Availability of atleast one adult hygiene products for people with dementia | GDO_q10x2_1AVAIL |
| Availability of atleast one housing adjustment for people with dementia | GDO_q10x2_HOSUE |
| Availability of behaviour and psychological management in community for dementia | GDO_q8x2_2 |
| Availability of cardiovascular risk stratification in 50% or more primary health care facilities | NCD_CCS_riskstrat |
| Availability of dementia care coordination standards/ guidelines/ protocols | GDO_q5x2 |
| Availability of dementia diagnostic rate | GDO_q7x1_AVAIL |
| Availability of dementia-friendly initiatives that improve accessibility | GDO_q14x1 |
| Availability of diagnostic services in community for dementia | GDO_q8x2_1 |
| Availability of education/training for assistive technology | ASSISTIVETECH_Q07 |
| Availability of estimates on impoverishment due to out-of-pocket health expenditures | FINPROTECTION_IMPOV_ESTIMATE_AVAILABLE |
| Availability of estimates on large health expenditures as a share of total expenditure or income | FINPROTECTION_CATA_ESTIMATE_AVAILABLE |
| Availability of funding for dementia national plan | GDO_q2x1x2 |
| Availability of funding for dementia-specific research plan/programme | GDO_q18x2 |
| Availability of funding for national road safety strategy | RS_229 |
| Availability of generic anti-dementia medication | GDO_q10x1x1 |
| Availability of government/registered services for assistive technology | ASSISTIVETECH_Q05 |
| Availability of investigational pharmaceutical trials for dementia | GDO_q19x3 |
| Availability of mechanisms to coordinate dementia care across sectors | GDO_q5x1 |
| Availability of naloxone | RSUD_520 |
| Availability of national list of approved medical devices for procurement or reimbursement | DEVICES18 |
| Availability of national standards or recommended lists of medical devices | DEVICES06 |
| Availability of palliative and end-of-life care services in community for dementia | GDO_q8x2_5 |
| Availability of psychosocial and rehabilitation services in community for dementia | GDO_q8x2_3 |
| Availability of public funding for assistive technology | ASSISTIVETECH_Q03 |
| Availability of routine antipsychotic prescription records for people with dementia for monitoring purposes | GDO_q16x2_5 |
| Availability of routine hospital admissions records for people with dementia for monitoring purposes | GDO_q16x2_1 |
| Availability of routine outpatient intervention and treatment records for people with dementia for monitoring purposes | GDO_q16x2_3 |
| Availability of routine outpatient visit records for people with dementia for monitoring purposes | GDO_q16x2_2 |
| Availability of routine pharmaceutical records for people with dementia for monitoring purposes | GDO_q16x2_4 |
| Availability of social and financial protection for dementia | GDO_q8x2_6 |
| Availability of technical specifications of medical devices to support procurement or donations | DEVICES20 |
| Average - taxes as a % of cigarette price - ad valorem excise | R_Ad_val_average |
| Average - taxes as a % of cigarette price - import duties | R_imp_duty_average |
| Average - taxes as a % of cigarette price - other taxes | R_Other_average |
| Average - taxes as a % of cigarette price - specific excise | R_Sp_excise_average |
| Average - taxes as a % of cigarette price - total tax | R_total_tax_average |
| Average - taxes as a % of cigarette price - value added tax | R_VAT_average |
| Average daily intake in grams of alcohol, population (15+) | SA_0000001845 |
| Average death rate due to natural disasters (per 100 000 population) | SDGDISASTER |
| Average of 13 International Health Regulations core capacity scores | SDGIHR |
| Average of 13 International Health Regulations core capacity scores, SPAR version, 1st edition | SDGIHR2018 |
| Average price 500 mls Beer in US$ | SA_0000001829 |
| Average price 500 mls Spirits in US$ | SA_0000001831 |
| Average price 750 mls Wine in US$ | SA_0000001830 |
| Awareness activities | SA_0000001647 |
| Awareness activities | SA_0000001647_ARCHIVED |
| BCG immunization coverage among 1-year-olds (%) (WUENIC) | WHS4_543 |
| BCG immunization coverage among one-year-olds (%) | bcgv |
| Ban on Corporate Social Responsibility activities (CSR) | E15d_csr_ban |
| Ban on Corporate Social Responsibility activities (CSR) | E17a_csr_ban |
| Ban on advertising at point of sale | E6a_pt_of_sale |
| Ban on advertising: Billboards and outdoor advertising | E5_billboards |
| Ban on advertising: International TV and radio (broadcast from abroad, including satellite) | E2_intl_tv_radio |
| Ban on advertising: International magazines and newspapers | E4_intl_print |
| Ban on advertising: Internet | E7_internet |
| Ban on advertising: Local magazines and newspapers | E3_nat_print |
| Ban on advertising: National TV and radio | E1_nat_tv_radio |
| Ban on advertising: Point of sale | E6_pt_of_sale |
| Ban on any form of contribution (financial or other support) to any event, activity or individual | E15b_sponsor_contribution |
| Ban on appearance of tobacco brands in TV and/or films (product placement) | E13_brand_placement |
| Ban on appearance of tobacco products in TV and/or films | E14a_prod_tv_films |
| Ban on brand name of non-tobacco products used for tobacco product | E12_brand_sharing |
| Ban on deceitful terms on cigarette packaging | W18_misleading_terms_A |
| Ban on deceitful terms on other smoked tobacco packaging | W18_misleading_terms_B |
| Ban on deceitful terms on smokeless tobacco packaging | W18_misleading_terms_C |
| Ban on display of tobacco products at points of sale | E25_ban_display_pt_of_sale |
| Ban on display of tobacco products at points of sale | E6b_ban_display_pt_of_sale |
| Ban on entities other than tobacco companies/the tobacco industry publicizing the CSR activities of the tobacco companies/industry | E17c_csr_promo_others |
| Ban on entities other than tobacco companies/tobacco industry publicizing the Corporate Social Responsibility activities of the tobacco companies | E17_csr_promo_others |
| Ban on free distribution of tobacco products in the mail or through other means | E9_free_distrib |
| Ban on internet sales of tobacco products | E24_internet_sales_ban |
| Ban on non-tobacco goods AND services identified with tobacco brand names | E11_brand_stretching |
| Ban on promotional discounts | E10_promo_discounts |
| Ban on tobacco companies funding or making contributions (including in-kind contributions) to smoking prevention media campaigns, including those directed at youth | E18_csr_anti_tobacco_media |
| Ban on tobacco companies/the tobacco industry publicizing their CSR activities | E17b_csr_promo_self |
| Ban on tobacco companies/tobacco industry publicizing their “Corporate Social Responsibility” activities | E16_csr_promo_self |
| Ban on tobacco vending machines | E23_vending_machines |
| Banning the publicity of financial or other sponsorship or support by the tobacco industry of events, activities, individuals | E15c_sponsor_publicity |
| Barriers to accessing assistive products (%) | ASSISTIVETECH_BARRIERAT |
| Base for ad valorem excise tax on beverage | TAXBEV_ADVALOREMBASE |
| Basis for NHA estimate | NHABASIS |
| Beds for mental health in general hospitals (per 100,000) | MH_13 |
| Beds for the treatment of substance use disorders, per 100 000 | RSUD_45 |
| Beds in community residential facilities (per 100,000) | MH_15 |
| Beds in mental hospitals (per 100,000) | MH_16 |
| Best-practice policy implemented for industrially produced trans-fatty acids (TFA) (Y/N) | UHCTRANSFATS |
| Beverage has become less affordable since last survey year | TAXBEV_AFFORD_LESS |
| Beverage price | TAXBEV_PRICE |
| Biomedical engineers density (per 10 000 population) | HRH_40 |
| Biomedical technicians density (per 10 000 population) | HRH_45 |
| Births attended by skilled health personnel (%) | MDG_0000000025 |
| Births attended by skilled health personnel (in the five years preceding the survey) (%) | sba5 |
| Births attended by skilled health personnel (in the two or three years preceding the survey) (%) | sba |
| Births attended by skilled health personnel, among girls aged 15-19 (%) | MDG_0000000025_AGE1519 |
| Births by caesarean section (%) | WHS4_115 |
| Births by caesarean section (in the five years preceding the survey) (%) | csection5 |
| Births by caesarean section (in the two or three years preceding the survey) (%) | csection |
| Blood Alcohol Concentration (BAC) limit for drivers | RS_207 |
| Brief interventions as health promotion/disease prevention | SA_0000001702 |
| Budget line for substance use disorder prevention | RSUD_74 |
| Budget line for substance use disorder treatment | RSUD_22 |
| Budget year | NTCP_budget_year |
| Bullied, past 30 days (%) | VIOLENCE_BULLIED |
| Buprenorphine provision in clinical and community-based settings | RSUD_59 |
| Buprenorphine used for detoxification or maintenance | RSUD_55 |
| Buprenorphine used for the treatment of opioid dependence | RSUD_54 |
| Buprenorphine/naloxone provision in clinical and community-based settings | RSUD_60 |
| Buprenorphine/naloxone used for detoxification or maintenance | RSUD_57 |
| Buprenorphine/naloxone used for the treatment of opioid dependence | RSUD_56 |
| Bupropion - cost covered | O_Bup_ins |
| Bupropion - legally sold | O_Bup_sold |
| Bupropion - legally sold | TOBACCO_0000000369 |
| Bupropion - place available | O_Bup_where |
| Bupropion - place available | TOBACCO_0000000370 |
| Campaign aired on television and/or radio | Camp_tv_radio |
| Campaign utilized media planning | Camp_media_planning |
| Campaign was part of a comprehensive tobacco control programme | Camp_gov_prog |
| Campaign was pre-tested | Camp_mat_tested |
| Cancer survival for those diagnosed with breast cancer, 5-year net survival (%) | CANCERSURVIVAL_BREASTCANCER |
| Cancer, age-standardized death rates (15+), per 100,000 population | SA_0000001807 |
| Cancer, alcohol-attributable, age-standardized death rates, per 100,000 population | SA_0000001807_AA |
| Capacity | GOE_Q057 |
| Capacity building required for new skills | GOE_Q200 |
| Carbamate resistance reported for at least one site | IR_CARBAMATE_PRESENCE |
| Care facilities [hospice centres] | GDO_q9_3 |
| Care facilities [long-term care] | GDO_q9_2 |
| Care-seeking by type of patient and source of care (%) | CARE_SOURCE |
| Care-seeking by type of patient and source of care (%) (see CARE_SOURCE) | CARE_SEEK |
| Care-seeking for children with symptoms of acute respiratory infection (%) | WHS4_106 |
| Cases started on MDR-TB treatment | TB_c_mdr_tx |
| Cataract surgical coverage of adults aged 50 and over (%) | CATARACTSURGICAL |
| Cautions and arrests for drink-driving, per 100,000 population | SA_0000001464 |
| Cautions and arrests for drink-driving, per 100,000 population | SA_0000001464_ARCHIVED |
| Cautions and arrests for public drunkenness, per 100,000 population | SA_0000001695 |
| Cautions and arrests for public drunkenness, per 100,000 population | SA_0000001695_ARCHIVED |
| Cellular subscribers (per 100 population) | WHS9_CS |
| Central coordinating entity for alcohol policy implementation | SA_0000001691 |
| Central coordinating entity for alcohol policy implementation | SA_0000001691_ARCHIVED |
| Cheapest brand of cigarettes - currency reported | R_Curr_lowest_cost |
| Cheapest brand of cigarettes - price in PPP$ | R_Price_lowest_cost_ppp |
| Cheapest brand of cigarettes - price in US$ at official exchange rates | R_Price_lowest_cost_usd |
| Cheapest brand of cigarettes - price in currency reported | R_Price_lowest_cost_estimate |
| Cheapest breand of e-liquid contains nicotine or not | R_contains_nicotine |
| Chemical | IHR12 |
| Chemical Events | IHRSPAR_CAPACITY12 |
| Chemical events | IHRSPAR2_C14 |
| Child maltreatment: Extent of implementation of home-visiting programmes | VIOLENCE_EXTENTIMP_CHILDHOMEVISIT |
| Childhood cancer survival for lymphoid leukaemia, age-standardized 5-year net survival (%) | CANCERSURVIVAL_CHILDREN_LEUKAEMIA |
| Children aged 36-59 months who are developmentally on track in at least three of the following domains: literacy-numeracy, physical development, social-emotional development and learning (%) | SE_DEV_ONTRK |
| Children aged 6-59 months who received vitamin A supplementation (%) | WHS4_124 |
| Children aged 6-59 months who received vitamin A supplementation (%) | vita |
| Children aged < 5 years sleeping under insecticide-treated nets (%) | itnch |
| Children aged < 5 years with diarrhoea receiving oral rehydration salts (%) | ors |
| Children aged < 5 years with diarrhoea receiving oral rehydration therapy and continued feeding (%) | ort |
| Children aged < 5 years with pneumonia symptoms taken to a health facility (%) | carep |
| Children aged <5 years overweight (%) | WHOSIS_000009 |
| Children aged <5 years sleeping under insecticide-treated nets (%) | MDG_0000000013 |
| Children aged <5 years stunted (%) | MDG_0000000027 |
| Children aged <5 years underweight (%) | WHOSIS_000008 |
| Children aged <5 years wasted for age (%) | NUTRITION_564 |
| Children aged <5 years with ARI symptoms who took antibiotic treatment (%) | WHS4_108 |
| Children aged <5 years with diarrhoea receiving ORS (%) | UNICEF_ORS |
| Children aged <5 years with diarrhoea receiving ORT (%) | WHS4_107 |
| Children aged <5 years with fever who received treatment with any antimalarial (%) | MDG_0000000014 |
| Chimera voltron indicator to show summary table | NUTRITION_VOLTRON |
| Cholera - number of reported cases | WHS3_40 |
| Cholera case fatality rate | CHOLERA_0000000003 |
| Chronic hepatitis B (HBV) diagnosis coverage as a percentage of infected (%) | HEPATITIS_HBV_DIAGNOSIS_PERINFECTED_PER100 |
| Chronic hepatitis B (HBV) infected persons diagnosed (number) | HEPATITIS_HBV_DIAGNOSED_NUM |
| Chronic hepatitis B (HBV) treatment rate as percentage of diagnosed (%) | HEPATITIS_HBV_TREATMENT_PERDIAGNOSED_PER100 |
| Chronic hepatitis B (HBV) treatment rate as percentage of total infected (%) | HEPATITIS_HBV_TREATMENT_PERINFECTED_PER100 |
| Chronic hepatitis C (HCV) cumulative treatment rate as percentage of total infected, including cured (%) | HEPATITIS_HCV_TREATMENT_CUM_PERINFECTED_CRD_PER100 |
| Chronic hepatitis C (HCV) diagnosis coverage as percentage of total HCV infected, including cured (%) | HEPATITIS_HCV_DIAGNOSIS_PERINFECTED_CRD_PER100 |
| Chronic hepatitis C (HCV) infected persons diagnosed (number) | HEPATITIS_HCV_DIAGNOSED_NUM |
| Chronic hepatitis C (HCV) infected persons diagnosed, including cured (number) | HEPATITIS_HCV_DIAGNOSED_CRD_NUM |
| Chronic hepatitis C (HCV) treatment rate as percentage of diagnosed (%) | HEPATITIS_HCV_TREATMENT_PERDIAGNOSED_PER100 |
| Cigarette packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas | W23_emissions_front_back_A |
| Cigarette packaging and labelling must display qualitative information on relevant constituents and emissions | W22_emissions_qual_A |
| Cigarette packaging and labelling must not display expiry dates | W24_exp_date_A |
| Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | W21_emissions_A |
| Cigarette packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | W21_emissions_quant_A |
| Cigarette packaging and labelling must not use descriptors depicting flavours | W20_flavours_A |
| Cigarette packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors | W19_colours_numbers_A |
| Citizen complaints and investigations | TOBACCO_0000000213 |
| Civil registration coverage of births (%) | WHS9_91 |
| Civil registration coverage of cause-of-death (%) | WHS10_8 |
| Civil registration coverage of causes of deaths (%) | WHS9_94 |
| Climate change attributable DALYs per 100'000 children under 5 years | CC_8 |
| Climate change attributable deaths per 100'000 children under 5 years | CC_6 |
| Climate change and health vulnerability and adaptation assessment conducted | CCH_SURVEY_VULNERABILITY_ADAPTATION_ASSESSMENT |
| Climate change attributable DALYs ('000) | CC_2 |
| Climate change attributable DALYs ('000) in children under 5 years | CC_7 |
| Climate change attributable DALYs per 100'000 capita | CC_4 |
| Climate change attributable deaths | CC_1 |
| Climate change attributable deaths ('000) in children under 5 years | CC_5 |
| Climate change attributable deaths per 100'000 capita | CC_3 |
| Clinical guidelines for brief interventions | SA_0000001772 |
| Clinical guidelines for brief interventions | SA_0000001772_ARCHIVED |
| Clinical supervision of health care staff | RSUD_81 |
| Collaboration with Intergovernmental Organizations | WCO_INTERGOVERNMENTALORGANIZATIONS |
| Collaboration with Intergovernmental Organizations by groups (%) | WCO_INTERGOVERNMENTALORGANIZATIONS_GROUPED_PER100 |
| Collaboration with United Nations System | WCO_UNCOLLABORATION |
| Collaboration with United Nations System (%) | WCO_UNCOLLABORATION_GROUPED_PER100 |
| Collaboration with government sectors | WCO_GOVERNMENTCOLLABORATION |
| Collaboration with government sectors by groups (%) | WCO_GOVERNMENTCOLLABORATION_GROUPED_PER100 |
| Commencement of treatment with opioid agonists | RSUD_67 |
| Commitments to recipient countries (Million, constant 2009 US$) | ODA_2 |
| Community Health Workers (number) | HWF_0024 |
| Community and traditional health workers density (per 1000 population) | HRH_29 |
| Community health workers density (per 10 000 population) | WHS6_150 |
| Community residential facilities (per 100,000) | MH_14 |
| Community-based interventions involving stakeholders | SA_0000001723 |
| Community-based interventions involving stakeholders | SA_0000001723_ARCHIVED |
| Community-based interventions/projects involving stakeholders | SA_0000001712 |
| Competing educational priorities | GOE_Q140 |
| Competing health system priorities | GOE_Q162 |
| Complete ban on sponsorship | E15a_sponsorship |
| Complete ban on tobacco vending machines | E21_vending_machines |
| Completeness of cause-of-death data (%) | SDGCODCOMPLETENESS |
| Compliance of ban on advertising at point of sale | E6_compliance |
| Compliance of ban on advertising on billboards and outdoor advertising | E5_compliance |
| Compliance of ban on advertising on local magazines and newspapers | E3_compliance |
| Compliance of ban on advertising on national TV and radio | E1_compliance |
| Compliance of ban on appearance of tobacco brands in TV and/or films (product placement) | E13_compliance |
| Compliance of ban on appearance of tobacco products in TV and/or films | E14_compliance |
| Compliance of ban on brand name of non-tobacco products used for tobacco product | E12_compliance |
| Compliance of ban on free distribution of tobacco products in the mail or through other means | E9_compliance |
| Compliance of ban on non-tobacco goods AND services identified with tobacco brand names | E11_compliance |
| Compliance of ban on promotional discounts | E10_compliance |
| Compliance of ban on smoking in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES | P2_compliance |
| Compliance of ban on smoking in GOVERNMENT FACILITIES | P4_compliance |
| Compliance of ban on smoking in HEALTH-CARE FACILITIES | P1_compliance |
| Compliance of ban on smoking in INDOOR OFFICES | P5_compliance |
| Compliance of ban on smoking in PUBLIC TRANSPORT | P8_compliance |
| Compliance of ban on smoking in PUBS AND BARS | P7_compliance |
| Compliance of ban on smoking in RESTAURANTS | P6_compliance |
| Compliance of ban on smoking in UNIVERSITIES | P3_compliance |
| Compliance of ban on sponsored events | E15_compliance |
| Compliance with ban on advertising at point of sale (score) | E_compl_e6 |
| Compliance with ban on advertising in local magazines and newspapers (score) | E_compl_e3 |
| Compliance with ban on advertising on national television and radio (score) | E_compl_e1 |
| Compliance with ban on appearance of tobacco brands in TV and/or films (score) | E_compl_e13 |
| Compliance with ban on appearance of tobacco products in TV and/or films (score) | E_compl_e14 |
| Compliance with ban on billboard and outdoor advertising (score) | E_compl_e5 |
| Compliance with ban on free distribution in mail or through other means (score) | E_compl_e9 |
| Compliance with ban on indentifying non-tobacco products with tobacco brand names (score) | E_compl_e12 |
| Compliance with ban on promotional discounts (score) | E_compl_e10 |
| Compliance with ban on sponsorship (contributions and/or publicity of contributions) (score) | E_compl_e15 |
| Compliance with ban on use of brand name of non-tobacco product for tobacco product (score) | E_compl_e11 |
| Compliance with bans on direct advertising | EC_direct_compliance |
| Compliance with bans on promotion and sponsorship | EC_indirect_compliance |
| Compliance with international health regulations | UHC_IHR |
| Compliance with regulations on smoke-free environments (national legislation) | PC_sfe_compliance |
| Compliance with smoke-free education facilities except universities law (score) | P_compl_p2 |
| Compliance with smoke-free government facilities law (score) | P_compl_p4 |
| Compliance with smoke-free health-care facilities law (score) | P_compl_p1 |
| Compliance with smoke-free indoor offices law (score) | P_compl_p5 |
| Compliance with smoke-free public transport law (score) | P_compl_p8 |
| Compliance with smoke-free pubs and bars law (score) | P_compl_p7 |
| Compliance with smoke-free restaurants law (score) | P_compl_p6 |
| Compliance with smoke-free universities law (score) | P_compl_p3 |
| Composite coverage index (%) | cci |
| Composite coverage index (%) | cci2030 |
| Comprehensive and regular reporting of alcohol situation | SA_0000001771 |
| Comprehensive and regular reporting of alcohol situation | SA_0000001771_ARCHIVED |
| Comprehensive bans in place subnationally | P16_subnat_complete_bans_exist |
| Compulsory treatment for people with alcohol use disorders in the criminal justice system | RSUD_230 |
| Compulsory treatment for people with drug use disorders in the criminal justice system | RSUD_240 |
| Concentrations of fine particulate matter (PM2.5) | SDGPM25 |
| Condom use at last high-risk sex (percent) | HIV_CONDOMUSE_PERCENT |
| Confidentiality of health records on substance use disorders protected by law | RSUD_20 |
| Confidentiality of people in treatment for substance use disorders | RSUD_200 |
| Confirmed cases of MDR-TB | TB_mdr |
| Confirmed cases of MDR-TB started treatment for MDR-TB (%) | TB_conf_mdr_tx_pct |
| Confirmed cases of RR-/MDR-TB | TB_rr_mdr |
| Congenital Rubella Syndrome - number of reported cases | WHS3_55 |
| Congenital syphilis number of cases, reported | CaseCS |
| Congenital syphilis rate per 100 000 live births, reported | RateCS |
| Consumer information about calories, additives, etc on containers | SA_0000001733 |
| Consumer information about calories, additives, etc on containers | SA_0000001733_ARCHIVED |
| Consumer information on alcohol and health at points of sale | SA_0000001700 |
| Contact coverage of treatment services for substance use disorders (%) | SUD_TREATMENTSERVICES_COVERAGE |
| Continued breastfeeding 12-23 months | NUT_BF_CBF |
| Continuing professional development in prevention | RSUD_780 |
| Continuing professional development in treatment | RSUD_810 |
| Contraceptive prevalence (%) | MDG_0000000005 |
| Contraceptive prevalence - modern and traditional methods (%) | cpmt |
| Contraceptive prevalence - modern methods (%) | cpmo |
| Contraceptive prevalence, among girls aged 15-19 (%) | MDG_0000000005_AGE1519 |
| Coordination | IHR02 |
| Cost-effectiveness | GOE_Q061 |
| Counselling | SA_0000001655 |
| Counselling to children in families with alcohol problems | SA_0000001715 |
| Counselling to pregnant women with alcohol problems | SA_0000001716 |
| Countries that have a comprehensive national health sector policy/ strategy/ plan with goals and targets updated within the last 5 years | HSS_COMPREHENSIVEHEALTHPOLICY |
| Countries that have monitored the progress of their national health policy/strategy/plan regularly | HSS_MONITORPROGRESS |
| Countries that have passed legislation on Universal Health Coverage (UHC) | HSS_UHCLEGISLATION |
| Countries that improved health information systems, measured by the SCORE Index | SCORE_INDEX_IMPROVED_HIS |
| Country Cooperation Strategy Priorities | WCO_CSSPRIORITIES |
| Country Cooperation Strategy Priorities by groups (%) | WCO_CSSPRIORITIES_GROUP_PER100 |
| Country has national policy or strategy regulating the use of big data in the health sector | GOE_Q196 |
| Country has national EHR | GOE_Q144 |
| Country has national policy or strategy on the use of social media by government organizations | GOE_Q181 |
| Country has national policy or strategy regulating the use of big data by private companies | GOE_Q197 |
| Country has specific legislation governing the use of national EHR system | GOE_Q146 |
| Country has telehealth policy or strategy | GOE_Q069 |
| Country uses societal dialogue as a mechanism for prioritizing and co-shaping the health agenda | SOCIETAL_DIALOGUE_HEALTH_AGENDA |
| Coverage of essential health services | ESSENTIAL_HEALTH_SERVICES_COVERAGE |
| Coverage of national cervical cancer screening program (%) | NCD_CCS_cervicalcancerpgmcvg |
| Coverage of opioid agonist maintenance therapy (percent) | HIV_OAMT_COVERAGE_PERCENT |
| Coverage of people in need of assistive technology by legislation | ASSISTIVETECH_Q02 |
| Crude suicide rates (per 100 000 population) | SDGSUICIDE |
| Current cigarette smoking, crude adjusted | M_Est_cig_curr_crude |
| Current health expenditure (CHE) as percentage of gross domestic product (GDP) (%) | GHED_CHEGDP_SHA2011 |
| Current health expenditure (CHE) per capita in PPP int$ | GHED_CHE_pc_PPP_SHA2011 |
| Current health expenditure (CHE) per capita in US$ | GHED_CHE_pc_US_SHA2011 |
| Current smokers of cigarettes (youth rate) | TOBACCO_0000000345 |
| Cytisine - cost covered | O_Cytisine_ins |
| Cytisine - legally sold | O_Cytisine_sold |
| Cytisine - place available | O_Cytisine_where |
| DALYs attributable to ambient air pollution (age-standardized) | AIR_44 |
| DALYs attributable to the environment in children under 5 years (%) | TOTENV_12 |
| DTP3 immunization coverage among one-year-olds (%) | dptv |
| Daily cigarette smoking, crude adjusted | M_Est_cig_daily_crude |
| Daily tobacco smoking, crude adjusted | M_Est_tob_daily_crude |
| Daily users of any smokeless tobacco product (crude rate) | TOBACCO_0000000342 |
| Data availability for UHC index of essential service coverage (ranking) | UHC_DATA_AVAIL_CODE |
| Data collected on harm from alcohol at workplace | SA_0000001777 |
| Data collected on harm from alcohol at workplace | SA_0000001777_ARCHIVED |
| Data collection on Foetal Alcohol Syndome | SA_0000001776 |
| Data collection on Foetal Alcohol Syndome | SA_0000001776_ARCHIVED |
| Data collection on alcohol-related health indicators | SA_0000001704 |
| Data in national radon database | RADON_Q304 |
| Data on substance use disorders disseminated in national annual reports | RSUD_11 |
| Data sources used to routinely monitor people with dementia (Administrative data) | GDO_q16x1x1_3 |
| Data sources used to routinely monitor people with dementia (Clinical records) | GDO_q16x1x1_1 |
| Data sources used to routinely monitor people with dementia (Facility survey or records) | GDO_q16x1x1_4 |
| Data sources used to routinely monitor people with dementia (Household surveys) | GDO_q16x1x1_2 |
| Data sources used to routinely monitor people with dementia (Other) | GDO_q16x1x1_other |
| Data used to routinely monitor people with dementia can be disaggregated | GDO_q16x1x2_2 |
| Deaths attributable to the environment | TOTENV_1 |
| Deaths attributable to the environment (%) | TOTENV_5 |
| Deaths attributable to the environment in children under 5 years (%) | TOTENV_11 |
| Deaths caused by chronic hepatitis B (HBV) infection (number) | HEPATITIS_HBV_DEATHS_NUM |
| Deaths caused by chronic hepatitis C (HCV) infection (number) | HEPATITIS_HCV_DEATHS_NUM |
| Deaths caused by hazards, aged 5 years and above | HAZARD_DTH_GE5 |
| Deaths caused by hazards, aged less than 5 years | HAZARD_DTH_LT5 |
| Deaths caused by hazards, all ages | HAZARD_DTH_TOTAL |
| Deaths due to HIV/AIDS (per 100 000 population) | WHS2_138 |
| Deaths due to malaria (per 100 000 population) | MDG_0000000016 |
| Deaths due to malaria (per 100 000 population) | WHS2_152 |
| Deaths due to tuberculosis among HIV-negative people (per 100 000 population) | MDG_0000000017 |
| Deaths due to tuberculosis among HIV-positive people (per 100 000 population) | MDG_0000000018 |
| Deaths per 1 000 live births | MORT_200 |
| Deaths per 100 000 population | MORT_400 |
| Decayed, missing, or filled teeth | OA_DMFT |
| Dedicated funds for enforcement | TOBACCO_0000000212 |
| Definition of drink-driving by BAC | RS_205 |
| Demand | GOE_Q062 |
| Demand for family planning satisfied - modern and traditional methods (%) | fps |
| Demand for family planning satisfied - modern methods (%) | fpsmo |
| Dementia care facilities [hospitals] | GDO_q9_1 |
| Dementia integrated into other national plan | GDO_q2x2 |
| Dementia integrated into other national research plan/programme | GDO_q17x2 |
| Dementia nongovernmental organization equipped with office | GDO_q11x2x1 |
| Dementia nongovernmental organization office branches (Local) | GDO_q11x2x2_2 |
| Dementia nongovernmental organization office branches (National only) | GDO_q11x2x2_3 |
| Dementia nongovernmental organization office branches (Sub-national) | GDO_q11x2x2_1 |
| Dementia nongovernmental organization staff primarily salaried/volunteer | GDO_q11x2x3 |
| Dementia nongovernmental organization's involvement in policy development | GDO_q11x2x6 |
| Dementia-specific adult day centre places (per 10,000 population) | GDO_q9x4_3 |
| Dementia-specific hospice care beds (per 10,000 population) | GDO_q9x3_3 |
| Dementia-specific hospital beds (per 10,000 population) | GDO_q9x1_3 |
| Dementia-specific residential long-term care beds (per 10,000 population) | GDO_q9x2_3 |
| Density of adult day centres (per 100,000 population) | GDO_q9x4_1 |
| Density of environment and public health workers (per 10 000 population) | WHS6_520 |
| Density of hospice centres (per 100,000 population) | GDO_q9x3_1 |
| Density of outpatient health centres (per 100,000 population) | GDO_q9x5_1 |
| Density of outpatient social centres (per 100,000 population) | GDO_q9x6_1 |
| Density of pharmaceutical personnel (per 10 000 population) | WHS6_519 |
| Density of residential long-term care facilities (per 100,000 population) | GDO_q9x2_1 |
| Dental Assistants and Therapists (number) | HWF_0012 |
| Dental Prosthetic Technicians (number) | HWF_0013 |
| Dental prosthetic technicians (per 10 000 population) | ORALHEALTH_HWF_DENTALPROSTHETICTECH_10K |
| Dentistry personnel density (per 10 000 population) | WHS6_144 |
| Dentistry personnel density (per 1000 population) | HRH_28 |
| Dentists (number) | HWF_0011 |
| Dentists (per 10,000) | HWF_0010 |
| Dentists in prisons (FTEs per 1000 prisoners) | PRISON_B9_1_DENTISTS_RATIO |
| Designation of a focal point responsible for health and climate change within the Ministry of Health | CCH_SURVEY_MOH_FOCALPOINT |
| Designation of alcohol tax revenues to health services | SA_0000001708 |
| Detection of marketing infringements | SA_0000001728 |
| Detection of marketing infringements | SA_0000001728_ARCHIVED |
| Diabetes treatment coverage, age-standardized | NCD_DIABETES_TREATMENT_AGESTD |
| Diabetes treatment coverage, crude | NCD_DIABETES_TREATMENT_CRUDE |
| Diphtheria - number of reported cases | WHS3_41 |
| Diphtheria tetanus toxoid and pertussis first-dose (DTP1) immunization coverage among 1-year-olds (%) (WUENIC) | VACCINECOVERAGE_DTP1 |
| Diphtheria tetanus toxoid and pertussis third-dose (DTP3) immunization coverage among 1-year-olds (%) (WUENIC) | WHS4_100 |
| Disability-adjusted life years (DALYs) | GHE_DALYNUM |
| Disability-adjusted life years (DALYs) (per 100 000 population) | GHE_DALYRATE |
| Disability-adjusted life years (DALYs) (per 100 000 population) due to leptospirosis | LEPTO_DALY100K |
| Disability-adjusted life years (DALYs) attributable to the environment | TOTENV_3 |
| Disability-adjusted life years (DALYs) attributable to the environment (%) | TOTENV_6 |
| Disability-adjusted life years (DALYs) due to leptospirosis | LEPTO_DALY |
| Disability-adjusted life years caused by hazards, aged 5 years and above | HAZARD_DALY_GE5 |
| Disability-adjusted life years caused by hazards, aged less than 5 years | HAZARD_DALY_LT5 |
| Disability-adjusted life years caused by hazards, all ages | HAZARD_DALY_TOTAL |
| Disbursements to recipient countries (Million, constant 2009 US$) | ODA_4 |
| Distribution of causes of death among children aged < 5 years (%) | MORT_300 |
| Distribution of causes of death among children aged <5 years (%) - Birth asphyxia | WHS2_523 |
| Distribution of causes of death among children aged <5 years (%) - Congenital anomalies | WHS2_516 |
| Distribution of causes of death among children aged <5 years (%) - Diarrhoea | WHS2_167 |
| Distribution of causes of death among children aged <5 years (%) - HIV/AIDS | WHS2_170 |
| Distribution of causes of death among children aged <5 years (%) - Injuries | WHS2_166 |
| Distribution of causes of death among children aged <5 years (%) - Malaria | WHS2_164 |
| Distribution of causes of death among children aged <5 years (%) - Measles | WHS2_168 |
| Distribution of causes of death among children aged <5 years (%) - Neonatal sepsis | WHS2_515 |
| Distribution of causes of death among children aged <5 years (%) - Other diseases | WHS2_171 |
| Distribution of causes of death among children aged <5 years (%) - Pneumonia | WHS2_165 |
| Distribution of causes of death among children aged <5 years (%) - Prematurity | WHS2_514 |
| Distribution of road traffic deaths by type of road user (%) | RS_246 |
| Distribution of years of life lost by broader causes (%) - Injuries | WHS2_174 |
| Distribution of years of life lost by major cause group | WHS2_126 |
| Do health warnings appear on each cigarette package and any outside packaging and labelling used in the retail sale? | W11_outside_pack_A |
| Do health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale? | W11_outside_pack_B |
| Do health warnings appear on each smokeless tobacco package and any outside packaging and labelling used in the retail sale? | W11_outside_pack_C |
| Do health warnings on cigarette packaging describe the harmful effects of tobacco use on health? | W14_harm_effects_A |
| Do health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health? | W14_harm_effects_B |
| Do health warnings on smokeless tobacco packaging describe the harmful effects of tobacco use on health? | W14_harm_effects_C |
| Do the health warnings on cigarette packaging include a photograph or graphic? | W10_graphic_A |
| Do the health warnings on other smoked tobacco packaging include a photograph or graphic? | W10_graphic_B |
| Do the health warnings on smokeless tobacco packaging include a photograph or graphic? | W10_graphic_C |
| Does the government provide non-national (including refugees and migrants) equal access to (i) essential and/or (ii) emergency health care | NONNATIONAL_HEALTHCARE_ACCESS |
| Does the law mandate font style, font size and colour of health warnings on cigarette packaging? | W6_font_A |
| Does the law mandate font style, font size and colour of health warnings on other smoked tobacco packaging? | W6_font_B |
| Does the law mandate font style, font size and colour of health warnings on smokeless tobacco packaging? | W6_font_C |
| Does the law mandate specific health warnings on cigarette packaging? | W15_specific_hw_A |
| Does the law mandate specific health warnings on other smoked tobacco packaging? | W15_specific_hw_B |
| Does the law mandate specific health warnings on smokeless tobacco packaging? | W15_specific_hw_C |
| Domestic Expenditure on Malaria | MALARIA_NMCP_CALCULATIONS |
| Domestic general government expenditure on PHC as % of primary health care expenditure (PHCE) (%) | GHED_PHC_GGHE-D_PHC_SHA2011 |
| Domestic general government health expenditure (GGHE-D) as percentage of current health expenditure (CHE) (%) | GHED_GGHE-DCHE_SHA2011 |
| Domestic general government health expenditure (GGHE-D) as percentage of general government expenditure (GGE) (%) | GHED_GGHE-DGGE_SHA2011 |
| Domestic general government health expenditure (GGHE-D) as percentage of gross domestic product (GDP) (%) | GHED_GGHE-DGDP_SHA2011 |
| Domestic general government health expenditure (GGHE-D) per capita in PPP int$ | GHED_GGHE-D_pc_PPP_SHA2011 |
| Domestic general government health expenditure (GGHE-D) per capita in US$ | GHED_GGHE-D_pc_US_SHA2011 |
| Domestic private health expenditure (PVT-D) as percentage of current health expenditure (CHE) (%) | GHED_PVT-DCHE_SHA2011 |
| Domestic private health expenditure (PVT-D) per capita in PPP int$ | GHED_PVT-D_pc_PPP_SHA2011 |
| Domestic private health expenditure (PVT-D) per capita in US$ | GHED_PVT-D_pc_US_SHA2011 |
| Donor commitments (Million, constant 2009 US$) | ODA_1 |
| Donor disbursements (Million, constant 2009 US$) | ODA_3 |
| Donor/ non-public development funding for eHealth | GOE_Q009 |
| Dracunculiasis cases | NTD_DRACASES |
| Dracunculiasis certification status of countries at the beginning of the year | NTD_2 |
| Drug courts | RSUD_18 |
| Duty paid or excise stamp on alcohol container | SA_0000001549 |
| Duty paid or excise stamp on alcohol container | SA_0000001549_ARCHIVED |
| Early Initiation of Breastfeeding, Children born in the last 24 months | NUT_BF_EIBF |
| Early initiation of breastfeeding (%) | NUTRITION_570 |
| Early initiation of breastfeeding (in the five years preceding the survey) (%) | ebreast5 |
| Early initiation of breastfeeding (in the two or three years preceding the survey) (%) | ebreast |
| Earned media/public relations were used to promote the campaign | Camp_news |
| Educational attainment in prevention | RSUD_760 |
| Educational attainment in treatment | RSUD_790 |
| Educational programmes involving target groups in school curriculum | SA_0000001701 |
| Effective cataract surgical coverage of adults aged 50 and over (%) | CATARACTSURGICALEFFECTIVE |
| Effective standards and best practices for data capture not fully established | GOE_Q198 |
| Effectiveness | GOE_Q060 |
| Egg and/or Flesh Food Consumption 6-23 months | NUT_CF_EFF |
| Elder abuse: Extent of implementation of caregiver-support programmes | VIOLENCE_EXTENTIMP_ELDERCAREGIVER |
| Electric field (V/m) | EMFLIMITELECTRICRF |
| Electric field (kV/m) | EMFLIMITELECTRIC |
| Electric field (kV/m) | EMFLIMITELECTRICLF |
| Electric field limit at 1800 MHz (V/m) | EMFLIMITELECTRIC1800 |
| Electric field limit at 900 MHz (V/m) | EMFLIMITELECTRIC900 |
| Electronic availability of data sources used to routinely monitor people with dementia | GDO_q16x1x2_1 |
| Eligible women attending antenatal care who were treated for HBV | HEPATITIS_HBV_TREATMENT_ANC_PERCENT |
| Employed population below the international poverty line of US$1.90 per day (the working poor) (%) | SI_POV_EMP1 |
| Employment services for alcohol use disorders | RSUD_700 |
| Employment services for drug use disorders | RSUD_710 |
| Enabling access to education where learning facilities are limited | GOE_Q104_3 |
| Enabling access to education where learning facilities are limited | GOE_Q119_3 |
| Enforcing bans on tobacco advertising, promotion and sponsorship | E_Group |
| Environmental and Occupational Health Inspectors and Associates (number) | HWF_0018 |
| Environmental and Occupational Health and Hygiene Professionals (number) | HWF_0017 |
| Environmental and public health workers density (per 1000 population) | HRH_31 |
| Epidemiological data collection for substance use | RSUD_820 |
| Epidemiological data collection system for substance use among children and adolescents | RSUD_870 |
| Epidemiological data collection system for substance use among children and adolescents | RSUD_880 |
| Epidemiological data collection system for substance use disorders | RSUD_8 |
| Essential list of medicines | RSUD_71 |
| Essential list of medicines, pharmacotherapy for substance use disorders | RSUD_72 |
| Estimate of current cigarette smoking prevalence (%) | M_Est_cig_curr |
| Estimate of current cigarette smoking prevalence (%) (age-standardized) | M_Est_cig_curr_std |
| Estimate of current tobacco smoking prevalence (%) | M_Est_smk_curr |
| Estimate of current tobacco smoking prevalence (%) (age-standardized) | M_Est_smk_curr_std |
| Estimate of current tobacco use prevalence (%) | M_Est_tob_curr |
| Estimate of current tobacco use prevalence (%) (age-standardized) | M_Est_tob_curr_std |
| Estimate of daily cigarette smoking prevalence (%) | M_Est_cig_daily |
| Estimate of daily cigarette smoking prevalence (%) (age-standardized) | M_Est_cig_daily_std |
| Estimate of daily tobacco smoking prevalence (%) | M_Est_smk_daily |
| Estimate of daily tobacco smoking prevalence (%) (age-standardized) | M_Est_smk_daily_std |
| Estimate of daily tobacco use prevalence (%) | M_Est_tob_daily |
| Estimate of daily tobacco use prevalence (%) (age-standardized) | M_Est_tob_daily_std |
| Estimated MDR-TB cases among notified pulmonary TB cases | TB_e_mdr_num |
| Estimated antiretroviral therapy coverage among children | HIV_0000000024 |
| Estimated antiretroviral therapy coverage among people living with HIV (%) | HIV_ARTCOVERAGE |
| Estimated direct deaths from major conflicts (per 100 000 population) | SDGCONFLICT |
| Estimated leptospirosis deaths (per 100 000 population) | LEPTO_MORTALITY |
| Estimated leptospirosis incidence (per 100 000 population) | LEPTO_MORBIDITY |
| Estimated malaria incidence (per 1000 population at risk) | MALARIA_EST_INCIDENCE |
| Estimated malaria mortality rate (per 100 000 population) | MALARIA_EST_MORTALITY |
| Estimated number of RR-TB incident cases | TB_e_inc_rr_num |
| Estimated number of children needing antiretroviral therapy based on WHO methods | HIV_0000000023 |
| Estimated number of dementia carers receiving financial benefits/social protection | GDO_q12x2x5x3 |
| Estimated number of dementia carers receiving information on legal rights | GDO_q12x2x4x3 |
| Estimated number of dementia carers receiving psycho-social supports | GDO_q12x2x2x3 |
| Estimated number of dementia carers receiving respite care | GDO_q12x2x3x3 |
| Estimated number of dementia carers receiving training and education | GDO_q12x2x1x3 |
| Estimated number of malaria cases | MALARIA002 |
| Estimated number of malaria cases | MALARIA_EST_CASES |
| Estimated number of malaria deaths | MALARIA003 |
| Estimated number of malaria deaths | MALARIA_EST_DEATHS |
| Estimated number of people (all ages) living with HIV | HIV_0000000001 |
| Estimated number of people eligible for antiretroviral therapy according to 2010 guidelines | HIV_0000000022 |
| Estimated number of people receiving activities of daily living support services in community for dementia | GDO_q8x5_4 |
| Estimated number of people receiving behaviour and psychological management services in community for dementia | GDO_q8x5_2 |
| Estimated number of people receiving palliative and end-of-life care services in community for dementia | GDO_q8x5_5 |
| Estimated number of people receiving psychosocial and rehabilitation services in community for dementia | GDO_q8x5_3 |
| Estimated number of people with dementia living in residential long-term care | GDO_q9x2_4 |
| Estimated number of people with dementia receiving services at outpatient health centre | GDO_q9x5_2 |
| Estimated number of people with dementia receiving services at outpatient social centre | GDO_q9x6_2 |
| Estimated number of people with dementia receiving social and financial protection for dementia | GDO_q8x5_6 |
| Estimated number of pregnant women living with HIV | HIV_0000000020 |
| Estimated number of pregnant women living with HIV needing antiretrovirals for preventing mother-to-child transmission | HIV_0000000021 |
| Estimated number of road traffic deaths | RS_196 |
| Estimated percentage of hospitals following national dementia standards | GDO_q9x1_7 |
| Estimated percentage of residential long-term care facilities following national dementia standards | GDO_q9x2_5 |
| Estimated population-based prevalence of depression | GDO_q35 |
| Estimated road traffic death rate (per 100 000 population) | RS_198 |
| Estimates of number of homicides | VIOLENCE_HOMICIDENUM |
| Estimates of rates of homicides per 100 000 population | VIOLENCE_HOMICIDERATE |
| Ethanol tax deducted from excise tax | SA_0000001815 |
| Evaluation of any government-sponsored telehealth programmes | GOE_Q081 |
| Ever breastfed | NUT_BF_EVBF |
| Excise duty (average) per hectolitre in Euros | SA_0000001547 |
| Excise duty (average) per hectolitre in Euros | SA_0000001547_ARCHIVED |
| Excise tax as a per cent of the retail price of alcoholic beverages | SA_0000001546 |
| Excise tax as a per cent of the retail price of alcoholic beverages | SA_0000001546_ARCHIVED |
| Excise tax as a per cent of the total retail price for 1 litre of pure alcohol | SA_0000001548 |
| Excise tax as a per cent of the total retail price for 1 litre of pure alcohol | SA_0000001548_ARCHIVED |
| Excise tax on alcoholic beverages | SA_0000001550 |
| Excise tax on alcoholic beverages | SA_0000001550_ARCHIVED |
| Excise taxes are applied on beverages | TAXBEV_EXCISE_APPLIED_YN |
| Excise taxes on beverages (%) | TAXBEV_EXCISE |
| Exclusive breastfeeding under 6 months (%) | NUTRITION_579 |
| Exclusive breastfeeding under six months | NUT_BF_EBF |
| Exclusive breastfeeding under six months (in thousands) | NUT_BF_EBF_NUMTH |
| Exclusively breastfed for the first two days after birth | NUT_BF_EBF2D |
| Existence of a current dementia research plan/programme | GDO_q17x1 |
| Existence of a diabetes registry | NCD_CCS_DiabetesReg |
| Existence of a formal pre-hospital care system | RS_237 |
| Existence of a health surveillance system which includes meteorological information | CCH_SURVEY_SURVEILLANCE_WHICH_METEOROLOGICAL |
| Existence of a multi-stakeholder mechanism on health and climate change | CCH_SURVEY_MULTISTAKEHOLDER_MECHANISM_EXISTS |
| Existence of a national child-restraint law | RS_213 |
| Existence of a national drink-driving law | RS_204 |
| Existence of a national multisectoral commission, agency or mechanism for NCDs | NCD_CCS_MultisecComm |
| Existence of a national road safety strategy | RS_228 |
| Existence of a national seat-belt law | RS_209 |
| Existence of a national target on NCD mortality | NCD_CCS_MORT_TARGET |
| Existence of a national target on alcohol | NCD_CCS_ALC_TARGET |
| Existence of a national target on blood pressure / hypertension | NCD_CCS_BP_TARGET |
| Existence of a national target on diabetes | NCD_CCS_DIAB_TARGET |
| Existence of a national target on drug therapy and counselling | NCD_CCS_DRUG_THERAPY_TARGET |
| Existence of a national target on essential medicines and technologies | NCD_CCS_ESS_MEDS_TECH_TARGET |
| Existence of a national target on obesity | NCD_CCS_OBES_TARGET |
| Existence of a national target on physical inactivity | NCD_CCS_PA_TARGET |
| Existence of a national target on salt | NCD_CCS_SALT_TARGET |
| Existence of a national target on tobacco | NCD_CCS_TOB_TARGET |
| Existence of a register of patients who had rheumatic fever and rheumatic heart disease | NCD_CCS_rheumreg |
| Existence of a road safety lead agency | RS_225 |
| Existence of a set of national NCD indicators and has set time-bound national targets for these indicators | NCD_CCS_NCDIndicators |
| Existence of a set of time-bound national targets based on WHO guidance | NCD_CCS_targets |
| Existence of a universal access telephone number for pre-hospital care | RS_238 |
| Existence of an NCD surveillance and monitoring system in place to enable reporting against the nine global NCD targets | NCD_CCS_SurvMonRep9NCD |
| Existence of an Operational Unit, Branch, or Dept. in Ministry of Health with responsibility for NCDs | NCD_CCS_NCDUnit_Operational |
| Existence of an health surveillance system | CCH_SURVEY_SURVEILLANCE_SYSTEM_EXISTS |
| Existence of an operational, multisectoral national NCD policy, strategy or action plan that integrates several NCDs and their risk factors | NCD_CCS_integNCDplan |
| Existence of any national radon activity | RADON_Q201 |
| Existence of any policies on marketing of foods to children | NCD_CCS_Mkting |
| Existence of any policies to reduce population salt consumption | NCD_CCS_SaltPol |
| Existence of any subnational radon activity | RADON_Q202 |
| Existence of approved government dementia standards/ guidelines/ protocols | GDO_q4x1x2 |
| Existence of at least one functioning dementia awareness campaign | GDO_q13x1 |
| Existence of at least one functioning risk reduction campaign | GDO_q13x3 |
| Existence of community-based health or social care services for dementia | GDO_q8x1 |
| Existence of dedicated resources for dementia carer support services | GDO_q12x1x2 |
| Existence of dementia carer support services | GDO_q12x1 |
| Existence of dementia legislation | GDO_q3x1 |
| Existence of dementia national nongovernmental organization | GDO_q11x1 |
| Existence of dementia national plan | GDO_q2x1 |
| Existence of dementia representative in ministry | GDO_q1x2 |
| Existence of dementia standards/ guidelines/ protocols | GDO_q4x1 |
| Existence of dementia sub-national plan(s) | GDO_q2x3 |
| Existence of dementia training for community workers | GDO_q15x2_5 |
| Existence of dementia training for financial service staff | GDO_q15x2_7 |
| Existence of dementia training for first responders | GDO_q15x2_3 |
| Existence of dementia training for legal professionals | GDO_q15x2_4 |
| Existence of dementia training for police and fire services | GDO_q15x2_2 |
| Existence of dementia training for retail and hospitality staff | GDO_q15x2_8 |
| Existence of dementia training for school children | GDO_q15x2_6 |
| Existence of dementia training for volunteers | GDO_q15x2_1 |
| Existence of dementia-friendly initiative for assistance with home modification | GDO_q14x2_3 |
| Existence of dementia-friendly initiative supporting community places for older people | GDO_q14x2_5 |
| Existence of dementia-friendly initiative supporting social opportunities | GDO_q14x2_6 |
| Existence of dementia-friendly initiative to improve accessibility of public spaces | GDO_q14x2_1 |
| Existence of dementia-friendly initiative to improve accessibility of public transportation | GDO_q14x2_2 |
| Existence of dementia-friendly initiative with assistive technology for loss of capacity | GDO_q14x2_4 |
| Existence of evidence-based national guidelines/protocols/standards for the management of alcohol use disorders | NCD_CCS_ALC_MGMT_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of cancer | NCD_CCS_CANCER_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of cardiovascular diseases | NCD_CCS_CVD_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of chronic respiratory diseases | NCD_CCS_CRD_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of diabetes | NCD_CCS_DIAB_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of major NCDs through a primary care approach | NCD_CCS_NCDGuide |
| Existence of evidence-based national guidelines/protocols/standards for the management of overweight/obesity | NCD_CCS_OBES_MGMT_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of physical inactivity | NCD_CCS_PA_MGMT_GUIDE |
| Existence of evidence-based national guidelines/protocols/standards for the management of tobacco dependence | NCD_CCS_TOB_MGMT_GUIDE |
| Existence of financial benefits/social protection for dementia carers | GDO_q12x2_5 |
| Existence of financial mechanisms for assistive technology | ASSISTIVETECH_Q08 |
| Existence of implementation plan for dementia carer support services | GDO_q12x1x3 |
| Existence of information on legal rights for dementia carers | GDO_q12x2_4 |
| Existence of initiatives/collaborations on assistive technology | ASSISTIVETECH_Q10 |
| Existence of legislation for advanced care directives for people with dementia | GDO_q3x4_1 |
| Existence of legislation for supported decision making for people with dementia | GDO_q3x3a_1 |
| Existence of legislation on access to assistive technology | ASSISTIVETECH_Q01 |
| Existence of legislation to end coercieve practices for people with dementia | GDO_q3x3b_1 |
| Existence of legislation to end discrimination against carers of people with dementia | GDO_q3x4_3 |
| Existence of legislation to end discrimination against people with dementia | GDO_q3x4_2 |
| Existence of legislation to file appeals protecting the rights of people with dementia | GDO_q3x3a_2 |
| Existence of legislation to promote community-based services for people with dementia | GDO_q3x3a_3 |
| Existence of legislation to promote monitoring of human rights conditions of people with dementia in facilities where they reside | GDO_q3x3a_4 |
| Existence of national HPV vaccination programme | NCD_CCS_hpv |
| Existence of national guidelines for physical activity | NCD_CCS_PA_GUIDELINES |
| Existence of national guidelines for physical activity for adults | NCD_CCS_PA_GUIDELINES_ADULTS |
| Existence of national guidelines for physical activity for children and adolescents aged 5-19 | NCD_CCS_PA_GUIDELINES_5to19 |
| Existence of national guidelines for physical activity for children under 5 | NCD_CCS_PA_GUIDELINES_UNDER5 |
| Existence of national guidelines for physical activity for older adults | NCD_CCS_PA_GUIDELINES_OLDADULTS |
| Existence of national policies on saturated fatty acids / trans-fats | NCD_CCS_SatFat |
| Existence of national policies on saturated fatty acids / trans-fats | NCD_CCS_SatTransFat |
| Existence of national policies on trans-fatty acid elimination | NCD_CCS_TransFat |
| Existence of national policy instruments for occupational health and safety for health workers | OHS_POLICYSTATUS |
| Existence of national radon action plan | RADON_Q401 |
| Existence of national radon action plan - Years covered | RADON_Q401_1 |
| Existence of national radon database | RADON_Q303 |
| Existence of national radon map | RADON_Q305 |
| Existence of national radon regulations | RADON_Q402 |
| Existence of national radon risk communication strategy | RADON_Q801 |
| Existence of national radon survey(s) | RADON_Q301 |
| Existence of national reference level for buildings with high public occupancy | RADON_Q502 |
| Existence of national reference level for dwellings and buildings with high public occupancy | RADON_Q501 |
| Existence of national reference level for workplaces | RADON_Q503 |
| Existence of national regulation | SUNBEDEXIST |
| Existence of national screening program for breast cancer | NCD_CCS_breastcancerscreening |
| Existence of national screening program for cervical cancer | NCD_CCS_cervicalcancerscreening |
| Existence of national speed limits | RS_214 |
| Existence of official protocols for radon measurements | RADON_Q601 |
| Existence of operational policy/strategy/action plan for cancer | NCD_CCS_CancerPlan |
| Existence of operational policy/strategy/action plan for cardiovascular diseases | NCD_CCS_CVDPlan |
| Existence of operational policy/strategy/action plan for chronic respiratory diseases | NCD_CCS_CRDPlan |
| Existence of operational policy/strategy/action plan for diabetes | NCD_CCS_DiabPlan |
| Existence of operational policy/strategy/action plan for eye health | NCD_CCS_EyePlan |
| Existence of operational policy/strategy/action plan for hearing health | NCD_CCS_HearingPlan |
| Existence of operational policy/strategy/action plan for oral health | NCD_CCS_oralhealthplan |
| Existence of operational policy/strategy/action plan to decrease tobacco use | NCD_CCS_TobPlan |
| Existence of operational policy/strategy/action plan to reduce overweight/obesity | NCD_CCS_OvwtPlan |
| Existence of operational policy/strategy/action plan to reduce physical inactivity | NCD_CCS_PAPlan |
| Existence of operational policy/strategy/action plan to reduce the harmful use of alcohol | NCD_CCS_AlcPlan |
| Existence of operational policy/strategy/action plan to reduce unhealthy diet related to NCDs | NCD_CCS_DietPlan |
| Existence of other laws that apply to the rights of people with dementia | GDO_q3x2 |
| Existence of policy promoting physical activity: active ageing | NCD_CCS_PA_POL_AGEING |
| Existence of policy promoting physical activity: childcare settings | NCD_CCS_PA_POL_CHILDCARE |
| Existence of policy promoting physical activity: community-based and sports initiatives | NCD_CCS_PA_POL_COMM_BASED |
| Existence of policy promoting physical activity: public open spaces | NCD_CCS_PA_POL_PUBLIC |
| Existence of policy promoting physical activity: walking and cycling | NCD_CCS_PA_POL_WALKBIKE |
| Existence of policy promoting physical activity: workplace initiatives | NCD_CCS_PA_POL_WORK |
| Existence of population-based cancer registry | NCD_CCS_CancerRegNational |
| Existence of population-based cancer registry | NCD_CCS_PBCR |
| Existence of price subsidies for healthy foods | NCD_CCS_PRICE_SUBS |
| Existence of psycho-social supports for dementia carers | GDO_q12x2_2 |
| Existence of regulations/standards/guidelines/protocols on assistive technology | ASSISTIVETECH_Q09 |
| Existence of respite care for dementia carers | GDO_q12x2_3 |
| Existence of responsible ministry/authority on assistive technology | ASSISTIVETECH_Q04 |
| Existence of standards | EMFSTANDARD |
| Existence of standards/ guidelines/ protocols for advance care directives, power of attorney or guardianship for people with dementia | GDO_q4x3x4_1 |
| Existence of standards/ guidelines/ protocols for diagnosis of dementia | GDO_q4x2_2 |
| Existence of standards/ guidelines/ protocols for management of dementia | GDO_q4x2_3 |
| Existence of standards/ guidelines/ protocols for other post-diagnostic supports of people with dementia | GDO_q4x2_4 |
| Existence of standards/ guidelines/ protocols for palliative and end-of-life care for people with dementia | GDO_q4x3x4_2 |
| Existence of standards/ guidelines/ protocols for prevention and risk reduction of dementia | GDO_q4x2_1 |
| Existence of standards/ guidelines/ protocols for treatment and support of carers and families of people with dementia | GDO_q4x2_5 |
| Existence of standards/ guidelines/ protocols of care in hospital for people with dementia | GDO_q4x3x4_4 |
| Existence of standards/ guidelines/ protocols of care in nursing & residential care facilities for people with dementia | GDO_q4x3x4_3 |
| Existence of subnational regulation | SUNBEDEXISTSUBNATIONAL |
| Existence of tax incentives to promote physical activity | NCD_CCS_PA_TAX |
| Existence of tax on foods high in fat, sugars or salt | NCD_CCS_FOOD_TAX |
| Existence of tax on sugar-sweetened beverages | NCD_CCS_SSBTAX |
| Existence of training/education on prevention/mitigation | RADON_Q706 |
| Exports of beer (barley) in 1000s hectolitres | SA_0000001679 |
| Exports of spirits in 1000s hectolitres | SA_0000001687 |
| Exports of wine (grape) in 1000s hectolitres | SA_0000001686 |
| Exposure to smoke at home | TOBACCO_0000000346 |
| Exposure to smoke outside home | TOBACCO_0000000347 |
| Extent of implementation of mental health services for victims of all types of violence | VIOLENCE_EXTENTIMP_ALLTYPES |
| Extent of implementation of child protection services | VIOLENCE_EXTENTIMP_CHILDPROTECTION |
| Extent of implementation of medico-legal services for victims of sexual violence | VIOLENCE_EXTENTIMP_VICTIMSMEDICOLEGAL |
| Extent to which countries have laws and regulations that guarantee full and equal access to women and men aged 15 years and older to sexual and reproductive health care, information and education (%) | FULL_EQUAL_ACCESS_SRHC |
| External health expenditure (EXT) as percentage of current health expenditure (CHE) (%) | GHED_EXTCHE_SHA2011 |
| External health expenditure (EXT) per capita in PPP int$ | GHED_EXT_pc_PPP_SHA2011 |
| External health expenditure (EXT) per capita in US$ | GHED_EXT_pc_US_SHA2011 |
| External resources for health as a percentage of total expenditure on health | WHS7_120 |
| Financial hardship in health and components (SDG 3.8.2, 2025 definition): population (%) | FINANCIALHARDSHIP_PROPORTIONOFPOP |
| Financial hardship in health and components (SDG 3.8.2, 2025 definition): population (millions) | FINANCIALHARDSHIP_MILLIONOFPOP |
| Financial support provided for mitigation (existing dwellings) | RADON_Q703 |
| Financing | IHRSPAR2_C03 |
| Financing method for substance use disorder treatment | RSUD_23 |
| Financing methods for treatment for alcohol use disorders | RSUD_270 |
| Financing methods for treatment for drug use disorders | RSUD_280 |
| Financing of WHO country offices - MTR (in US$ million) | WCO_FUNDING_TYPE |
| Fines for violations | TOBACCO_0000000209 |
| Fines on the establishment | TOBACCO_0000000210 |
| Fines on the patron | TOBACCO_0000000211 |
| Five years change in international cooperation for prevention for substance use | RSUD_120 |
| Five years change in international cooperation for treatment of substance use disorders | RSUD_190 |
| Five-year change in government resources for prevention for substance use | RSUD_250 |
| Five-year change in government resources for treatment of substance use disorders | RSUD_260 |
| Font style, font size and colour of health warnings are mandated for other smoked tobacco packaging | TOBACCO_0000000394 |
| Food Safety (SPAR) | IHRSPAR_CAPACITY04 |
| Food safety | IHR11 |
| Food safety | IHRSPAR2_C13 |
| Food safety IHR (%) | FOODSAFETY_IHR_PERCENT |
| Food safety JEE (score) | FOODSAFETY_JEE_SCORE |
| Foodborne deaths | FOODBORNE_DTH |
| Foodborne deaths per 100 000 | FOODBORNE_DTH_100K |
| Foodborne deaths per 100 000, aged 5 years and above | FOODBORNE_DTH_100K_GE5 |
| Foodborne deaths per 100 000, aged less than 5 years | FOODBORNE_DTH_100K_LT5 |
| Foodborne deaths per 100 000, all ages | FOODBORNE_DTH_100K_TOTAL |
| Foodborne deaths per case | FOODBORNE_DTH_CASE |
| Foodborne deaths, aged 5 years and above | FOODBORNE_DTH_GE5 |
| Foodborne deaths, aged less than 5 years | FOODBORNE_DTH_LT5 |
| Foodborne deaths, all ages | FOODBORNE_DTH_TOTAL |
| Foodborne disability-adjusted life years | FOODBORNE_DALY |
| Foodborne disability-adjusted life years per 100 000 | FOODBORNE_DALY_100k |
| Foodborne disability-adjusted life years per 100 000, aged 5 years and above | FOODBORNE_DALY_100k_GE5 |
| Foodborne disability-adjusted life years per 100 000, aged less than 5 years | FOODBORNE_DALY_100k_LT5 |
| Foodborne disability-adjusted life years per 100 000, all ages | FOODBORNE_DALY_100k_TOTAL |
| Foodborne disability-adjusted life years per case | FOODBORNE_DALY_CASE |
| Foodborne disability-adjusted life years per case, aged 5 years and above | FOODBORNE_DALY_CASE_GE5 |
| Foodborne disability-adjusted life years per case, aged less than 5 years | FOODBORNE_DALY_CASE_LT5 |
| Foodborne disability-adjusted life years per case, all ages | FOODBORNE_DALY_CASE_TOTAL |
| Foodborne disability-adjusted life years, aged 5 years and above | FOODBORNE_DALY_GE5 |
| Foodborne disability-adjusted life years, aged less than 5 years | FOODBORNE_DALY_LT5 |
| Foodborne disability-adjusted life years, all ages | FOODBORNE_DALY_TOTAL |
| Foodborne illnesses | FOODBORNE_ILL |
| Foodborne illnesses per 100 000 | FOODBORNE_ILL_100K |
| Foodborne illnesses per 100 000, aged 5 years and above | FOODBORNE_ILL_100K_GE5 |
| Foodborne illnesses per 100 000, aged less than 5 years | FOODBORNE_ILL_100K_LT5 |
| Foodborne illnesses per 100 000, all ages | FOODBORNE_ILL_100K_TOTAL |
| Foodborne illnesses, aged 5 years and above | FOODBORNE_ILL_GE5 |
| Foodborne illnesses, aged less than 5 years | FOODBORNE_ILL_LT5 |
| Foodborne illnesses, all ages | FOODBORNE_ILL_TOTAL |
| Foodborne years lived with disability | FOODBORNE_YLD |
| Foodborne years lived with disability per 100 000 | FOODBORNE_YLD_100K |
| Foodborne years lived with disability per 100 000, aged 5 years and above | FOODBORNE_YLD_100K_GE5 |
| Foodborne years lived with disability per 100 000, aged less than 5 years | FOODBORNE_YLD_100K_LT5 |
| Foodborne years lived with disability per 100 000, all ages | FOODBORNE_YLD_100K_TOTAL |
| Foodborne years lived with disability per case | FOODBORNE_YLD_CASE |
| Foodborne years lived with disability per case, aged 5 years and above | FOODBORNE_YLD_CASE_GE5 |
| Foodborne years lived with disability per case, aged less than 5 years | FOODBORNE_YLD_CASE_LT5 |
| Foodborne years lived with disability per case, all ages | FOODBORNE_YLD_CASE_TOTAL |
| Foodborne years lived with disability, aged 5 years and above | FOODBORNE_YLD_GE5 |
| Foodborne years lived with disability, aged less than 5 years | FOODBORNE_YLD_LT5 |
| Foodborne years lived with disability, all ages | FOODBORNE_YLD_TOTAL |
| Foodborne years of life lost | FOODBORNE_YLL |
| Foodborne years of life lost per 100 000 | FOODBORNE_YLL_100K |
| Foodborne years of life lost per 100 000, aged 5 years and above | FOODBORNE_YLL_100K_GE5 |
| Foodborne years of life lost per 100 000, aged less than 5 years | FOODBORNE_YLL_100K_LT5 |
| Foodborne years of life lost per 100 000, all ages | FOODBORNE_YLL_100K_TOTAL |
| Foodborne years of life lost per case | FOODBORNE_YLL_CASE |
| Foodborne years of life lost per case, aged 5 years and above | FOODBORNE_YLL_CASE_GE5 |
| Foodborne years of life lost per case, aged less than 5 years | FOODBORNE_YLL_CASE_LT5 |
| Foodborne years of life lost per case, all ages | FOODBORNE_YLL_CASE_TOTAL |
| Foodborne years of life lost, aged 5 years and above | FOODBORNE_YLL_GE5 |
| Foodborne years of life lost, aged less than 5 years | FOODBORNE_YLL_LT5 |
| Foodborne years of life lost, all ages | FOODBORNE_YLL_TOTAL |
| Formative research was conducted | Camp_aud_research |
| Framework of national alcohol policy | SA_0000001692 |
| Framework of national alcohol policy | SA_0000001692_ARCHIVED |
| Full immunization coverage among one-year-olds (%) | fullv |
| Functional capability assessment for health emergency preparedness and response using simulation exercises (SimEx) and action reviews | SIMEX_HEP_AND_RESPONSE_CAP_ASSESS |
| Funding | GOE_Q059 |
| Funding for assistive products (%) | ASSISTIVETECH_PAYERSAT |
| Funding method for substance use disorder prevention | RSUD_75 |
| Funds available per level of the Organization (%) | WCO_FUNDING_LEVEL_PER100 |
| Funds available per type of country office by Strategy (%) | WCO_FUNDING_TYPE_STRATEGY_PER100 |
| GDP per capita to purchase a volume of beverage (%) | TAXBEV_AFFORD_GDP |
| Gender distribution between international and local WCO staff | WCO_DISTRIBUTION_INTANDLOC_PER100 |
| Gender inequality index rank | CCO_3 |
| General availability of ACE inhibitors in the public health sector | NCD_CCS_ACE |
| General availability of Angiotensin II receptor blockers (ARBs) in the public health sector | NCD_CCS_ARB |
| General availability of CC blockers in the public health sector | NCD_CCS_CCBlkrs |
| General availability of Fixed dose combination avail (lisinopril + amlodipine) in the public health sector | NCD_CCS_LIS_AML_COMBO |
| General availability of Fixed dose combination avail (lisinopril + hydrochlorothiazide) in the public health sector | NCD_CCS_LIS_HYDRO_COMBO |
| General availability of Fixed dose combination avail (telmisartan + amlodipine) in the public health sector | NCD_CCS_TEL_AML_COMBO |
| General availability of Fixed dose combination avail (telmisartan + hydrochlorothiazide) in the public health sector | NCD_CCS_TEL_HYDRO_COMBO |
| General availability of alteplase for acute stroke management in the public health system | NCD_CCS_alteplase |
| General availability of aspirin (100 mg) in the public health sector | NCD_CCS_Aspirin |
| General availability of beta blockers in the public health sector | NCD_CCS_betablockers |
| General availability of blood pressure measurement at the primary health care level | NCD_CCS_BPmsmt |
| General availability of bone marrow transplantation in the public health system | NCD_CCS_bone_marrow |
| General availability of breast cancer screening (by palpation or mammogram) at the primary health care level | NCD_CCS_BreastCancer |
| General availability of bronchodilators in the public health sector | NCD_CCS_Bronchodilators |
| General availability of cancer centres or cancer departments at tertiary level in the public sector | NCD_CCS_CANCER_DEPT |
| General availability of cancer surgery in the public sector | NCD_CCS_cancer_surgery |
| General availability of cervical cytology at the primary health care level | NCD_CCS_CervCy |
| General availability of chemotherapy in the public health system | NCD_CCS_chemo |
| General availability of colon cancer screening at the primary health care level | NCD_CCS_BowelCancer |
| General availability of combination budesonide formoterol inhaler in the public health sector | NCD_CCS_ComboInhaler |
| General availability of coronary bypass or stenting in the public health system | NCD_CCS_coronary |
| General availability of diabetes testing (by HbA1c) at the primary health care level | NCD_CCS_HbA1c |
| General availability of diabetes testing (by blood glucose measurement, OGTT) at the primary health care level | NCD_CCS_diabtest |
| General availability of diabetes testing (by blood glucose measurement, OGTT, or HbA1c) at the primary health care level | NCD_CCS_DiabetesTest |
| General availability of diabetic retinopathy screening in the public health system | NCD_CCS_diab_retin |
| General availability of dialysis in the public health system | NCD_CCS_dialysis |
| General availability of dilated fundus examination at the primary health care level | NCD_CCS_dilated_fundus |
| General availability of foot vibration perception by tuning fork at the primary health care level | NCD_CCS_foot_vibr |
| General availability of insulin in the public health sector | NCD_CCS_Insulin |
| General availability of metformin in the public health sector | NCD_CCS_Metformin |
| General availability of nicotine replacement therapy in the public health sector | NCD_CCS_Nicotine |
| General availability of oral morphine in the public health sector | NCD_CCS_OralMorph |
| General availability of palliative care in community or home-based care in the public health system | NCD_CCS_palliative_home |
| General availability of palliative care in primary health care in the public health system | NCD_CCS_palliative_prim |
| General availability of pathology services (laboratories) in the public sector | NCD_CCS_path_lab |
| General availability of peak flow measurement at the primary health care level | NCD_CCS_PeakFlow |
| General availability of radiotherapy in the public sector | NCD_CCS_radio |
| General availability of renal replacement by transplantation in the public health system | NCD_CCS_renaltrans |
| General availability of retinal photocoagulation in the public health system | NCD_CCS_photocoag |
| General availability of spirometry at the primary health care level | NCD_CCS_Spirom |
| General availability of statins in the public health sector | NCD_CCS_Statins |
| General availability of steroid inhalers in the public health sector | NCD_CCS_Steroid |
| General availability of sulphonylurea(s) in the public health sector | NCD_CCS_sulphonylurea |
| General availability of thiazide diuretics in the public health sector | NCD_CCS_Thiazide |
| General availability of thrombolytic therapy in the public health system | NCD_CCS_thrombolytic |
| General availability of total cholesterol measurement at the primary health care level | NCD_CCS_CholMsmt |
| General availability of urine strips for glucose and ketone measurement at the primary health care level | NCD_CCS_urine_strips_gluc_ketone |
| General availability of urine testing for albumin | NCD_CCS_UrineAlbumin |
| General government expenditure on health as a percentage of total expenditure on health | WHS7_149 |
| General government expenditure on health as a percentage of total government expenditure | WHS7_113 |
| General government expenditure on health as percentage of gross domestic product | NHAGGHEGDP |
| Generalist medical practitioners (number) | HWF_0003 |
| Geriatric-specific hospital beds (per 10,000 population) | GDO_q9x1_4 |
| Governement benefits for persons with substance use disorders | RSUD_26 |
| Government benefits for alcohol use disorders, subsidy or disability pension | RSUD_27 |
| Government benefits for drug use disorders, subsidy or disability pension | RSUD_28 |
| Government benefits for people with alcohol use disorders | RSUD_300 |
| Government benefits for people with drug use disorders | RSUD_310 |
| Government expenditures on mental health as a percentage of total government expenditures on health (%) | MH_4 |
| Government expenditures on mental hospitals as a percentage of total government expenditures on mental health (%) | MH_5 |
| Government monopoly on production | SA_0000001542 |
| Government monopoly on production | SA_0000001542_ARCHIVED |
| Government monopoly on retail sales | SA_0000001543 |
| Government monopoly on retail sales | SA_0000001543_ARCHIVED |
| Government objectives on tobacco control exist | NTCP_govt_obj |
| Government support for community action | SA_0000001722 |
| Government support for community action | SA_0000001722_ARCHIVED |
| Government unit for substance use disorder prevention | RSUD_73 |
| Government unit for substance use disorder treatment | RSUD_21 |
| Government unit/official responsible for prevention for substance use | RSUD_100 |
| Government unit/official responsible for treatment of substance use disorders | RSUD_130 |
| Government-sponsored mHealth programmes are being evaluated | GOE_Q047 |
| Government-supported health internet sites provide information in multiple languages | GOE_Q017 |
| Graduated licensing | SA_0000001791 |
| Gross national income per capita (Atlas method) | RS_576 |
| Gross national income per capita (PPP int. $) | WHS9_93 |
| Groups and agencies for the prevention of substance use disorders | RSUD_88 |
| Groups and agencies involved in prevention programs | RSUD_570 |
| Guidelines on pharmacological treatment for substance use disorders | RSUD_420 |
| Guidelines on the pharmacological treatment of substance use disorders | RSUD_15 |
| H5N1 influenza - number of reported cases | WHS3_51 |
| HIV tests performed where results were received by a person (testing volume), estimated number per 1000 population | HIV_0000000028 |
| HIV tests performed where results were received by a person (testing volume), reported number | HIV_0000000027 |
| HIV tests performed where results were received by a person (testing volume), reporting period | HIV_0000000029 |
| HIV, Hepatitis counselling and treatment availability in specialized facilities and services | RSUD_620 |
| HIV, Hepatitis, and STI-related laws and policies | HHS_LAWPOLICY |
| HIV-positive TB patients on ART (antiretroviral therapy) (%) | TB_hiv_art_pct |
| HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) (%) | TB_hiv_cpt_pct |
| HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%) | SDGHPVRECEIVED |
| Handwashing with soap after cleaning child's stool (%) | HWWS_2 |
| Handwashing with soap after using the toilet (%) | HWWS_1 |
| Harm reduction programmes for IDUs | RSUD_79 |
| Has a STEPS survey or a comprehensive health examination survey every 5 years | NCD_CCS_PM3_Surv |
| Has conducted a recent, national adult risk factor survey covering harmful alcohol use | NCD_CCS_ALC_SVY |
| Has conducted a recent, national adult risk factor survey covering overweight and obesity | NCD_CCS_OVWT_SVY |
| Has conducted a recent, national adult risk factor survey covering physical inactivity | NCD_CCS_PA_SVY |
| Has conducted a recent, national adult risk factor survey covering raised blood glucose/diabetes | NCD_CCS_DIAB_SVY |
| Has conducted a recent, national adult risk factor survey covering raised blood pressure/hypertension | NCD_CCS_BP_SVY |
| Has conducted a recent, national adult risk factor survey covering raised total cholesterol | NCD_CCS_CHOL_SVY |
| Has conducted a recent, national adult risk factor survey covering salt/sodium intake | NCD_CCS_SALT_SVY |
| Has conducted a recent, national adult risk factor survey covering tobacco use | NCD_CCS_TOB_SVY |
| Has conducted a recent, national adult risk factor survey covering unhealthy diet | NCD_CCS_DIET_SVY |
| Has systems for follow-up/recall to deliver long-term penicillin prophylaxis to patients with rheumatic fever and rheumatic heart disease | NCD_CCS_rheumfollowup |
| Health Service Provision | IHRSPAR_CAPACITY09 |
| Health emergency management | IHRSPAR2_C07 |
| Health management & support workers density (per 1000 population) | HRH_32 |
| Health professionals mostly involved in treatment of substance use disorders | RSUD_80 |
| Health professionals providing treatment for alcohol and drug use disorders | RSUD_740 |
| Health services provision | IHRSPAR2_C08 |
| Health technology (medical device) national policy | DEVICES15 |
| Health warning labels on alcohol advertising | SA_0000001554 |
| Health warning labels on alcohol advertising | SA_0000001554_ARCHIVED |
| Health warning labels on alcohol containers | SA_0000001555 |
| Health warning labels on alcohol containers | SA_0000001555_ARCHIVED |
| Health warning labels on drink-driving | SA_0000001805 |
| Health warning labels on pregnancy | SA_0000001803 |
| Health warning labels on under-age drinking | SA_0000001804 |
| Health warnings appear on each other smoked tobacco package and any outside packaging and labelling used in the retail sale | TOBACCO_0000000392 |
| Health warnings on cigarette packaging do not remove or diminish the liability of the tobacco industry | W13_ind_liability_A |
| Health warnings on cigarette packaging law applys to products whether manufactured domestically imported AND for duty-free sale | W12_imports_dutyfree_A |
| Health warnings on cigarette packaging law requires or establishes fines for violations | W17_fines_A |
| Health warnings on cigarette packaging must be placed at the top of the principal display areas of the package | W5_top_side_A |
| Health warnings on cigarette packaging must not be obscured in any way including by required markings such as tax stamps | W9_no_obscure_A |
| Health warnings on other smoked tobacco packaging describe the harmful effects of tobacco use on health | TOBACCO_0000000393 |
| Health warnings on other smoked tobacco packaging do not remove or diminish the liability of the tobacco industry | W13_ind_liability_B |
| Health warnings on other smoked tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale | W12_imports_dutyfree_B |
| Health warnings on other smoked tobacco packaging law requires or establishes fines for violations | W17_fines_B |
| Health warnings on other smoked tobacco packaging must be placed at the top of the principal display areas of the package | W5_top_side_B |
| Health warnings on other smoked tobacco packaging must be rotated | TOBACCO_0000000390 |
| Health warnings on other smoked tobacco packaging must be written in the principal language(s) of the country | TOBACCO_0000000395 |
| Health warnings on other smoked tobacco packaging must include a photograph or graphic | TOBACCO_0000000396 |
| Health warnings on other smoked tobacco packaging must not be obscured in any way including by required markings such as tax stamps | W9_no_obscure_B |
| Health warnings on smokeless tobacco packaging do not remove or diminish the liability of the tobacco industry | W13_ind_liability_C |
| Health warnings on smokeless tobacco packaging law applys to products whether manufactured domestically imported AND for duty-free sale | W12_imports_dutyfree_C |
| Health warnings on smokeless tobacco packaging law requires or establishes fines for violations | W17_fines_C |
| Health warnings on smokeless tobacco packaging must be placed at the top of the principal display areas of the package | W5_top_side_C |
| Health warnings on smokeless tobacco packaging must not be obscured in any way including by required markings such as tax stamps | W9_no_obscure_C |
| Healthcare sector greenhouse gas emissions | HEALTHCARE_GREENHOUSE_GAS_EMISSION |
| Healthcare staff in prisons (FTEs per 1000 prisoners) | PRISON_B9_STAFF_RATIO |
| Healthy life expectancy (HALE) at age 60 (years) | WHOSIS_000007 |
| Healthy life expectancy (HALE) at birth (years) | WHOSIS_000002 |
| Heavy episodic drinking (youth 15 -19 years) past 30 days (%) | SA_0000001819 |
| Heavy episodic drinking (youth 15 -19 years), drinkers only, past 30 days (%) | SA_0000001820 |
| Hepatitis - Deaths caused by chronic hepatitis B and C | HEPATITIS_DEATHS_NUM |
| Hepatitis - Deaths caused by chronic hepatitis B and C (per 100 000 population) | HEPATITIS_DEATHS_RATE |
| Hepatitis B (HepB3) immunization coverage among 1-year-olds (%) (WUENIC) | WHS4_117 |
| Hepatitis B surface antigen (HBsAG) carriers (per 100 000 population) | HEPB_HBSAG_CARRIER |
| Hepatitis B surface antigen (HBsAg) prevalence (%) | SDGHEPHBSAGPRV |
| Hepatitis EMTCT voltron indicator | HEP_EMTCT_VOLTRON |
| Hepatitis GAM-sourced indicator | HEP_GAM_VOLTRON |
| Hepatitis overview voltron indicator | HEP_OVERVIEW_VOLTRON |
| Hepatitis testing and treatment indicator (number) | HEP_TEST_TREAT_NUM_VOLTRON |
| Hepatitis testing and treatment indicator (percent) | HEP_TEST_TREAT_PCT_VOLTRON |
| Hib (Hib3) immunization coverage among 1-year-olds (%) (WUENIC) | WHS4_129 |
| Hospice centre beds (per 10 000 population) | GDO_q9x3_2 |
| Hospital beds (per 10 000 population) | WHS6_102 |
| Hospital discharges, alcohol-related injuries and poisoning, per 100,000 | SA_0000001465 |
| Hospital discharges, alcoholic liver disease, per 100,000 | SA_0000001466 |
| Household air pollution attributable DALYs per 100'000 children under 5 years | AIR_18 |
| Household air pollution attributable deaths per 100'000 children under 5 years | AIR_14 |
| Household air pollution attributable DALYs | AIR_15 |
| Household air pollution attributable DALYs (per 100 000 population) | AIR_17 |
| Household air pollution attributable DALYs (per 100 000, age-standardized) | AIR_39 |
| Household air pollution attributable DALYs in children under 5 years | AIR_16 |
| Household air pollution attributable death rate (per 100 000 population) | AIR_51 |
| Household air pollution attributable death rate (per 100 000 population, age-standardized) | AIR_52 |
| Household air pollution attributable deaths | AIR_11 |
| Household air pollution attributable deaths in children under 5 years | AIR_12 |
| Household air pollution attributable deaths per 100'000 capita | AIR_13 |
| Household and ambient air pollution attributable DALYs | AIR_60 |
| Household and ambient air pollution attributable DALYs (per 100 000 capita) | AIR_61 |
| Household and ambient air pollution attributable DALYs (per 100 000 capita, age-standardized) | AIR_62 |
| Household and ambient air pollution attributable DALYs in children under 5 years ('000) | AIR_63 |
| Households impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national) | FINPROTECTION_IMP_BNLFHU_FURIMP_HH |
| Households further impoverished by out-of-pocket payments (relative poverty line reflecting basic needs: food, housing, utilities - developed by WHO/Europe) (%, national) | FINPROTECTION_IMP_BNLFHU_P_HH |
| Households pushed below or further below a relative poverty line (reflecting basic needs: food, housing, utilities - developed by WHO/Europe) by out-of-pocket payments (%, national) | FINPROTECTION_IMP_BNLFHU_TOT_HH |
| Households with out-of-pocket payments greater than 40% of capacity to pay for health care (food, housing and utilities approach - developed by WHO/Europe) (%, national) | FINPROTECTION_CATA_CTPFHU_40_HH |
| How many health warnings are approved by the law for cigarette packaging? | W16_number_hw_A |
| How many health warnings are approved by the law for other smoked tobacco packaging? | W16_number_hw_B |
| How many health warnings are approved by the law for smokeless tobacco packaging? | W16_number_hw_C |
| Human Resources (SPAR) | IHRSPAR_CAPACITY07 |
| Human development index rank | CCO_2 |
| Human resources | IHR07 |
| Human resources | IHRSPAR2_C06 |
| Hypertension among adults aged 30-79 years, prevalence, age-standardized | NCD_HYP_PREVALENCE_A |
| Hypertension among adults aged 30-79 years, prevalence, crude | NCD_HYP_PREVALENCE_C |
| Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%) | NCD_HYP_CONTROL_A |
| Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%) | NCD_HYP_TREATMENT_A |
| Hypertension treatment coverage among adults aged 30-79 with hypertension, crude (%) | NCD_HYP_TREATMENT_C |
| Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, age-standardized (%) | NCD_HYP_DIAGNOSIS_A |
| Hypertension: diagnosis coverage among adults aged 30-79 with hypertension, crude (%) | NCD_HYP_DIAGNOSIS_C |
| Hypertension: effective treatment coverage (controlled hypertension) among adults aged 30-79 with hypertension, crude (%) | NCD_HYP_CONTROL_C |
| Hypothecated taxes to be spent on prevention and treatment for substance use disorders | RSUD_290 |
| ICD-11 implementation progress level | ICD11_IMPL_LVL |
| ICT Development Index (IDI) | ITU_IDI |
| ICT Development Index (IDI) rank | ITU_IDI_RANK |
| IHR Coordination and National IHR Focal Point Functions | IHRSPAR_CAPACITY02 |
| IHR Coordination, National IHR Focal Point functions and advocacy | IHRSPAR2_C02 |
| Identification of different sectors in dementia care coordination (Health) | GDO_q5x1x1_1 |
| Identification of different sectors in dementia care coordination (Civil society) | GDO_q5x1x1_7 |
| Identification of different sectors in dementia care coordination (Education) | GDO_q5x1x1_3 |
| Identification of different sectors in dementia care coordination (Employment) | GDO_q5x1x1_4 |
| Identification of different sectors in dementia care coordination (Housing) | GDO_q5x1x1_6 |
| Identification of different sectors in dementia care coordination (Justice) | GDO_q5x1x1_5 |
| Identification of different sectors in dementia care coordination (Other) | GDO_q5x1x1_other |
| Identification of different sectors in dementia care coordination (Private sector) | GDO_q5x1x1_8 |
| Identification of different sectors in dementia care coordination (Social) | GDO_q5x1x1_2 |
| Identification of other plans in which dementia is integrated (Ageing) | GDO_Q2x2x1_AGE |
| Identification of other plans in which dementia is integrated (Disability) | GDO_Q2x2x1_DISAB |
| Identification of other plans in which dementia is integrated (Mental health) | GDO_Q2x2x1_MENTAL |
| Identification of other plans in which dementia is integrated (NCD) | GDO_Q2x2x1_NCD |
| Identification of other plans in which dementia is integrated (Other) | GDO_q2x2x1_other |
| Identification of other research plans in which dementia is integrated (Ageing) | GDO_q17x2x1_2 |
| Identification of other research plans in which dementia is integrated (Mental health) | GDO_q17x2x1_1 |
| Identification of other research plans in which dementia is integrated (NCD) | GDO_q17x2x1_4 |
| Identification of other research plans in which dementia is integrated (Neuro or neurodegenerative disease) | GDO_q17x2x1_3 |
| If tiered on the beverage, the tiers are alcohol-based | TAXBEV_ALCOHOLBASEDTIERED |
| If tiered on the beverage, the tiers are sugar-content-based | TAXBEV_SUGARBASEDTIERED |
| Ill-defined causes in cause-of-death registration (%) | WHS10_9 |
| Illnesses caused by hazards, aged 5 years and above | HAZARD_ILL_GE5 |
| Illnesses caused by hazards, aged less than 5 years | HAZARD_ILL_LT5 |
| Illnesses caused by hazards, all ages | HAZARD_ILL_TOTAL |
| Implementation level [national/subnational] of dementia awareness campaign | GDO_q13x1x1 |
| Implementation level [national/subnational] of dementia care coordination | GDO_q5x1x2 |
| Implementation level [national/subnational] of dementia carer support services | GDO_q12x1x1 |
| Implementation level [national/subnational] of dementia legislation | GDO_q3x1x1_1 |
| Implementation level [national/subnational] of dementia research plan/programme | GDO_q17x1x1 |
| Implementation level [national/subnational] of dementia risk reduction campaign | GDO_q13x3x1 |
| Implementation level [national/subnational] of research plan in which dementia is integrated | GDO_q17x2x2 |
| Implementation level of dementia standards/ guidelines/ protocols (National) | GDO_q4x1x1_SQ001 |
| Implementation level of dementia standards/ guidelines/ protocols (Sub-national) | GDO_q4x1x1_SQ002 |
| Implementation of a nutrition public awareness program | NCD_CCS_DIET_AWARE |
| Implementation of a recent mass participation event | NCD_CCS_PA_MASS_PART |
| Implementation of diet and/or physical activity public awareness program | NCD_CCS_dietpaaware |
| Implementation of physical activity public awareness program | NCD_CCS_paaware |
| Implementing policy measures aiming to reduce free sugars intake | ORALHEALTH_FREESUGARSREDUCTION |
| Import duties on beverages (%) | TAXBEV_IMPORTDUTIES |
| Importance of measures for enhancing compliance with age limits | SA_0000001721 |
| Importance of measures for enhancing compliance with age limits | SA_0000001721_ARCHIVED |
| Imports in 1000s hectolitres | SA_0000001677 |
| Improving access to content and experts | GOE_Q104_2 |
| Improving access to content and experts | GOE_Q119_2 |
| In-prison COVID-19 diagnosis (number of diagnoses) | PRISON_D4_COVID_TOT |
| In-prison COVID-19 mortality rate (per 100 000 incarcerated persons per year) | PRISON_D3_DEATHS_COVID_MRATE |
| In-prison HIV diagnosis (number of diagnoses) | PRISON_D4_HIV_DIAG_TOT |
| In-prison Hepatitis B diagnosis (number of diagnoses) | PRISON_D4_HEPB_DIAG_TOT |
| In-prison Hepatitis C diagnosis (number of diagnoses) | PRISON_D4_HEPC_DIAG_TOT |
| In-prison MDR-TB diagnosis (number of diagnoses) | PRISON_D4_MDRTB_DIAG_TOT |
| In-prison STIs diagnosis (number of diagnoses) | PRISON_D4_STI_DIAG_TOT |
| In-prison TB diagnosis (number of diagnoses) | PRISON_D4_TB_DIAG_TOT |
| In-prison active drug use diagnosis (number of diagnoses) | PRISON_D4_SUD_DIAG_TOT |
| In-prison cancer diagnosis (number of diagnoses) | PRISON_D4_CANCER_DIAG_TOT |
| In-prison cardiovascular disease diagnosis (number of diagnoses) | PRISON_D4_CARDIOVASC_DIAG_TOT |
| In-prison clinical health records | PRISON_B20_CLINICALREP |
| In-prison condoms free of charge | PRISON_C8_CONDOMS |
| In-prison diabetes mellitus diagnosis (number of diagnoses) | PRISON_D4_DIABETES_DIAG_TOT |
| In-prison drug overdose mortality rate (per 100 000 incarcerated persons per year) | PRISON_D3_DEATHS_DRUG_MRATE |
| In-prison laboratory tests | PRISON_C16_LABTESTS |
| In-prison mental disorder diagnosis (number of diagnoses) | PRISON_D4_MH_DIAG_TOT |
| In-prison needles free of charge | PRISON_C8_NEEDLES |
| In-prison patient involvement in healthcare planning and reform | PRISON_B17_INVOLVEMENT |
| In-prison people who currently use tobacco (number of prisoners) | PRISON_F1_TOBACCO_TOT |
| In-prison people who drink/drank alcohol (number of prisoners, in the last 12 months) | PRISON_F1_ALCOHOL_TOT |
| In-prison people who have BMI >= 25 (number of prisoners who are overweight) | PRISON_F1_BMI25_TOT |
| In-prison people who have BMI >= 30 (number of prisoners who are obese) | PRISON_F1_BMI30_TOT |
| In-prison people who inject/have injected drugs (number of prisoners, over the last 12 months) | PRISON_F1_INJECTDRUGUSERS_TOT |
| In-prison people who regularly exercise for a minimum of 150 minutes/week (number of prisoners) | PRISON_F1_EXERCISE_TOT |
| In-prison people who use/have used drugs (number of prisoners, in the last 12 months) | PRISON_F1_DRUGUSERS_TOT |
| In-prison regular assessments of essential medicines | PRISON_B13_ASSESSMENTS |
| In-prison standardized process for adverse drug events | PRISON_B15_REPDRUGEVENTS |
| In-prison standardized process for medication errors | PRISON_B14_ERRORS |
| In-prison standardized protocol for suicide | PRISON_B16_SUICIDERISK |
| In-prison suicide mortality rate (per 100 000 incarcerated persons per year) | PRISON_D3_DEATHS_SUICIDE_MRATE |
| In-prison total deaths | PRISON_D3_DEATHS_TOT |
| In-prison vaccination for DTP | PRISON_B11_VACPREV_DTP |
| In-prison vaccination for HPV | PRISON_B11_VACPREV_HPV |
| In-prison vaccination for Hepatitis A | PRISON_B11_VACPREV_HEPA |
| In-prison vaccination for Hepatitis B | PRISON_B11_VACPREV_HEPB |
| In-prison vaccination for MMR | PRISON_B11_VACPREV_MMR |
| In-prison vaccination for seasonal flu | PRISON_B11_VACPREV_FLU |
| Inactivated first-dose polio vaccine (IPV1) immunization coverage among 1-year-olds (%) (WUENIC) | VACCINECOVERAGE_IPV1 |
| Incidence of tuberculosis (per 100 000 population per year) | MDG_0000000020 |
| Incidence of tuberculosis (per 100 000 population) (HIV-positive cases) | TB_e_inc_tbhiv_100k |
| Incidence rate of lip and oral cavity cancer (per 100 000 population) | ORAL_HEALTH_CANCER_LIPORALCAVITY_100K |
| Incident cases of active syphilis in 15-49 year olds (in thousands) | STI_SYPHILIS_INCIDENTCASES |
| Incident cases of chlamydia in individuals (in thousands) | STI_CHLAMYDIA_INCIDENTCASES |
| Incident cases of chlamydia in individuals (per 1000) | STI_CHLAMYDIA_INCIDENCE_PER1000 |
| Incident cases of gonorrhoea in individuals (in thousands) | STI_GONORRHOEA_INCIDENTCASES |
| Incident cases of gonorrhoea in individuals (per 1000) | STI_GONORRHOEA_INCIDENCE_PER1000 |
| Incident cases of trichomoniasis in individuals (in thousands) | STI_TRICHOMONIASIS_INCIDENTCASES |
| Incident cases of trichomoniasis in individuals (per 1000) | STI_TRICHOMONIASIS_INCIDENCE_PER1000 |
| Incident rate of active syphilis (per 1000) | STI_SYPHILIS_INCIDENCE_PER1000 |
| Inclusion of basic dementia competencies in training of nurses | GDO_q6x2_3 |
| Inclusion of basic dementia competencies in training of personal support workers | GDO_q6x2_6 |
| Inclusion of basic dementia competencies in training of pharmaceutical personnel | GDO_q6x2_4 |
| Inclusion of basic dementia competencies in training of physicians | GDO_q6x2_1 |
| Inclusion of basic dementia competencies in training of social workers | GDO_q6x2_5 |
| Inclusion of basic dementia competencies in training of specialists | GDO_q6x2_2 |
| Inclusion of dementia diagnosis, care and support as a specific action of the dementia plan | GDO_q2x5_3 |
| Inclusion of dementia in a branch of government [health, ageing, social services, mental health, noncommunicable disease] | GDO_q1x1x1 |
| Inclusion of dementia in ministry portfolio | GDO_q1x1 |
| Inclusion of dementia risk reduction as a specific action of the dementia plan | GDO_q2x5_2 |
| Inclusion of dementia training and education for non-health workers | GDO_q15x1 |
| Inclusion of dementia workforce training as a specific action of the dementia plan | GDO_q2x5_4 |
| Inclusion of dementia-friendly communities as a specific action of the dementia plan | GDO_q2x5_1 |
| Inclusion of empowerment as a guiding principle of the dementia plan | GDO_q2x4_3 |
| Inclusion of equity as a guiding principle of the dementia plan | GDO_q2x4_2 |
| Inclusion of human rights as a guiding principle of the dementia plan | GDO_q2x4_1 |
| Inclusion of improved information system as a specific action of the dementia plan | GDO_q2x5_6 |
| Inclusion of multisectoral collaboration as a guiding principles of the dementia plan | GDO_q2x4_4 |
| Inclusion of radon education for building professionals | RADON_Q707 |
| Inclusion of radon in national cancer control strategy | RADON_Q803 |
| Inclusion of radon measurements in property transactions | RADON_Q802 |
| Inclusion of research and innovation as a specific action of the dementia plan | GDO_q2x5_7 |
| Inclusion of support for dementia carers and families as a specific action of the dementia plan | GDO_q2x5_5 |
| Inclusion of universal health coverage as a guiding principle of the dementia plan | GDO_q2x4_5 |
| Income level | RS_193 |
| Increase in poverty gap due to household health expenditures at the $1.90 a day poverty line, in cents of international dollars | FINPROTECTION_IMP_PG_190 |
| Increase in poverty gap due to household health expenditures at the $3.10a day poverty line, in cents of international dollars | FINPROTECTION_IMP_PG_310 |
| Increase in poverty gap due to household health expenditures, expressed as a proportion of the $1.90 a-day poverty line (%) | FINPROTECTION_IMP_PG_190_STD |
| Increase in poverty gap due to household health expenditures, expressed as a proportion of a relative poverty line - 60% of median daily per capita consumption or income (%, national, rural, urban) | FINPROTECTION_IMP_PG_RELPL_STD |
| Increase in poverty gap due to household health expenditures, expressed as a proportion of the $2.15 a-day poverty line (%, national, rural, urban) | FINPROTECTION_IMP_PG_215_STD |
| Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.20 a-day poverty line (%, national, rural, urban) | FINPROTECTION_IMP_PG_310_STD |
| Increase in poverty gap due to household health expenditures, expressed as a proportion of the $3.65 a-day poverty line (%, national, rural, urban) | FINPROTECTION_IMP_PG_365_STD |
| Index of Essential Service Coverage (Actual) | UHC_INDEX_ACTUAL |
| Indicator 16.2.1: Proportion of children aged 1-17 years who experienced any physical punishment and/or psychological aggression by caregivers in the past month | CHILDVIOL |
| Individuals have the legal right to specify which health-related data from their EHR can be shared with health professionals of their choice | GOE_Q178 |
| Infant mortality rate (deaths per 1000 live births) | imr |
| Infant mortality rate (probability of dying between birth and age 1 per 1000 live births) | MDG_0000000001 |
| Infants exclusively breastfed for the first six months of life (%) | WHOSIS_000006 |
| Infection prevention and control (IPC) | IHRSPAR2_C09 |
| Inflation-adjusted prices for most sold brand of cigarettes: Price in local currency adjusted by year on year changes in average consumer prices in each country | R_afford_inflation_adjusted_price_lcu |
| Inflation-adjusted prices for most sold brand of cigarettes: Prices in purchasing power parity adjusted by year on year changes in average consumer prices in the United States of America | R_afford_inflation_adjusted_price_ppp |
| Information requirements | SUNBEDREG_INFO |
| Information, education, prevention | SA_0000001648 |
| Infrastructure | GOE_Q058 |
| Insitutional educational policy does not include eLearning as an approach to teaching health sciences | GOE_Q139 |
| Institutions offer in-service training to health professionals on ICT for health | GOE_Q022 |
| Insufficient incentives for data sharing | GOE_Q199 |
| Insufficiently active (crude estimate) | NCD_PAC_ADO |
| International Health Regulations core capacity scores, SPAR version, 2nd edition | SDGIHR2021 |
| International Statistical Classification of Diseases and Related Health Problems (ICD) | WHS10_10 |
| Interventions, projects, training | SA_0000001652 |
| Interventions/projects actively involving young people and civil society | SA_0000001713 |
| Intimate partner violence prevalence among ever partnered women (%) | RHR_IPV |
| Intimate partner violence: Extent of implementation of dating violence prevention programmes | VIOLENCE_EXTENTIMP_PARTNERVIOLPREVENTION |
| Introduction of solid, semi-solid or soft foods 6-8 months | NUT_CF_ISSSF |
| Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for prevention for alcohol and drugs | RSUD_170 |
| Involvement of representatives of affected or targeted populations in the development and formulation of policies and strategies for treatment of substance use disorders | RSUD_150 |
| Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for prevention for alcohol and drugs | RSUD_180 |
| Involvement of representatives of affected or targeted populations in the development and implementation of national programmes for treatment of substance use disorders | RSUD_160 |
| Japanese encephalitis - number of reported cases | WHS3_42 |
| Joint effects of air pollution attributable deaths | AIR_35 |
| Joint effects of air pollution attributable deaths in children under 5 years | AIR_36 |
| Key functions | WCO_KEYFUNCTIONS |
| Key functions by groups (%) | WCO_KEYFUNCTIONS_GROUPED_PER100 |
| Kidney transplants (absolute number) | ORGANKIDNEYNUM |
| Kidney transplants (per million) | ORGANKIDNEYRATE |
| Laboratories providing drug susceptibility testing (DST) (per 5 million population) | TB_c_lab_dst_5m |
| Laboratories providing tuberculosis diagnostic services using culture (per 5 million population) | TB_c_lab_cul_5m |
| Laboratories providing tuberculosis diagnostic services using sputum smear microscopy (per 100 000 population) | TB_c_lab_sm_100k |
| Laboratory | IHR08 |
| Laboratory | IHRSPAR2_C04 |
| Laboratory (SPAR) | IHRSPAR_CAPACITY05 |
| Laboratory health workers density (per 1000 population) | HRH_27 |
| Lack of capacity | GOE_Q131 |
| Lack of capacity | GOE_Q153 |
| Lack of demand by health professionals and patients | GOE_Q158 |
| Lack of demand for eLearning programmes | GOE_Q137 |
| Lack of evidence over cost-effectiveness | GOE_Q136 |
| Lack of evidence showing cost-effectiveness or EHR | GOE_Q157 |
| Lack of evidence that eLearning is effective | GOE_Q135 |
| Lack of funding | GOE_Q133 |
| Lack of funding | GOE_Q155 |
| Lack of infrastructure | GOE_Q132 |
| Lack of infrastructure | GOE_Q154 |
| Lack of integration between various health services | GOE_Q203 |
| Lack of legislation or regulations covering use of EHR | GOE_Q159 |
| Lack of national or international standards for interoperability of EHR | GOE_Q161 |
| Lack of suitable courses available | GOE_Q138 |
| Law mandates that health warnings appear on other smoked tobacco packages | W1_HW_law_B |
| Law mandates that health warnings appear on smokeless tobacco packages | W1_HW_law_C |
| Law mandates that health warnings appear on tobacco packages | W1_HW_law_A |
| Law requires fines for violations of advertising bans | E21a_direct_ad_fines |
| Law requires fines for violations of direct advertising bans | E26_direct_ad_fines |
| Law requires fines for violations of direct advertising bans | E8_direct_ad_fines |
| Law requires fines for violations of indirect advertising bans | E19_indirect_ad_fines |
| Law requires fines for violations of indirect advertising bans | E27_indirect_ad_fines |
| Law requires fines for violations of promotion and sponsorship bans | E21b_indirect_ad_fines |
| Law requires helmet to be fastened | RS_223_BIS |
| Lead attributable DALYs ('000) | LEAD_6 |
| Lead attributable DALYs ('000) in children under 5 years | LEAD_9 |
| Lead attributable DALYs per 100'000 capita | LEAD_8 |
| Lead attributable DALYs per 100'000 children under 5 years | LEAD_10 |
| Lead attributable deaths | LEAD_5 |
| Lead attributable deaths per 100'000 capita | LEAD_7 |
| Legal | GOE_Q063 |
| Legal blood alcohol concentration (BAC) limits | SA_0000001520 |
| Legal blood alcohol concentration (BAC) limits | SA_0000001520_ARCHIVED |
| Legal obligation for schools to include alcohol use prevention | SA_0000001765 |
| Legal obligation for schools to include alcohol use prevention | SA_0000001765_ARCHIVED |
| Legal obligation for schools to interact with parents regarding education and well-being | SA_0000001766 |
| Legal obligation for schools to interact with parents regarding education and well-being | SA_0000001766_ARCHIVED |
| Legal requirement for size of health warning labels | SA_0000001806 |
| Legally-binding controls on lead paint | LEADCONTROL |
| Legislation | IHR01 |
| Legislation and Financing | IHRSPAR_CAPACITY01 |
| Legislation on alcohol testing at workplaces | SA_0000001767 |
| Legislation on alcohol testing at workplaces | SA_0000001767_ARCHIVED |
| Legislative provision for compulsory treatment | RSUD_17 |
| Legislative provision for treatment and rehabilitation of substance use disorders | RSUD_16 |
| Legislative status | EMFSTATUS |
| Length of stay for inpatient detoxification, days | RSUD_46 |
| Length of stay for inpatient long-term residential treatment, days | RSUD_48 |
| Length of stay for inpatient short-term treatment, days | RSUD_47 |
| Leprosy - New leprosy cases with G2D rate per 1 000 000 population | NTD_LEPR7 |
| Leprosy - Number of cases registered for treatment | NTD_LEPR3 |
| Leprosy - Number of new leprosy cases among children (less than 15 years of age) | NTD_LEPR8 |
| Leprosy registered prevalence rate per 1 000 000 population | NTD_LEPR4 |
| Level of adoption of national alcohol policy | SA_0000001693 |
| Level of adoption of national alcohol policy | SA_0000001693_ARCHIVED |
| Level of enforcement of BAC limits | SA_0000001779 |
| Level of taxation adjusted for inflation | SA_0000001731 |
| Level of taxation adjusted for inflation | SA_0000001731_ARCHIVED |
| Licence required for production | SA_0000001544 |
| Licence required for production | SA_0000001544_ARCHIVED |
| Licence required for retail sales | SA_0000001545 |
| Licence required for retail sales | SA_0000001545_ARCHIVED |
| Licenses issued for production, change since 2010 | SA_0000001797 |
| Licenses issued for retail sale, change since 2010 | SA_0000001798 |
| Licenses issued for wholesale/distribution, change since 2010 | SA_0000001799 |
| Licensing required for exports of alcoholic beverages | SA_0000001794 |
| Licensing required for imports of alcoholic beverages | SA_0000001795 |
| Licensing required for wholesale/distribution of alcoholic beverages | SA_0000001796 |
| Life expectancy at age 60 (years) | WHOSIS_000015 |
| Life expectancy at birth (years) | WHOSIS_000001 |
| Lifetime prevalence of child emotional abuse (%) | VIOLENCE_CHILD_EMOTIONAL |
| Lifetime prevalence of child physical abuse (%) | VIOLENCE_CHILD_PHYSICAL |
| Lifetime prevalence of child physical neglect (%) | VIOLENCE_CHILD_NEGLECT |
| Lifetime prevalence of child sexual abuse (%) | VIOLENCE_CHILD_SEXUAL |
| Literacy rate among adults aged >= 15 years (%) | CCO_WHS9_85 |
| Literacy rate among adults aged >= 15 years (%) | WHS9_85 |
| Liver cirrhosis, age-standardized death rates (15+), per 100,000 population | SA_0000001457 |
| Liver cirrhosis, age-standardized death rates (15+), per 100,000 population | SA_0000001457_ARCHIVED |
| Liver cirrhosis, alcohol-attributable, age-standardized death rates, per 100,000 population | SA_0000001457_AA |
| Liver transplants (absolute number) | ORGANLIVERNUM |
| Liver transplants (per million) | ORGANLIVERRATE |
| Locations and facilities | WHO_LOCATIONFACILITIES |
| Locations and facilities by groups (%) | WHO_LOCATIONFACILITIES_GROUPED_PER100 |
| Low birth weight number (in thousands) | LBW_NUMBER |
| Low birth weight prevalence (%) | LBW_PREVALENCE |
| Low-birth-weight newborns (%) | WHOSIS_000005 |
| Magnetic flux density (microT) | EMFLIMITMAGNETIC |
| Main sector for treatment for alcohol use disorders | RSUD_320 |
| Main sector for treatment for drug use disorders | RSUD_330 |
| Main substance at treatment entry | RSUD_400 |
| Majority provider of activities of daily living support services in community for dementia [public, private] | GDO_q8x4_4 |
| Majority provider of behaviour and psychological management in community for dementia [public, private] | GDO_q8x4_2 |
| Majority provider of dementia carer training and education (NGO) | GDO_q12x2x1x1_1NGO |
| Majority provider of dementia carer training and education (Private sector) | GDO_q12x2x1x1_1PRV |
| Majority provider of dementia carer training and education (Public sector) | GDO_q12x2x1x1_1PUB |
| Majority provider of diagnostic services in community for dementia [public, private] | GDO_q8x4_1 |
| Majority provider of information on financial benefits/social protection for dementia carers (Public sector) | GDO_q12x2x1x1_5PUB |
| Majority provider of information on legal rights for dementia carers (Public sector) | GDO_q12x2x1x1_4PUB |
| Majority provider of information on financial benefits/social protection for dementia carers (NGO) | GDO_q12x2x1x1_5NGO |
| Majority provider of information on financial benefits/social protection for dementia carers (Private sector) | GDO_q12x2x1x1_5PRV |
| Majority provider of information on legal rights for dementia carers (NGO) | GDO_q12x2x1x1_4NGO |
| Majority provider of information on legal rights for dementia carers (Private sector) | GDO_q12x2x1x1_4PRV |
| Majority provider of palliative and end-of-life care services in community for dementia [public, private] | GDO_q8x4_5 |
| Majority provider of psycho-social supports for dementia carers (NGO) | GDO_q12x2x1x1_2NGO |
| Majority provider of psycho-social supports for dementia carers (Private sector) | GDO_q12x2x1x1_2PRV |
| Majority provider of psycho-social supports for dementia carers (Public sector) | GDO_q12x2x1x1_2PUB |
| Majority provider of psychosocial and rehabilitation services in community for dementia [public, private] | GDO_q8x4_3 |
| Majority provider of respite care for dementia carers (NGO) | GDO_q12x2x1x1_3NGO |
| Majority provider of respite care for dementia carers (Private sector) | GDO_q12x2x1x1_3PRV |
| Majority provider of respite care for dementia carers (Public sector) | GDO_q12x2x1x1_3PUB |
| Majority provider of social and financial protection for dementia [public, private] | GDO_q8x4_6 |
| Malaria - number of reported confirmed cases | WHS3_48 |
| Malaria - number of reported deaths | MALARIA001 |
| Malaria ITN use: Population in malaria-endemic areas who slept under an insecticide-treated bed net (ITN) the previous night (%) | MALARIA_ITN_USE |
| Malaria incidence (per 1 000 population at risk) | SDGMALARIA |
| Malaria incidence per 100 000 population | MALARIA005 |
| Mandatory mitigation measures if legal value is exceeded (existing buildings) | RADON_Q702 |
| Mandatory preventive measures (new buildings) | RADON_Q701 |
| Maternal mortality ratio (per 100 000 live births) | MDG_0000000026 |
| Maternal mortality ratio (per 100 000 live births) - Country reported estimates | MDG_0000000032 |
| Maximum speed limits | RS_217 |
| Mean BMI (kg/m²) (crude estimate) | NCD_BMI_MEANC |
| Mean BMI (kg/m²) (age-standardized estimate) | NCD_BMI_MEAN |
| Mean HDL cholesterol, age-standardized | NCD_CHOL_MEANHDL_A |
| Mean HDL cholesterol, crude | NCD_CHOL_MEANHDL_C |
| Mean Non-HDL cholesterol, age-standardized | NCD_CHOL_MEANNONHDL_A |
| Mean Non-HDL cholesterol, crude | NCD_CHOL_MEANNONHDL_C |
| Mean fasting blood glucose (mmol/l) (age-standardized estimate) | NCD_GLUC_01 |
| Mean fasting blood glucose (mmol/l) (crude estimate) | NCD_GLUC_02 |
| Mean fasting plasma glucose | UHC_NCD_FPG |
| Mean hemoglobin level of children aged 6-59 months | HEMOGLOBINLEVEL_CHILDREN_MEAN |
| Mean hemoglobin level of non-pregnant women (aged 15-49 years) | HEMOGLOBINLEVEL_NONPREGNANT_MEAN |
| Mean hemoglobin level of pregnant women (aged 15-49 years) | HEMOGLOBINLEVEL_PREGNANT_MEAN |
| Mean hemoglobin level of women of reproductive age (aged 15-49 years) | HEMOGLOBINLEVEL_REPRODUCTIVEAGE_MEAN |
| Mean systolic blood pressure (age-standardized estimate) | BP_06 |
| Mean systolic blood pressure (crude estimate) | BP_05 |
| Mean total cholesterol, age-standardized | NCD_CHOL_MEANTOTALCHOL_A |
| Mean total cholesterol, crude | NCD_CHOL_MEANTOTALCHOL_C |
| Measles - number of reported cases | WHS3_62 |
| Measles immunization coverage among one-year-olds (%) | mslv |
| Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC) | WHS8_110 |
| Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC) | MCV2 |
| Measures to phase down the use of dental amalgam | ORALHEALTH_DENTALAMALGAMPHASEDOWN |
| Median availability of selected generic medicines (%) - Private | WHS6_101 |
| Median availability of selected generic medicines (%) - Public | MDG_0000000010 |
| Median consumer price ratio of selected generic medicines - Private | WHS6_116 |
| Median consumer price ratio of selected generic medicines - Public | MDG_0000000011 |
| Medical and Pathology Laboratory Technicians (number) | HWF_0020 |
| Medical and Pathology Laboratory scientists (number) | HWF_0019 |
| Medical doctors (%) | HWF_0025 |
| Medical doctors (number) | HWF_0002 |
| Medical doctors (per 10,000) | HWF_0001 |
| Medical doctors not further defined (number) | HWF_0005 |
| Men who have sex with men (MSM) with active syphilis (%) | PercposMSM |
| Men who have sex with men: Condom use (percent) | MSM_CONDOMUSE_PERCENT |
| Men who have sex with men: Population size estimate (number) | MSM_PSE_NUM |
| Men who have sex with men: Syphilis prevalence (percent) | MSM_SYPHILISPREV_PERCENT |
| Meningitis - number of reported cases | WHS3_47 |
| Meningococcal A conjugate (MENGA) vaccine immunization coverage (%) (WUENIC) | VACCINECOVERAGE_MENA_C |
| Mental health day treatment facilities (per 100,000) | MH_11 |
| Mental health outpatient facilities (per 100,000) | MH_10 |
| Mental health plan | MH_2 |
| Mental health policy | MH_1 |
| Mental health units in general hospitals (per 100,000) | MH_18 |
| Mental health units in general hospitals admissions (per 100,000) | MH_24 |
| Mental hospital admissions (per 100,000) | MH_19 |
| Mental hospitals (per 100,000) | MH_17 |
| Methadone formulation used for the treatment of opiod dependence | RSUD_53 |
| Methadone provision in clinical and community-based settings | RSUD_58 |
| Methadone used for detoxification or maintenance | RSUD_52 |
| Methadone used for the treatment of opioid dependence | RSUD_51 |
| Midwifery personnel (number) | HWF_0009 |
| Minimum Acceptable Diet 6-23 months | NUT_CF_MAD |
| Minimum Meal Frequency 6-23 months | NUT_CF_MMF |
| Minimum dietary diversity 6-23 months | NUT_CF_MDD |
| Minimum legal drinking age | SA_0000001519 |
| Minimum specific excise tax applied on the beverage | TAXBEV_MINSPECEXCISETAX |
| Ministry/office that takes primary responsibility for prevention for substance use | RSUD_110 |
| Ministry/office that takes primary responsibility for treatment of substance use disorders | RSUD_140 |
| Mobile-cellular telephone subscriptions per 100 inhabitants | ITU_ICT_2 |
| Monitoring | SA_0000001651 |
| Monitoring tobacco use and prevention policies | M_Group |
| Monopoly on exports of alcoholic beverages | SA_0000001800 |
| Monopoly on imports of alcoholic beverages | SA_0000001801 |
| Monopoly on wholesale /distribution of alcoholic beverages | SA_0000001802 |
| Mortality rate among children ages 10 to 14 years (per 1000 children aged 10) | CHILDMORT_MORTALITY_10TO14 |
| Mortality rate among children ages 5 to 9 years (per 1000 children aged 5) | WHOSIS_000016 |
| Mortality rate attributed to exposure to unsafe WASH services (per 100 000 population) (SDG 3.9.2) | SDGWSHBOD |
| Mortality rate attributed to unintentional poisoning (per 100 000 population) | SDGPOISON |
| Mortality rate for 5-14 year-olds (probability of dying per 1000 children aged 5-14 years) | CHILDMORT5TO14 |
| Most recent census (year) | WHS10_1 |
| Most recent school-based survey among adolescents was recent (in the past 5 years) | M4_youth_recent |
| Most recent school-based survey among adolescents was representative of the national population | M5_youth_representative |
| Most recent survey among adults was recent (in the past 5 years) | M1_adult_recent |
| Most recent survey among adults was representative of the national population | M2_adult_representative |
| Most sold brand of cigarettes - currency reported | R_Curr_mp |
| Most sold brand of cigarettes - price in PPP$ | R_Price_mp_estimate_ppp |
| Most sold brand of cigarettes - price in US$ at official exchange rates | R_Price_mp_estimate_usd |
| Most sold brand of cigarettes - price in currency reported | R_Price_mp_estimate |
| Most sold brand of cigarettes - taxes as a % of price - ad valorem excise | R_Ad_val_estimate |
| Most sold brand of cigarettes - taxes as a % of price - import duties | R_imp_duty_estimate |
| Most sold brand of cigarettes - taxes as a % of price - other taxes | R_Other_estimate |
| Most sold brand of cigarettes - taxes as a % of price - specific excise | R_Sp_excise_estimate |
| Most sold brand of cigarettes - taxes as a % of price - total tax | R_total_tax_estimate |
| Most sold brand of cigarettes - taxes as a % of price - value added tax | R_VAT_estimate |
| Most sold brand of other tobacco type | R_type_variant |
| Most sold type of spirit | TAXBEV_MOSTSOLDSPIRIT |
| Most widely used screening method in national cervical cancer screening program | NCD_CCS_cervicalcancermethod |
| Mumps - number of reported cases | WHS3_53 |
| NCD country capacity survey response | NCDCCS_COUNTRYRESPONSE |
| NGOs for alcohol use disorders | RSUD_85 |
| NGOs for drug use disorders | RSUD_86 |
| NLIS: Children with diarrhoea <5 y receiving oral rehydration therapy (ORT) and continued feeding (%) | NLIS_NU_CA_041 |
| NLIS: Children with diarrhoea receiving zinc and ORS (%) | NLIS_NU_CA_049 |
| NLIS: Continued breastfeeding at 1 year in infants 12-15 months (%) | NLIS_NU_CA_114 |
| NLIS: Continued breastfeeding at 2 years in infants 20-23 months (%) | NLIS_NU_CA_115 |
| NLIS: Early initiation of breastfeeding within 1 hour of birth (%) | NLIS_NU_CA_003 |
| NLIS: Introduction to solid, semisolid or soft foods in infants 6-8 months (%) | NLIS_NU_CA_053 |
| NLIS: Minimum acceptable diet (MAD) in children 6-23 months (%) | NLIS_NU_CA_095 |
| NLIS: Minimum dietary diversity (MDD) in children 6-23 months (%) | NLIS_NU_CA_116 |
| NSP coverage among PWID per year (rate) | HIV_NSP_COVERAGE_RATE |
| Name of latest youth prevalence survey (nonsmoked) | Yth_nonsmoked_svy_title |
| Name of survey of adults | M_survey_title_adult |
| Name of survey of adults - smokeless | M_smkless_survey_title_adult |
| Name of survey of youth | M_survey_title_youth |
| Name of survey of youth - smokeless | M_smkless_survey_title_youth |
| National health information system (HIS) policy or strategy | GOE_Q006 |
| National Health Emergency Framework | IHRSPAR_CAPACITY08 |
| National Health Technology Assessment (HTA) unit including the assessment of medical devices, and diagnostics | DEVICES25 |
| National agency for tobacco control exists | NTCP_agcy |
| National alcohol policy specifically involves young people activities | SA_0000001725 |
| National alcohol policy specifically involves young people activities | SA_0000001725_ARCHIVED |
| National authority responsible for regulating medical devices | DEVICES24 |
| National drinking guidelines | SA_0000001649 |
| National drinking guidelines | SA_0000001790 |
| National eHealth strategy | GOE_Q003 |
| National eHealth strategy refers to objectives of UHC | GOE_Q004 |
| National guidelines for alcohol problem prevention and counselling at workplaces | SA_0000001762 |
| National guidelines for alcohol problem prevention and counselling at workplaces | SA_0000001762_ARCHIVED |
| National guidelines for implementing effective community-based interventions | SA_0000001724 |
| National guidelines for implementing effective community-based interventions | SA_0000001724_ARCHIVED |
| National guidelines for the prevention and reduction of alcohol-related harm in schools | SA_0000001761 |
| National guidelines for the prevention and reduction of alcohol-related harm in schools | SA_0000001761_ARCHIVED |
| National guidelines, policies or recommendations on the procurement of medical devices | DEVICES19 |
| National health and climate change plan or strategy developed | CCH_SURVEY_PLAN_STRATEGY_DEVELOPED |
| National legislation to prevent illegal alcohol | SA_0000001506 |
| National legislation to prevent illegal alcohol | SA_0000001506_ARCHIVED |
| National legislation to prevent illegal alcohol sales | SA_0000001792 |
| National organization for monitoring alcohol | SA_0000001813 |
| National radon concentration levels | RADON_Q302 |
| National regulator approval of anti-dementia medication | GDO_q10x1 |
| National smoking ban in ALL OTHER INDOOR PUBLIC PLACES | P9_all_other |
| National smoking ban in EDUCATIONAL FACILITIES EXCEPT UNIVERSITIES | P2_education |
| National smoking ban in GOVERNMENT FACILITIES | P4_govt |
| National smoking ban in HEALTH-CARE FACILITIES | P1_healthcare |
| National smoking ban in INDOOR OFFICES | P5_indoor_off |
| National smoking ban in PUBLIC TRANSPORT | P8_pub_transp |
| National smoking ban in PUBS AND BARS | P7_pubs |
| National smoking ban in RESTAURANTS | P6_restaurants |
| National smoking ban in UNIVERSITIES | P3_universities |
| National smoking ban: CITIZEN COMPLAINTS AND INVESTIGATIONS | P15_complaints |
| National smoking ban: DEDICATED FUNDS FOR ENFORCEMENT | P14_funds_for_enforce |
| National smoking ban: FINES FOR VIOLATIONS | P11_fines_any |
| National smoking ban: FINES ON THE ESTABLISHMENT | P12_fines_establishment |
| National smoking ban: FINES ON THE PATRON | P13_fines_smoker |
| National smoking ban: NUMBER OF PLACES SMOKE-FREE | P_count_places_sf |
| National strategy does not promote the adoption of EHR | GOE_Q160 |
| National survey on substance use among children and adolescents | RSUD_10 |
| National surveys on adult alcohol consumption | SA_0000001773 |
| National surveys on adult alcohol consumption | SA_0000001773_ARCHIVED |
| National surveys on drink-driving | SA_0000001709 |
| National surveys on heavy espisodic drinking | SA_0000001775 |
| National surveys on heavy espisodic drinking | SA_0000001775_ARCHIVED |
| National surveys on youth alcohol consumption | SA_0000001774 |
| National surveys on youth alcohol consumption | SA_0000001774_ARCHIVED |
| National system of data collection based on health service delivery | SA_0000001810 |
| National system of epidemiological data collection for alcohol use | SA_0000001809 |
| National systems for monitoring alcohol consumption and harms | SA_0000001769 |
| National systems for monitoring alcohol consumption and harms | SA_0000001769_ARCHIVED |
| National treatment policy for alcohol use disorders | SA_0000001706 |
| National universal health coverage strategy | GOE_Q001 |
| Neonatal mortality rate (deaths per 1000 live births) | nmr |
| Neonatal mortality rate (per 1000 live births) | WHOSIS_000003 |
| Neonatal tetanus - number of reported cases | WHS3_56 |
| Neonates protected at birth against neonatal tetanus (PAB) (%) | WHS4_128 |
| Net primary school enrolment ratio (%) | WHS9_87 |
| New HIV infections (per 1000 uninfected population) | SDGHIV |
| New HIV infections among adults 15-24 years old (per 1000 uninfected population) | SDGHIV1524 |
| New cases tested for RR-/MDR-TB (%) | TB_c_dst_rlt_new_pct |
| New cases: Pulmonary, smear-negative/unknown/not done and other new cases | TB_new_snsuoth |
| New cases: Pulmonary, smear-positive | TB_new_sp |
| New cases: extrapulmonary | TB_new_ep |
| New cases: other | TB_new_oth |
| New cases: pulmonary smear unknown/not done | TB_new_su |
| New cases: pulmonary smear-negative | TB_new_sn |
| New chronic hepatitis B (HBV) infections (number) | HEPATITIS_HBV_INFECTIONS_NEW_NUM |
| New chronic hepatitis C (HCV) infections (number) | HEPATITIS_HCV_INFECTIONS_NEW_NUM |
| New leprosy case detection rate per 1 000 000 population | NTD_LEPR2 |
| New leprosy child case detection rate (less than 15 years of age) per 1 000 000 child population | NTD_LEPR13 |
| New or unknown treatment history cases: Pulmonary, bacteriologically confirmed | TB_new_labconf |
| New or unknown treatment history cases: Pulmonary, clinically diagnosed | TB_new_clindx |
| New types of alcoholic beverages emerging | SA_0000001732 |
| New types of alcoholic beverages emerging | SA_0000001732_ARCHIVED |
| Nicotine replacement therapy - cost covered | O_NRT_ins |
| Nicotine replacement therapy - legally sold | O_NRT_sold |
| Nicotine replacement therapy - legally sold | TOBACCO_0000000367 |
| Nicotine replacement therapy - place available | O_NRT_where |
| Nicotine replacement therapy - place available | TOBACCO_0000000368 |
| Nicotine replacement therapy on the Essential Medicines List | O_NRT_EML |
| Not possible to gain a health sciences degree entirely through eLearning | GOE_Q134 |
| Number of Heads of WHO Country Offices/WRs | WCO_HEADSWHO_WRS_NUM |
| Number of WCO staff considered as core by the CPCP initiative | WCO_CORESTAFFCPCP_NUM |
| Number of WCO staff considered as core by the CPCP initiative (%) | WCO_CORESTAFFCPCP_PER100 |
| Number of biomedical engineers | HRH_44 |
| Number of biomedical technicians | HRH_46 |
| Number of cases of cutaneous leishmaniasis reported | NTD_LEISHCNUM |
| Number of cases of visceral leishmaniasis reported | NTD_LEISHVNUM |
| Number of cases of yaws reported | NTD_YAWSNUM |
| Number of cause-of-death registration years available | WHS10_2 |
| Number of children aged 6-59 months with anaemia (thousands) | NUTRITION_ANAEMIA_CHILDREN_NUM |
| Number of community and traditional health workers | HRH_22 |
| Number of community health workers | HRH_06 |
| Number of community health workers | WHS6_140 |
| Number of confirmed cases of Buruli ulcer reported | NTD_BU_CONF |
| Number of confirmed malaria cases | MALARIA_CONF_CASES |
| Number of confirmed yaws cases reported | NTD_YAWSNUM_CONF |
| Number of countries that have conducted at least one population and housing census in the last 10 years | SG_REG_CENSUSN |
| Number of current cigarette smokers, estimate | M_Est_cig_curr_users |
| Number of current of tobacco users, estimate | M_Est_tob_curr_users |
| Number of current tobacco smokers, estimate | M_Est_smk_curr_users |
| Number of deaths | MORT_500 |
| Number of deaths among adolescents (10 to 19 years of age) | DEATHADO |
| Number of deaths among children 5 to 14 years of age | CHILDDEATH5TO14 |
| Number of deaths among children ages 10 to 14 years | CHILDMORT_DEATHS_10TO14 |
| Number of deaths among children ages 5 to 9 years | CM_04 |
| Number of deaths attributed to non-communicable diseases, by type of disease and sex | SDG_SH_DTH_RNCOM |
| Number of deaths due to tuberculosis, excluding HIV | TB_e_mort_exc_tbhiv_num |
| Number of deaths in children aged <5 years, by cause | MORT_100 |
| Number of dental technicians/assistants | HRH_10 |
| Number of dentistry personnel | HRH_21 |
| Number of dentistry personnel | WHS6_123 |
| Number of dentists | HRH_15 |
| Number of diarrhoea DALYs from inadequate hygiene | WSH_30_HYG |
| Number of diarrhoea DALYs from inadequate sanitation | WSH_30_SAN |
| Number of diarrhoea DALYs from inadequate water | WSH_30_WAT |
| Number of diarrhoea DALYs from inadequate water, sanitation and hygiene | WSH_30 |
| Number of diarrhoea deaths from inadequate hygiene | WSH_10_HYG |
| Number of diarrhoea deaths from inadequate sanitation | WSH_10_SAN |
| Number of diarrhoea deaths from inadequate water | WSH_10_WAT |
| Number of diarrhoea deaths from inadequate water, sanitation and hygiene | WSH_10 |
| Number of environment and public health workers | HRH_12 |
| Number of environment and public health workers | WHS6_518 |
| Number of female leprosy new cases | NTD_LEPR11 |
| Number of full-time equivalent staff in national agency | NTCP_FTE |
| Number of geriatricians or psychogeriatricians (per 100,000) | GDO_q6x1_3 |
| Number of health management & support workers | HRH_11 |
| Number of health warnings approved by the law for other smoked tobacco packaging | TOBACCO_0000000389 |
| Number of imported cases of cutaneous leishmaniasis reported | NTD_LEISHCNUM_IM |
| Number of imported cases of visceral leishmaniasis reported | NTD_LEISHVNUM_IM |
| Number of imported malaria cases | MALARIA_IMPORTED |
| Number of incident tuberculosis cases | TB_e_inc_num |
| Number of incident tuberculosis cases in children aged 0 - 14 | TB_e_inc_num_014 |
| Number of incident tuberculosis cases, (HIV-positive cases) | TB_e_inc_tbhiv_num |
| Number of indigenous P. falciparum malaria cases | MALARIA_PF_INDIG |
| Number of indigenous P. vivax malaria cases | MALARIA_PV_INDIG |
| Number of indigenous malaria cases | MALARIA_INDIG |
| Number of individuals in the country requiring preventive chemotherapy for onchocerciasis | NTD_ONCHEMO |
| Number of infant deaths | CM_02 |
| Number of insecticide classes to which resistance was reported | IR_INSECTICIDERESISTANCE_PREV |
| Number of investigational pharmaceutical trials for dementia | GDO_q19x3x1_1 |
| Number of isolates tested for azithromycin | GASPTIAZM |
| Number of isolates tested for cefixime | GASPTICFM |
| Number of isolates tested for ceftriaxone | GASPTICRO |
| Number of isolates tested for ciprofloxacin | GASPTICIP |
| Number of isolates tested for extended-spectrum cephalosporins | GASPTIESC |
| Number of laboratory health workers | HRH_20 |
| Number of laboratory scientists | HRH_13 |
| Number of laboratory technicians/assistants | HRH_14 |
| Number of labour days needed to buy annual supply of fluoride toothpaste per person | ORALHEALTH_FLUORIDETOOTHPHASTE_LABOURDAYS |
| Number of licensed qualified anaesthesiologists actively working | HRH_43 |
| Number of licensed qualified obstetricians actively working | HRH_42 |
| Number of licensed qualified surgeons actively working | HRH_41 |
| Number of malaria cases treated with any first line tx courses (including artemisinin-based combination therapies (ACTs)) | MALARIA_1STLINE_TREATED |
| Number of malaria cases treated with artemisinin-based combination therapies (ACTs) | MALARIA_ACT_TREATED |
| Number of malaria positive cases by microscopy | MALARIA_MICR_POS |
| Number of malaria positive cases by rapid diagnostic test (RDT) | MALARIA_RDT_POS |
| Number of malaria suspects examined by microscopy | MALARIA_MICR_TEST |
| Number of malaria suspects examined by rapid diagnostic test (RDT) | MALARIA_RDT_TEST |
| Number of maternal deaths | MORT_MATERNALNUM |
| Number of medical assistants | HRH_17 |
| Number of meningitis epidemic districts | MENING_3 |
| Number of midwifery personnel | HRH_03 |
| Number of national population surveys - HIV prevalence | WHS10_6 |
| Number of national population surveys - adult health | WHS10_7 |
| Number of national population surveys - child anthropometry | WHS10_3 |
| Number of national population surveys - child mortality | WHS10_4 |
| Number of national population surveys - maternal mortality | WHS10_5 |
| Number of neonatal deaths | CM_03 |
| Number of neurologists (per 100,000) | GDO_q6x1_2 |
| Number of new G2D leprosy cases | NTD_LEPR5 |
| Number of new HIV infections | HIV_0000000026 |
| Number of new cases of lip and oral cavity cancer | ORAL_HEALTH_CANCER_LIPORALCAVITY_NEWCASE_NUMBER |
| Number of new leprosy cases | WHS3_45 |
| Number of new leprosy cases with G2D among children (less than 15 years of age) | NTD_LEPR9 |
| Number of new reported cases of Buruli ulcer | NTD_1 |
| Number of new reported cases of human African trypanosomiasis (T.b. gambiense) | NTD_4 |
| Number of new reported cases of human African trypanosomiasis (T.b. rhodesiense) | NTD_5 |
| Number of non-autochthonous leprosy cases | NTD_LEPR14 |
| Number of non-pregnant women (aged 15-49 years) with anaemia (thousands) | NUTRITION_ANAEMIA_NONPREGNANT_NUM |
| Number of nursing and midwifery personnel | HRH_24 |
| Number of nursing and midwifery personnel | WHS6_127 |
| Number of nursing personnel | HRH_01 |
| Number of other health workers | HRH_09 |
| Number of other health workers | HRH_23 |
| Number of people diagnosed with new episode TB who by age group and sex. | TB_notif_num_agesex |
| Number of people diagnosed with new episode of pulmonary TB who are bacteriologically confirmed. | TB_notif_num_labconf |
| Number of people diagnosed with new episode of pulmonary TB who are clinically diagnosed. | TB_notif_num_newrel_clindx |
| Number of people diagnosed with new episode of pulmonary TB who have extrapulmonary TB. | TB_notif_num_newrel_ep |
| Number of people dying from HIV-related causes | HIV_0000000006 |
| Number of people newly-admitted to prison (per 100 000 inhabitants) | PRISON_A4_NEWPRISONERS_PER100KPOP |
| Number of people notified with new episode of TB in a given year | TB_notif_num |
| Number of people operated for trachomatous trichiasis | NTD_TRA5 |
| Number of people protected from malaria by indoor residual spraying (IRS) | MALARIA_IRS_COVERAGE |
| Number of people who received treatment with antibiotics for trachoma | NTD_8 |
| Number of people with dementia involved in research routinely monitored | GDO_q19x2 |
| Number of personal care workers | HRH_18 |
| Number of pharmaceutical personnel | HRH_19 |
| Number of pharmaceutical personnel | WHS6_517 |
| Number of pharmaceutical technicians/assistants | HRH_05 |
| Number of pharmacists | HRH_04 |
| Number of physicians | HRH_02 |
| Number of pigs in the country | NTD_TSOL3 |
| Number of pregnant women (aged 15-49 years) with anaemia (thousands) | NUTRITION_ANAEMIA_PREGNANT_NUM |
| Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission | HIV_0000000015 |
| Number of pregnant women living with HIV who received antiretrovirals for preventing mother-to-child transmission | HIV_0000000016 |
| Number of presumed malaria cases | MALARIA_PRES_CASES |
| Number of prevalent tuberculosis cases | TB_e_prev_num |
| Number of prisoners | PRISON_A2_PRISIONERS_N |
| Number of prisoners (per 100 000 inhabitants) | PRISON_A2_PRISIONERS_PER100KPOP |
| Number of radiographers | HRH_08 |
| Number of registered vehicles | RS_194 |
| Number of reported cases of cholera | CHOLERA_0000000001 |
| Number of reported cases of poliomyelitis by wild poliovirus (WPV) | VACCINEPREVENTABLE_WILDPOLIO |
| Number of reported cases of tuberculosis | WHS3_522 |
| Number of reported cases of tuberculosis (DOTS) | WHS3_54 |
| Number of reported deaths from cholera | CHOLERA_0000000002 |
| Number of standard alcoholic drinks displayed on containers | SA_0000001734 |
| Number of standard alcoholic drinks displayed on containers | SA_0000001734_ARCHIVED |
| Number of suicide deaths | SDG_SH_STA_SCIDEN |
| Number of suspected cases of Buruli ulcer reported | NTD_BU_SUSP |
| Number of suspected malaria cases | MALARIA_SUSPECTS |
| Number of suspected meningitis cases reported | MENING_2 |
| Number of suspected meningitis deaths reported | MENING_1 |
| Number of suspected yaws cases reported | NTD_YAWSNUM_SUSP |
| Number of traditional birth attendants | HRH_07 |
| Number of traditional medicine practitioners | HRH_16 |
| Number of under-five deaths | CM_01 |
| Number of under-five deaths from malaria | MALARIA004 |
| Number of women of reproductive age (aged 15-49 years) with anaemia (thousands) | NUTRITION_ANAEMIA_REPRODUCTIVEAGE_NUM |
| Nurses in prisons (FTEs per 1000 prisoners) | PRISON_B9_1_NURSES_RATIO |
| Nurses working in mental health sector (per 100,000) | MH_7 |
| Nursing and midwifery personnel (number) | HWF_0007 |
| Nursing and midwifery personnel (per 10,000) | HWF_0006 |
| Nursing and midwifery personnel density (per 10 000 population) | WHS6_148 |
| Nursing and midwifery personnel density (per 1000 population) | HRH_33 |
| Nursing personnel (%) | HWF_0026 |
| Nursing personnel (number) | HWF_0008 |
| Obesity among adults, BMI ≥ 30 kg/m2 (age-standardized estimate) (%) | NCD_BMI_30A |
| Obesity among adults, BMI ≥ 30 kg/m2 (crude estimate) (%) | NCD_BMI_30C |
| Obesity among children and adolescents, BMI-for-age > +2 standard deviations above the median (crude estimate) (%) | NCD_BMI_PLUS2C |
| Obesity prevalence in non-pregnant women aged 15-49 years, BMI >= 30 (%) | obesewm |
| Obstetric and gynaecological admissions owing to abortion | OBGYN_ADMISSIONS_ABORTION |
| Occupational airborne particulates attributable DALYs ('000) | OCC_6 |
| Occupational airborne particulates attributable DALYs per 100'000 capita | OCC_8 |
| Occupational airborne particulates attributable deaths | OCC_5 |
| Occupational airborne particulates attributable deaths per 100'000 capita | OCC_7 |
| Occupational carcinogens attributable DALYs ('000) | OCC_10 |
| Occupational carcinogens attributable DALYs per 100'000 capita | OCC_12 |
| Occupational carcinogens attributable deaths | OCC_9 |
| Occupational carcinogens attributable deaths per 100'000 capita | OCC_11 |
| Occupational ergonomic stressors attributable DALYs ('000) | OCC_16 |
| Occupational ergonomic stressors attributable DALYs per 100'000 capita | OCC_18 |
| Occupational ergonomic stressors attributable deaths | OCC_15 |
| Occupational ergonomic stressors attributable deaths per 100'000 capita | OCC_17 |
| Occupational injuries attributable DALYs ('000) | OCC_20 |
| Occupational injuries attributable DALYs per 100'000 capita | OCC_22 |
| Occupational injuries attributable deaths | OCC_19 |
| Occupational injuries attributable deaths per 100'000 capita | OCC_21 |
| Occupational noise attributable DALYs ('000) | OCC_13 |
| Occupational noise attributable DALYs per 100'000 capita | OCC_14 |
| Occupational risk factors attributable DALYs ('000) | OCC_2 |
| Occupational risk factors attributable DALYs per 100'000 capita | OCC_4 |
| Occupational risk factors attributable deaths | OCC_1 |
| Occupational risk factors attributable deaths per 100'000 capita | OCC_3 |
| Occupational therapists in mental health sector (per 100,000) | MH_22 |
| Off-premise sales restrictions at petrol stations | SA_0000001530 |
| Off-premise sales restrictions at petrol stations | SA_0000001530_ARCHIVED |
| Off-premise sales restrictions at specific events | SA_0000001529 |
| Off-premise sales restrictions at specific events | SA_0000001529_ARCHIVED |
| Off-premise sales restrictions on days | SA_0000001525 |
| Off-premise sales restrictions on days | SA_0000001525_ARCHIVED |
| Off-premise sales restrictions on hours | SA_0000001526 |
| Off-premise sales restrictions on hours | SA_0000001526_ARCHIVED |
| Off-premise sales restrictions on outlet density | SA_0000001528 |
| Off-premise sales restrictions on outlet density | SA_0000001528_ARCHIVED |
| Off-premise sales restrictions on places | SA_0000001527 |
| Off-premise sales restrictions on places | SA_0000001527_ARCHIVED |
| Offering help to quit tobacco use | O_Group |
| Official development assistance for medical research and basic health sectors as a percentage of GNI (%), by donor country | SDGODA02 |
| Official prison capacity (count) | PRISON_A1_CAPACITY |
| Official standards/guidelines for prevention/mitigation | RADON_Q705 |
| On-premise sales restrictions at specific events | SA_0000001535 |
| On-premise sales restrictions at specific events | SA_0000001535_ARCHIVED |
| On-premise sales restrictions on days | SA_0000001531 |
| On-premise sales restrictions on days | SA_0000001531_ARCHIVED |
| On-premise sales restrictions on hours | SA_0000001532 |
| On-premise sales restrictions on hours | SA_0000001532_ARCHIVED |
| On-premise sales restrictions on outlet density | SA_0000001534 |
| On-premise sales restrictions on outlet density | SA_0000001534_ARCHIVED |
| On-premise sales restrictions on places | SA_0000001533 |
| On-premise sales restrictions on places | SA_0000001533_ARCHIVED |
| On-premise sales restrictions to intoxicated persons | SA_0000001536 |
| On-premise sales restrictions to intoxicated persons | SA_0000001536_ARCHIVED |
| Open access interventions for alcohol | RSUD_720 |
| Open access interventions for drugs | RSUD_730 |
| Open access services for substance use disorders | RSUD_43 |
| Opioid agonist pharmacotherapy for the treatment of opioid dependence (detoxification or maintenance) | RSUD_49 |
| Opioid agonist pharmacotherapy for the treatment of opioid dependence (maintenance) | RSUD_89 |
| Oral diseases prevalence (%) | ORALHEALTH_ORALDISEASES |
| Oral health care services generally available in primary health care facilities | ORALHEALTH_SERVICESPHCFACILITIES |
| Oral health interventions as part of health benefit packages: Advanced curative oral health care | ORALHEALTH_UHC_ADVANCE_CURATIVE |
| Oral health interventions as part of health benefit packages: Coverage of the largest government health financing scheme (%) | ORALHEALTH_UHC_GOVSCHEME |
| Oral health interventions as part of health benefit packages: Essential curative oral health care | ORALHEALTH_UHC_ESSENTIAL_CURATIVE |
| Oral health interventions as part of health benefit packages: Rehabilitatative oral health care | ORALHEALTH_UHC_REHABILITATION |
| Oral health interventions as part of health benefit packages: Routine and preventive oral health care | ORALHEALTH_UHC_PREVENTIVE |
| Oral health screening for early detection of oral diseases | ORALHEALTH_AVAILABILITY_SCREENING |
| Oral health: Basic restorative dental procedures to treat existing dental decay | ORALHEALTH_AVAILABILITY_RESTORATIVE |
| Oral health: Noma recognized as a national public health problem | ORALHEALTH_NOMA |
| Oral health: Urgent treatment for providing emergency oral care and pain relief | ORALHEALTH_AVAILABILITY_URGENTCARE |
| Organochlorine resistance reported for at least one site | IR_ORGANOCHLORINE_PRESENCE |
| Organophosphate resistance reported for at least one site | IR_ORGANOPHOSPHATE_PRESENCE |
| Other health workers density (per 1000 population) | HRH_30 |
| Other non-specialized doctors in mental health sector (per 100,000) | MH_23 |
| Other smoked tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas | W23_emissions_front_back_B |
| Other smoked tobacco packaging and labelling must display qualitative information on relevant constituents and emissions | W22_emissions_qual_B |
| Other smoked tobacco packaging and labelling must not display expiry dates | W24_exp_date_B |
| Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | W21_emissions_B |
| Other smoked tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | W21_emissions_quant_B |
| Other smoked tobacco packaging and labelling must not use descriptors depicting flavours | W20_flavours_B |
| Other smoked tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors | W19_colours_numbers_B |
| Other taxes on beverages (%) | TAXBEV_OTHERTAXES |
| Out-of-Pocket expenditure on health as percentage of total health expenditure?? | NHAOOPSTHE |
| Out-of-pocket expenditure (OOP) per capita in PPP int$ | GHED_OOP_pc_PPP_SHA2011 |
| Out-of-pocket expenditure (OOP) per capita in US$ | GHED_OOP_pc_US_SHA2011 |
| Out-of-pocket expenditure as a percentage of private expenditure on health | WHS7_139 |
| Out-of-pocket expenditure as a percentage of total expenditure on health | SDGOOP |
| Out-of-pocket expenditure as a percentage of total expenditure on health | WHS7_150 |
| Out-of-pocket expenditure as percentage of current health expenditure (CHE) (%) | GHED_OOPSCHE_SHA2011 |
| Outcome evaluation was employed to assess effectiveness | Camp_eval_impact |
| Outpatient health centres | GDO_q9_5 |
| Outpatient social centres | GDO_q9_6 |
| Outpatient visits (per 100,000) | MH_20 |
| Overall compliance with bans on direct advertising (score) | E_compl_all_dir |
| Overall compliance with bans on promotion and sponsorship (score) | E_compl_e_all_indir |
| Overall compliance with regulations on smoke-free environments (score) | P_compl_all_sfe |
| Overweight among adults, BMI ≥ 25 kg/m2 (age-standardized estimate) (%) | NCD_BMI_25A |
| Overweight among adults, BMI ≥ 25 kg/m2 (crude estimate) (%) | NCD_BMI_25C |
| Overweight among children and adolescents, BMI-for-age > +1 standard deviations above the median (crude estimate) (%) | NCD_BMI_PLUS1C |
| Overweight numbers among children under 5 years of age (thousands), model-based estimates | NUTOVERWEIGHTNUM |
| Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), model-based estimates | NUTOVERWEIGHTPREV |
| Overweight prevalence among children under 5 years of age (% weight-for-height >+2 SD), survey-based estimates | NUTRITION_ANT_WHZ_NE2 |
| Overweight prevalence in children aged <five years (%) | overwgt5 |
| Overweight prevalence in children aged <three years (%) | overwgt3 |
| Participation rate in organized learning (one year before the official primary entry age) (%) | SE_PRE_PARTN |
| Partners and donors | WCO_PARTNERSDONORS |
| Partners and donors by groups (%) | WCO_PARTNERSDONORS_GROUPED_PER100 |
| Patient safety core indicator aggregated (%) | PATIENTSAFETY_COREINDICATORAGGREGATE |
| Patient safety core indicator survey response | PATIENTSAFETY_COREINDICATORRESPONSE |
| Patient safety strategic objective (%) | PATIENTSAFETY_STRATEGICOBJECTIVEAGGREGATE |
| Patient safety strategy score | PATIENTSAFETY_STRATEGYSCORE |
| Pattern of antibiotic consumption at national level (relative use by AWaRe classification) | GLASSAMC_AWARE |
| Penalties for drink driving | SA_0000001726 |
| Penalties for drink driving | SA_0000001726_ARCHIVED |
| Penalties for drink driving, repeated offense | SA_0000001793 |
| Penalties for marketing infringements | SA_0000001729 |
| Penalties for marketing infringements | SA_0000001729_ARCHIVED |
| People living with HIV diagnosed with chronic hepatitis C infection (percent) | HEPATITIS_HCV_TESTING_HIV_PERCENT |
| People living with HIV treated for chronic hepatitis C infection (percent) | HEPATITIS_HCV_TREATMENT_HIV_PERCENT |
| People living with HIV who inject drugs, diagnosed with chronic hepatitis C infection (percent) | HEPATITIS_HCV_TESTING_PWID_PERCENT |
| People living with HIV who inject drugs, treated for chronic hepatitis C infection (percent) | HEPATITIS_HCV_TREATMENT_PWID_PERCENT |
| People living with chronic hepatitis B (HBV) (number) | HEPATITIS_HBV_LIVINGWITH_NUM |
| People living with chronic hepatitis C (HCV) (number) | HEPATITIS_HCV_LIVINGWITH_NUM |
| People living with chronic hepatitis C (HCV) including cured (all ages) (adjusted number) | HEPATITIS_HCV_LIVINGWITH_CRD_NUM |
| People who identify the use of condoms as a way to avoid AIDS (%) | EQ_CONDOMUSE |
| People who inject drugs: Population size estimates (number) | PWID_PSE_NUM |
| Per capita availability of refined sugar (g/day) | ORALHEALTH_SUGAR_AVAILABILITY |
| Per capita current health expenditure in PPP (oral health) | ORALHEALTH_DENOMINATOR_CHEPPP |
| Per capita expenditure on dental healthcare (US$) | ORALHEALTH_DENTALHEALTHCARE_EXP_PERCAP |
| Per capita government expenditure on health (PPP int. $) | WHS7_108 |
| Per capita government expenditure on health at average exchange rate (US$) | WHS7_104 |
| Per capita total expenditure on health (PPP int. $) | WHS7_105 |
| Per capita total expenditure on health at average exchange rate (US$) | WHS7_156 |
| Perceived trend in alcohol-related harm and consequences | SA_0000001467 |
| Perceived trend in exports | SA_0000001683 |
| Perceived trend in imports | SA_0000001681 |
| Perceived trend in production | SA_0000001680 |
| Perceived trend in sales | SA_0000001682 |
| Percent of all DALYs attributable to alcohol | SA_0000001834 |
| Percent of urban inhabitants living in cities covered by PM measurements | AIR_3_1 |
| Percentage of HIV-positive results returned to people in the calendar year | HIV_POSITIVITY |
| Percentage of HWCOs/WRs, by sex | WCO_HWCO_PER100 |
| Percentage of Heads of WHO Country Offices/WRs from outside the region | WCO_HEADSWHO_WRS_OUTSIDEREGIONS_PER100 |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to DR-TB. | TB_cc_prct_DRTB |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to DS-TB. | TB_cc_prct_DSTB |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q1 (lowest) income or expenditure quantile. | TB_cc_prct_Q1 |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q2 income or expenditure quantile. | TB_cc_prct_Q2 |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q3 income or expenditure quantile. | TB_cc_prct_Q3 |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q4 income or expenditure quantile. | TB_cc_prct_Q4 |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB among Q5 (highest) income or expenditure quantile. | TB_cc_prct_Q5 |
| Percentage of TB-affected households facing costs >20% of household income or expenditure due to TB. | TB_cc_prct |
| Percentage of WHO’s minimum requirements for IPC met at the national level, particularly to support outbreak preparedness, readiness, and response | MIN_IPC_REQTS_MET |
| Percentage of children under 15 years exposed to second-hand smoke | SHS_1 |
| Percentage of health-care facilities with no access to any electricity supply (%) | HCF_NO_ELECTRICITY |
| Percentage of health-care facilities with reliable electricity supply (%) | HCF_REL_ELECTRICITY |
| Percentage of health-care facilities with unreliable electricity supply (%) | HCF_UNREL_ELECTRICITY |
| Percentage of individuals using the Internet | ITU_ICT_1 |
| Percentage of men (15+ years) exposed to second-hand smoke | SHS_3 |
| Percentage of older people receiving long-term care at a residential care facility and home | LTC_OLDER_PEOPLE |
| Percentage of people living with HIV receiving treatment who have suppressed viral loads | HIV_VIRALLOADSUPPRESSEDART |
| Percentage of people living with HIV who have suppressed viral loads | HIV_VIRALLOADSUPPRESSED |
| Percentage of people living with HIV who know their HIV status | HIV_STATUSKNOWNHIV |
| Percentage of people living with HIV who know their status receiving antiretroviral therapy | HIV_STATUSKNOWNART |
| Percentage of population reporting perceived barriers to care (geographical, sociocultural, financial) [DHS] | POP_PERCEIVED_BARRIERS_CARE_DHS |
| Percentage of population reporting perceived barriers to care (geographical, sociocultural, financial) [Eurostat] | POP_PERCEIVED_BARRIERS_CARE_EUROSTAT |
| Percentage of principal display area mandated to be covered by health warnings - back of cigarette packaging | W4_pc_back_A |
| Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging | TOBACCO_0000000391 |
| Percentage of principal display area mandated to be covered by health warnings - back of other smoked tobacco packaging | W4_pc_back_B |
| Percentage of principal display area mandated to be covered by health warnings - back of smokeless tobacco packaging | W4_pc_back_C |
| Percentage of principal display area mandated to be covered by health warnings - front and back of cigarette packaging | W2_pc_front_back_A |
| Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging | TOBACCO_0000000386 |
| Percentage of principal display area mandated to be covered by health warnings - front and back of other smoked tobacco packaging | W2_pc_front_back_B |
| Percentage of principal display area mandated to be covered by health warnings - front and back of smokeless tobacco packaging | W2_pc_front_back_C |
| Percentage of principal display area mandated to be covered by health warnings - front of cigarette packaging | W3_pc_front_A |
| Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging | TOBACCO_0000000387 |
| Percentage of principal display area mandated to be covered by health warnings - front of other smoked tobacco packaging | W3_pc_front_B |
| Percentage of principal display area mandated to be covered by health warnings - front of smokeless tobacco packaging | W3_pc_front_C |
| Percentage of sites for which carbamate resistance was reported | IR_CARBAMATE_EXTENT |
| Percentage of sites for which organochlorine resistance was reported | IR_ORGANOCHLORINE_EXTENT |
| Percentage of sites for which organophosphate resistance was reported | IR_ORGANOPHOSPHATE_EXTENT |
| Percentage of sites for which pyrethroid resistance was reported | IR_PYRETHROID_EXTENT |
| Percentage of sub-national regions covered by dementia plan | GDO_q2x3x1_1 |
| Percentage of the adults (15+ years) with blood lead levels above 10ug/dl | LEAD_4 |
| Percentage of the adults (15+ years) with blood lead levels above 5ug/dl | LEAD_3 |
| Percentage of the children under 15 years with blood lead levels above 10ug/dl | LEAD_2 |
| Percentage of the children under 15 years with blood lead levels above 5ug/dl | LEAD_1 |
| Percentage of the total population living in cities > 100'000 inhabitants | AIR_3 |
| Percentage of total deaths due to NCDs overall and percentage of total deaths due to 7 main categories (5 different NCD categories plus 2 non-NCD categories which together total all deaths) | NCDMORTPERCENT |
| Percentage of women (15+ years) exposed to second-hand smoke | SHS_2 |
| Percentage of women consuming at least 90 iron-containing supplements during pregnancy | NUTRITION_ANE_IFA_W_90P |
| Persistence to last grade of primary (% of cohort) | SE_PRM_PRSL_ZS |
| Persons initiated chronic hepatitis C(HCV) treatment (number) | HEPATITIS_HCV_TREATMENT_INITIATED_NUM |
| Persons on chronic hepatitis B (HBV) treatment (number) | HEPATITIS_HBV_TREATMENT_NUM |
| Persons on chronic hepatitis C (HCV) treatment, cumulative (number) | HEPATITIS_HCV_TREATMENT_CUM_NUM |
| Persons with alcohol use disorders receiving treatment (%) | SA_0000001707 |
| Pertussis - number of reported cases | WHS3_43 |
| Pharmaceutical Technicians and Assistants (number) | HWF_0016 |
| Pharmaceutical personnel density (per 1000 population) | HRH_25 |
| Pharmacists (number) | HWF_0015 |
| Pharmacists (per 10,000) | HWF_0014 |
| Pharmacotherapy used for the management of alcohol withdrawal | RSUD_68 |
| Pharmacotherapy used for the management of benzodiazepine withdrawal | RSUD_69 |
| Pharmacotherapy used for the management of cannabis withdrawal | RSUD_70 |
| Pharmacotherapy with buprenorphine | RSUD_440 |
| Pharmacotherapy with buprenorphine/naloxone | RSUD_450 |
| Pharmacotherapy with methadone | RSUD_430 |
| Physical activity active environments | PHYSICALACTIVITY_ACTIVEENVIRONMENTS |
| Physical activity among adolescents, active on all 7 days of the past week, prevalence (%) | PHYSICALACTIVITY_ADO_PREV_7DAY |
| Physical activity among adolescents, mean active days per week | PHYSICALACTIVITY_ADO_DAY |
| Physical activity among adolescents, no active days in the past week, prevalence (%) | PHYSICALACTIVITY_ADO_PREV_0DAY |
| Physical activity policies focused on active people | PHYSICALACTIVITY_ACTIVEPEOPLE |
| Physical activity policies focused on active systems | PHYSICALACTIVITY_ACTIVESYSTEMS |
| Physical activity policies for activie societies | PHYSICALACTIVITY_ACTIVESOCIETIES |
| Physical activity regional summary | PHYSICALACTIVITY_REGION |
| Physical fighting, past 12 months (%) | VIOLENCE_PHYSICAL_FIGHTING |
| Physicians density (per 1000 population) | HRH_26 |
| Physicians in prisons (FTEs per 1000 prisoners) | PRISON_B9_1_PHYSICIANS_RATIO |
| Physiotherapists (number) | HWF_0021 |
| Physiotherapy Technicians and Assistants (number) | HWF_0022 |
| Plague - number of reported cases | WHS3_52 |
| Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | W26_plainSPACEpackaging_A |
| Plain packaging of cigarettes is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | W26_plain_packaging_A |
| Plain packaging of other smoked tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | W26_plain_packaging_B |
| Plain packaging of smokeless tobacco products is mandatory (ie. the use of logos colours brand images or promotional information on packaging other than brand names and product names displayed in a standard colour and font style is prohibited). | W26_plain_packaging_C |
| Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC) | PCV3 |
| Point prevalence (%), alcohol use disorders, 15+ years | RSUD_1 |
| Point prevalence (%), drug use disorders, 15+ years | RSUD_2 |
| Points of Entry (SPAR) | IHRSPAR_CAPACITY11 |
| Points of entry | IHR09 |
| Points of entry (PoEs) and border health | IHRSPAR2_C11 |
| Policy | GOE_Q064 |
| Policy documents on the pharmacological treatment of substance use disorders | RSUD_14 |
| Policy or strategy makes specific reference tothe use of social media in the health domain | GOE_Q182 |
| Policy, Legal and normative Instruments to implement IHR | IHRSPAR2_C01 |
| Polio immunization coverage among one-year-olds (%) | poliov |
| Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC) | WHS4_544 |
| Poliomyelitis - number of reported cases | WHS3_49 |
| Population | RS_1845 |
| Population pushed below the $1.90 a day poverty line by household health expenditures (%) | FINPROTECTION_IMP_NP190_POP |
| Population (in thousands) total | WHS9_86 |
| Population (millions) | ORGANPOP |
| Population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS (%) | MDG_0000000021 |
| Population in areas that warrant treatment with antibiotics, facial cleanliness and environmental improvement for elimination of trachoma as a public health problem | NTD_7 |
| Population living in urban areas (%) | WHS9_96 |
| Population living on <$1 (PPP int. $) a day (%) | WHS9_90 |
| Population median age (years) | WHS9_88 |
| Population practising open defecation (%) | WSH_SANITATION_OD |
| Population proportion over 60 (%) | WHS9_92 |
| Population proportion under 15 (%) | WHS9_89 |
| Population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban) | FINPROTECTION_IMP_NPRELPL_POP |
| Population pushed below the $2.15 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_NP215_POP |
| Population pushed below the $3.20 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_NP310_POP |
| Population pushed below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_NP365_POP |
| Population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, national, rural, urban) | FINPROTECTION_IMP_PRELPL_POP |
| Population pushed further below the $1.90 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_P190_POP |
| Population pushed further below the $2.15 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_P215_POP |
| Population pushed further below the $3.20 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_P310_POP |
| Population pushed further below the $3.65 a day poverty line by household health expenditures (%, national, rural, urban) | FINPROTECTION_IMP_P365_POP |
| Population using at least basic drinking-water services (%) | WSH_WATER_BASIC |
| Population using at least basic sanitation services (%) | WSH_SANITATION_BASIC |
| Population using safely managed drinking-water services (%) | WSH_WATER_SAFELY_MANAGED |
| Population using safely managed sanitation services (%) | WSH_SANITATION_SAFELY_MANAGED |
| Population using solid fuels (%) | WHS5_512 |
| Population with access to an insecticide-treated bed net (ITN) for malaria protection (%), modelled | MALARIA_ITN_COVERAGE |
| Population with basic handwashing facilities at home (%) | WSH_HYGIENE_BASIC |
| Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (%) | FINPROTECTION_CATA_TOT_10_LEVEL_SH |
| Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, estimated data) (millions) | FINPROTECTION_CATA_TOT_10_LEVEL_MILLION |
| Population with household spending on health greater than 10% of total household budget (SDG 3.8.2, reported data) (%) | FINPROTECTION_CATA_TOT_10_POP |
| Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (%) | FINPROTECTION_CATA_TOT_25_LEVEL_SH |
| Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, estimated data) (millions) | FINPROTECTION_CATA_TOT_25_LEVEL_MILLION |
| Population with household spending on health greater than 25% of total household budget (SDG 3.8.2, reported data) (%) | FINPROTECTION_CATA_TOT_25_POP |
| Population with primary reliance on clean fuels and technologies for cooking (in millions) | PHE_HHAIR_POP_CLEAN_FUELS |
| Population with primary reliance on fuels and technologies for cooking, by fuel type (in millions) | PHE_HHAIR_POP_CATEGORY_FUELS |
| Population with primary reliance on polluting fuels and technologies for cooking (in millions) | PHE_HHAIR_POP_POLLUTING_FUELS |
| Postgraduate training programme in prevention | RSUD_770 |
| Postgraduate training programme in treatment | RSUD_800 |
| Postnatal care visit within two days of birth (in the five years preceding the survey) (%) | pncall5 |
| Postnatal care visit within two days of birth (in the three years preceding the survey) (%) | pncall3 |
| Postnatal care visit within two days of birth (in the x years preceding the survey) (%) | pncall |
| Postnatal care visit within two days of birth - born outside a health facility (in the five years preceding the survey) (%) | pnchome5 |
| Postnatal care visit within two days of birth - born outside a health facility (in the three years preceding the survey) (%) | pnchome3 |
| Postnatal care visit within two days of birth - born outside a health facility (in the x years preceding the survey) (%) | pnchome |
| Poverty headcount ratio at $1.25 a day (PPP) (% of population) | CCO_1 |
| Power density (W/m^2) | EMFLIMITPOWERDENSITY |
| Power density limit at 1800 MHz (W/m^2) | EMFLIMITPOWERDENSITY1800 |
| Power density limit at 900 MHz (W/m^2) | EMFLIMITPOWERDENSITY900 |
| Power frequency (Hz) | EMFPOWERFREQUENCY |
| Practice of backyard pig production | NTD_TSOL4 |
| Pre-service eLearning programmes have been evaluated | GOE_Q109 |
| Pregnant women attending antenatal care who received additional testing for HBV (percent) | HEPATITIS_HBV_ADDEDTEST_ANC_PERCENT |
| Pregnant women attending antenatal care, tested for HBsAg (percent) | HEPATITIS_HBV_TESTING_ANC_PERCENT |
| Pregnant women attending antenatal care, tested positive for HBsAg (percent) | HEPATITIS_HBV_TESTPOSITIVE_ANC_PERCENT |
| Pregnant women attending antenatal care at least once and receiving at least 3 doses of Intermittent Preventive Treatment of Malaria for Pregnant Women (IPTp3) (%) | MALARIA_IPTP3_COVERAGE |
| Pregnant women sleeping under insecticide-treated nets (%) | itnwm |
| Premature deaths due to noncommunicable diseases (NCD) as a proportion of all NCD deaths | NCD_UNDER70 |
| Premium brand of cigarettes - currency reported | R_Curr_premium_cost |
| Premium brand of cigarettes - price in US$ at official exchange rates | R_Price_premium_usd |
| Premium brand of cigarettes - price in currency reported | R_Price_premium_estimate |
| Premium brand of cigarettes - price in international dollars | R_Price_premium_ppp |
| Prepaid plans as percentage of total health expenditure? | NHAPREPAIDTHE |
| Preparedness | IHR05 |
| Prescription requirements for buprenorphine | RSUD_65 |
| Prescription requirements for buprenorphine/naloxone | RSUD_66 |
| Prescription requirements for methadone | RSUD_64 |
| Presence of an EML with dental preparations | ORALHEALTH_EMLDENTALPREP |
| Presence of dedicated staff for oral health working on NCDs at the MoH | ORALHEALTH_NCD_STAFF |
| Presence of formal agreement/joint plan for dementia care coordination | GDO_q5x1x3 |
| Presence of porcine cysticercosis | NTD_TSOL2 |
| Preterm birth (number) | PRETERMBIRTH_NUMBER |
| Preterm birth rate (per 100 live births) | PRETERMBIRTH_RATE |
| Preterm birth rate (per 100 live births) | WHS_PBR |
| Prevalence of HIV among adults aged 15 to 49 (%) | MDG_0000000029 |
| Prevalence of HIV among adults aged >=15 years (per 100 000 population) | MDG_0000000019 |
| Prevalence of active syphilis in 15-49 year olds (%) | STI_SYPHILIS_PREVALENCE_PER100 |
| Prevalence of anaemia in children aged 6-59 months (%) | NUTRITION_ANAEMIA_CHILDREN_PREV |
| Prevalence of anaemia in non-pregnant women (aged 15-49) (%) | NUTRITION_ANAEMIA_NONPREGNANT_PREV |
| Prevalence of anaemia in pregnant women (aged 15-49) (%) | NUTRITION_ANAEMIA_PREGNANT_PREV |
| Prevalence of anaemia in women of reproductive age (aged 15-49) (%) | NUTRITION_ANAEMIA_REPRODUCTIVEAGE_PREV |
| Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population | TB_ps_prev_bc_100k |
| Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population by age group | TB_ps_prev_bc_100k_byagegroup |
| Prevalence of bacteriologically-confirmed pulmonary TB among those aged ≥15 years, per 100,000 population by sex. | TB_ps_prev_bc_100k_bysex |
| Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population | TB_ps_prev_bc_100k_sp |
| Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by age group | TB_ps_prev_bc_100k_byagegroup_sp |
| Prevalence of bacteriologically-confirmed pulmonary TB who are smear positive among those aged ≥15 years, per 100,000 population by sex. | TB_ps_prev_bc_100k_bysex_sp |
| Prevalence of cervical cancer screening among women aged 30-49 years (%) | NCD_CXCA_SCREENED_WITHIN_TIMEPERIOD |
| Prevalence of chlamydia in individuals (%) | STI_CHLAMYDIA_PREVALENCE_PER100 |
| Prevalence of chronic hepatitis B (HBV) in the general population (%) | HEPATITIS_HBV_PREVALENCE_PER100 |
| Prevalence of chronic hepatitis C (HCV) ) in the general population (%) | HEPATITIS_HCV_PREVALENCE_PER100 |
| Prevalence of condom use by adults during higher-risk sex (15-49) (%) | MDG_0000000015 |
| Prevalence of current cigarette smoking among adolescents (%) | Yth_curr_cig_smoking |
| Prevalence of current e-cigarette use among adolescents (%) | Yth_curr_e-cig |
| Prevalence of current smokeless tobacco use among adolescents (%) | Yth_curr_smokeless |
| Prevalence of current tobacco smoking among adolescents (%) | Yth_curr_tob_smoking |
| Prevalence of current tobacco use among adolescents (%) | Yth_curr_tob_use |
| Prevalence of current tobacco use among adolescents (13-15 years) (%) | WHOSIS_000013 |
| Prevalence of current tobacco use among adolescents aged 13-15 years | TOBACCO_0000000344 |
| Prevalence of daily cigarette smoking among adolescents (%) | Yth_daily_cig_smoking |
| Prevalence of daily e-cigarette use among adolescents (%) | Yth_daily_e-cig |
| Prevalence of daily smokeless tobacco use among adolescents (%) | Yth_daily_smokeless |
| Prevalence of daily tobacco smoking among adolescents (%) | Yth_daily_tob_smoking |
| Prevalence of daily tobacco use among adolescents (%) | Yth_daily_tob_use |
| Prevalence of diabetes, age-standardized | NCD_DIABETES_PREVALENCE_AGESTD |
| Prevalence of diabetes, crude | NCD_DIABETES_PREVALENCE_CRUDE |
| Prevalence of edentulism in people 20+ years (%) | ORALHEALTH_EDENTULISM_PREVALENCE |
| Prevalence of gonorrhoea in individuals (%) | STI_GONORRHOEA_PREVALENCE_PER100 |
| Prevalence of insufficient physical activity among adults aged 18+ years (age-standardized estimate) (%) | NCD_PAA |
| Prevalence of insufficient physical activity among adults aged 18+ years (crude estimate) (%) | NCD_PAC |
| Prevalence of met need of assistive products (%) | ASSISTIVETECH_METNEED |
| Prevalence of need of assistive products (%) | ASSISTIVETECH_TOTALNEED |
| Prevalence of non-elevated blood pressure (%) | UHC_NCD_NONELEVBP |
| Prevalence of non-use of tobacco | UHC_TOBACCONO |
| Prevalence of obesity among children and adolescents, BMI > +2 standard deviations above the median (age-standardized estimate) (%) | NCD_BMI_PLUS2A |
| Prevalence of overweight among children and adolescents, BMI > +1 standard deviations above the median (age-standardized estimate) (%) | NCD_BMI_PLUS1A |
| Prevalence of overweight and obesity | EQ_OVERWEIGHTADULT |
| Prevalence of rifampicin resistance among pulmonary TB cases. | TB_drs_rr_prct |
| Prevalence of severe periodontal disease in people 15+ year (%) | ORALHEALTH_SEVEREPERIODONTALDISEASE |
| Prevalence of smoking any tobacco product among adults (≥15 years) (%) | WHOSIS_000012 |
| Prevalence of smoking any tobacco product among persons aged >= 15 years | TOBACCO_0000000192 |
| Prevalence of thinness among children and adolescents, BMI < -2 standard deviations below the median (age-standardized estimate) (%) | NCD_BMI_MINUS2A |
| Prevalence of trichomoniasis in individuals (%) | STI_TRICHOMONIASIS_PREVALENCE_PER100 |
| Prevalence of tuberculosis (per 100 000 population) | MDG_0000000023 |
| Prevalence of untreated caries of deciduous teeth in children 1-9 years (%) | ORALHEALTH_UNTREATEDCARIESDECIDUOUS |
| Prevalence of untreated caries of permanent teeth in people 5+ years (%) | ORALHEALTH_UNTREATEDCARIESPERMANENT |
| Prevalence of use of assistive products (%) | ASSISTIVETECH_USEPREVALENCE |
| Prevalent cases of active syphilis (in thousands) | STI_SYPHILIS_PREVALENTCASES |
| Prevalent cases of chlamydia in individuals (in thousands) | STI_CHLAMYDIA_PREVALENTCASES |
| Prevalent cases of gonorrhoea in individuals (in thousands) | STI_GONORRHOEA_PREVALENTCASES |
| Prevalent cases of trichomoniasis in individuals (in thousands) | STI_TRICHOMONIASIS_PREVALENTCASES |
| Prevention activities for substance use disorders, main focus | RSUD_76 |
| Prevention programmes for alcohol | RSUD_580 |
| Prevention programmes for drugs | RSUD_600 |
| Prevention programmes for specific populations for alcohol | RSUD_590 |
| Prevention programmes for specific populations for drugs | RSUD_610 |
| Prevention/counselling at workplaces for those with alcohol problems | SA_0000001717 |
| Previously treated cases, excluding relapse | TB_ret_nrel |
| Previously treated cases tested for RR-/MDR-TB (%) | TB_c_dst_rlt_ret_pct |
| Price measures | SA_0000001730 |
| Price measures | SA_0000001730_ARCHIVED |
| Prices for alcoholic beverages (average, US$) | SA_0000001523 |
| Prices for alcoholic beverages (average, US$) | SA_0000001523_ARCHIVED |
| Primary data availability for UHC Service Coverage Index (SDG 3.8.1) (%) | UHC_AVAILABILITY_SCORE |
| Primary health care expenditure (PHCE) per сapita in US$ | GHED_PHC_pc_US_SHA2011 |
| Priorities | GOE_Q065 |
| Privacy and security laws need to be in place | GOE_Q201 |
| Private expenditure on health as a percentage of total expenditure on health | WHS7_147 |
| Private funding for eHealth | GOE_Q008 |
| Private prepaid plans as a percentage of private expenditure on health | WHS7_103 |
| Probability (%) of dying between age 30 and exact age 70 from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease | NCDMORT3070 |
| Probability of spillover of zoonotic diseases | ZOONOTIC_DISEASES_SPILLOVER |
| Process evaluation was employed to assess implementation | Camp_airtime |
| Process evaluation was employed to assess implementation of the campaign | Camp_media_monitor |
| Procurement of medical devices carried out at the national level | DEVICES17 |
| Production in 1000s hectolitres | SA_0000001676 |
| Programme budget (%) | WCO_PROGRAMBUDGET_PER100 |
| Programme budget (in US$ million) | WCO_PROGRAMBUDGET_NUM |
| Programmes diverting clients from the justice system towards treatment | RSUD_19 |
| Programmes for the prevention of substance use disorders for special populations | RSUD_77 |
| Programmes readily available | RSUD_630 |
| Projection of deaths per 100 000 population | MORT_700 |
| Projection of number of deaths | MORT_600 |
| Promoting standards and interoperability | GOE_Q030_2 |
| Promoting the development and adoption of mHealth | GOE_Q030_5 |
| Proportion of births delivered in a health facility (Facility births) (%) | SRHINSTITUTIONALBIRTH |
| Proportion of bloodstream infection due to Escherichia coli resistant to third-generation cephalosporins (%) | AMR_INFECT_ECOLI |
| Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%) | AMR_INFECT_MRSA |
| Proportion of children aged 6-23 months who receive a minimum acceptable diet | NUTRITION_2005 |
| Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in mathematics (%) | SE_LSC_MATH |
| Proportion of children at the end of lower secondary achieving at least a minimum proficiency level in reading (%) | SE_LSC_RDNG |
| Proportion of children at the end of primary achieving at least a minimum proficiency level in mathematics (%) | SE_PRM_MATH |
| Proportion of children at the end of primary achieving at least a minimum proficiency level in reading (%) | SE_PRM_RDNG |
| Proportion of children in grades 2/3 achieving at least a minimum proficiency level in mathematics (%) | SE_G23_MATH |
| Proportion of children in grades 2/3 achieving at least a minimum proficiency level in reading (%) | SE_G23_RDG |
| Proportion of children under 5 years of age whose births have been registered with a civil authority | SG_REG_BRTH |
| Proportion of cities, municipalities and localities in regional Healthy City networks that are health-promoting | HEALTH_PROMOTING_CITIES |
| Proportion of countries that have conducted at least one population and housing census in the last 10 years (%) | SG_REG_CENSUS |
| Proportion of donor/non public development funding | GOE_Q014 |
| Proportion of ever-partnered women and girls aged 15 years or older subjected to physical and/or sexual violence by a current or former intimate partner in the previous 12 months | SDGIPV12M |
| Proportion of ever-partnered women and girls aged 15–49 years subjected to physical and/or sexual violence by a current or former intimate partner in their lifetime | SDGIPVLT |
| Proportion of girls and women aged 15-49 years who have undergone female genital mutilation/cutting (FMG/C) (%) | SH_STA_FGMS |
| Proportion of health facilities that provide comprehensive post-rape care as per WHO guidelines | HEALTH_FACILITIES_POST_RAPE_CARE |
| Proportion of health facilities with a core set of relevant essential medicines available and affordable on a sustainable basis | SDGHEALTHFACILITIESESSENTIALMEDS |
| Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP | GASPRSCFM |
| Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP | GASPRSCRO |
| Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP | GASPRSESC |
| Proportion of isolates with resistance to azithromycin reported to WHO-GASP | GASPRSAZM |
| Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP | GASPRSCIP |
| Proportion of newborns who have postnatal contact with a health provider within 2 days of delivery (%) | UNICEF_PNCNEWBORN |
| Proportion of population below the international poverty line of US$1.90 per day (%) | SI_POV_DAY1 |
| Proportion of population covered by at least one social protection benefit | POP_COVERED_SOCIAL_PROT_BENEFIT |
| Proportion of population with primary reliance on clean fuels and technologies for cooking (%) | PHE_HHAIR_PROP_POP_CLEAN_FUELS |
| Proportion of population with primary reliance on fuels and technologies for cooking, by fuel type (%) | PHE_HHAIR_PROP_POP_CATEGORY_FUELS |
| Proportion of population with primary reliance on polluting fuels and technologies for cooking (%) | PHE_HHAIR_PROP_POP_POLLUTING_FUELS |
| Proportion of private funding | GOE_Q013 |
| Proportion of public funding | GOE_Q012 |
| Proportion of urban population living in slums, informal settlements or inadequate housing | URBAN_POP_SLUM |
| Proportion of vaccination cards seen (%) | IMMUNIZATION_VACCINATIONCARDSSEEN |
| Proportion of women aged 15-49 years who make their own informed decisions regarding sexual relations, contraceptive use and reproductive health care (%) | SG_DMK_SRCR_FN_ZS |
| Proportion of women aged 20-24 years who were married or in a union by age 15 (%) | SP_DYN_MRBF15 |
| Proportion of women aged 20-24 years who were married or in a union by age 18 (%) | SP_DYN_MRBF18 |
| Proportion of women and girls aged 15 years and older who have been subjected to sexual violence by someone other than a partner in their lifetime since age 15 (%) | RHR_NPSV |
| Proportion of women and girls aged 15 years or older who have been subjected to sexual violence by someone other than a partner in the past 12 months (%) – related to SDG 5.2.2 | RHR_NPSV12M |
| Proportion ofpublic private partnerships funding | GOE_Q015 |
| Protecting people from tobacco smoke | P_Group |
| Providing guidance on privacy and security | GOE_Q030_3 |
| Providing incentives and guidance for innovation research and evaluation of health | GOE_Q032 |
| Providing oversight and enforcement of data ownership | GOE_Q030_4 |
| Provision for care of acute stroke and rehabilitation in more than 50% of public sector health facilities | NCD_CCS_stroke |
| Provision for secondary prevention of rheumatic fever and rheumatic heart disease in more than 50% of public sector health facilities | NCD_CCS_rheum |
| Provision of a mobile cessation service | O_mCessation |
| Provision of governmental funding to dementia nongovernmental organization for activities/services | GDO_q11x2x5 |
| Psychiatrists in prisons (FTEs per 1000 prisoners) | PRISON_B9_1_PHYCHIATRISTS_RATIO |
| Psychiatrists working in mental health sector (per 100,000) | MH_6 |
| Psychoactive substance causing entry into treatment | RSUD_7 |
| Psychologists working in mental health sector (per 100,000) | MH_9 |
| Public funding for eHealth | GOE_Q007 |
| Public funds designated for alcohol research/monitoring programmes, in Euros | SA_0000001711 |
| Public-funded alcohol research/monitoring programmes | SA_0000001710 |
| Public-private partnerships for eHealth | GOE_Q010 |
| Publication year of the policy or plan (latest revision) | MH_27 |
| Pyrethroid resistance reported for at least one site | IR_PYRETHROID_PRESENCE |
| Radiation Emergencies | IHRSPAR_CAPACITY13 |
| Radiation emergencies | IHRSPAR2_C15 |
| Radionuclear | IHR13 |
| Radiotherapy units (per 1 000 000 population) | WHS6_100 |
| Radon concentration measurements for existing buildings | RADON_Q603 |
| Radon concentration measurements for new buildings | RADON_Q602 |
| Radon in building regulations for existing buildings i.e. renovation/remodeling/major alteration | RADON_Q404 |
| Radon in building regulations for new buildings | RADON_Q403 |
| Radon in national drinking-water regulations | RADON_Q405 |
| Raised blood pressure (SBP>=140 OR DBP>=90) (age-standardized estimate) | BP_04 |
| Raised blood pressure (SBP>=140 OR DBP>=90) (crude estimate) | BP_03 |
| Raised fasting blood glucose (>= 7.0 mmol/L) (crude estimate) | NCD_GLUC_03 |
| Raised fasting blood glucose (>=7.0 mmol/L) (age-standardized estimate) | NCD_GLUC_04 |
| Raising taxes on tobacco | R_Group |
| Random breath testing (RBT) use | SA_0000001521 |
| Random breath testing (RBT) use | SA_0000001521_ARCHIVED |
| Recommendations for screening and brief interventions for substance use in antenatal services | RSUD_560 |
| Recommendations for screening and brief interventions for substance use in primary health care | RSUD_550 |
| Reducing cost of delivering content | GOE_Q104_1 |
| Reducing cost of delivering content | GOE_Q119_1 |
| Reference level for buildings with high public occupancy (Bq/m3) | RADON_Q502_1 |
| Reference level for dwellings (Bq/m3) | RADON_Q501_1 |
| Reference level for workplaces (Bq/m3) | RADON_Q503_1 |
| Regional prevalence, AAFs (15+), cancer | SA_0000001827 |
| Regional prevalence, AAFs (15+), liver cirrhosis deaths (%) | SA_0000001825 |
| Regional prevalence, AAFs (15+), road traffic crash deaths (%) | SA_0000001826 |
| Regional prevalence, AAFs ,all-cause deaths (%) | SA_0000001828 |
| Regional prevalence, alcohol-attributable DALYs, (%) | SA_0000001828_AA |
| Registration of medications for alcohol dependence and withdrawal | RSUD_480 |
| Registration of medications for opioid dependence | RSUD_490 |
| Registration of medications for opioid withdrawal | RSUD_500 |
| Registration of naloxone for injection for opioid overdose | RSUD_510 |
| Regular reports from national monitoring systems | SA_0000001770 |
| Regular reports from national monitoring systems | SA_0000001770_ARCHIVED |
| Regular reports on epidemiological and service delivery data for substance use | RSUD_840 |
| Regulating mobile devices and software | GOE_Q030_1 |
| Regulatory oversight of mobile apps for quality, safety and reliability | GOE_Q031 |
| Relapse cases (pre-2013 definition) | TB_ret_rel |
| Relapse cases: Pulmonary, bacteriologically confirmed | TB_ret_rel_labconf |
| Relapse cases: Pulmonary, clinically diagnosed | TB_ret_rel_clindx |
| Relapse cases: extrapulmonary | TB_ret_rel_ep |
| Relevants Country Offices links | WCO_COLINKS |
| Remote ordering of alcohol regulated | SA_0000001849 |
| Repeating interval for survey of youth (years) | TOBACCO_0000000507 |
| Report with data from health services on alcohol use and AUDs | SA_0000001812 |
| Report with epidemiological data on lcohol use and AUDs | SA_0000001811 |
| Reported cases of chlamydia (number) | STI_CHLAMYDIA_CASES_NUM |
| Reported cases of gonorrhea (number) | STI_GONORRHEA_CASES_NUM |
| Reported cases of syphilis (number) | STI_SYPHILIS_CASES_NUM |
| Reported cases of urethral discharge among men (number) | STI_URETHRAL_CASES_NUM |
| Reported currency | NTCP_curr |
| Reported number of children receiving antiretroviral therapy | HIV_0000000011 |
| Reported number of children receiving antiretroviral therapy, month and year of report | HIV_0000000012 |
| Reported number of human rabies deaths | NTD_RAB2 |
| Reported number of individuals treated for onchocerciasis | NTD_ONCTREAT |
| Reported number of people receiving antiretroviral therapy | HIV_0000000009 |
| Reported number of people requiring interventions against NTDs | SDGNTDTREATMENT |
| Reported treatment coverage for substance dependence | RSUD_410 |
| Reported use of earmarked tobacco taxes | R_earmarking |
| Reporting countries | GASPRP |
| Representation of latest youth prevalence survey (nonsmoked) | Yth_nonsmoked_national |
| Representativeness of most recent adolescent survey | Youth_svy_national |
| Representativeness of survey of adults | M_svy_national_adult |
| Representativeness of survey of adults - smokeless | M_smkless_svy_national_adult |
| Representativeness of survey of youth - smokeless | M_smkless_svy_national_youth |
| Representativeness of youth survey | M_svy_national_youth |
| Representativeness of youth survey | TOBACCO_0000000506 |
| Required anti-tobacco ads for any visual entertainment media product that depicts tobacco products, use or images | E19_movies_anti_tob_ads |
| Requirement to present prescribed anti-tobacco ads before, during or after the broadcasting or showing of any visual entertainment media product that depicts tobacco products, use or images | E14b_movies_anti_tob_ads |
| Research and development (R&D) expenditure as a proportion of GDP | GB_XPD_RSDV |
| Research into new analytical methods needs occur to meet the challenges of working with big data | GOE_Q202 |
| Residential long-term care beds (per 10 000 population) | GDO_q9x2_2 |
| Response | IHR04 |
| Restriction and inspection of facilities | SUNBEDREG_CONTROL |
| Restrictions on alcohol use in public places | SA_0000001553 |
| Restrictions on alcohol use in public places | SA_0000001553_ARCHIVED |
| Restrictions on product placement in films/movies | SA_0000001720 |
| Restrictions on product placement in films/movies | SA_0000001720_ARCHIVED |
| Restrictions on product placement on cable television | SA_0000001517 |
| Restrictions on product placement on cable television | SA_0000001517_ARCHIVED |
| Restrictions on product placement on national television | SA_0000001516 |
| Restrictions on product placement on national television | SA_0000001516_ARCHIVED |
| Restrictions on sales promotion from owners of pubs and bars (alcohol for free) | SA_0000001541 |
| Restrictions on sales promotion from owners of pubs and bars (alcohol for free) | SA_0000001541_ARCHIVED |
| Restrictions on sales promotion from producers (parties, events) | SA_0000001539 |
| Restrictions on sales promotion from producers (parties, events) | SA_0000001539_ARCHIVED |
| Restrictions on sales promotion from retailers (sales below cost) | SA_0000001540 |
| Restrictions on sales promotion from retailers (sales below cost) | SA_0000001540_ARCHIVED |
| Restrictions on sponsorship of sporting events | SA_0000001537 |
| Restrictions on sponsorship of sporting events | SA_0000001537_ARCHIVED |
| Restrictions on sponsorship of youth events | SA_0000001538 |
| Restrictions on sponsorship of youth events | SA_0000001538_ARCHIVED |
| Retail price for tobacco and nicotine products | TOB_R_PRICE |
| Retreatment cases: other | TB_ret_oth |
| Retreatment cases: treatment after default (pulmonary smear and/or culture positive) | TB_ret_tad |
| Retreatment cases: treatment after failure (pulmonary smear and/or culture positive) | TB_ret_taf |
| Risk Communication (SPAR) | IHRSPAR_CAPACITY10 |
| Risk communication | IHR06 |
| Risk communication and community engagement (RCCE) | IHRSPAR2_C10 |
| Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population | SA_0000001459 |
| Road traffic crash deaths, age-standardized death rates (15+), per 100,000 population | SA_0000001459_ARCHIVED |
| Road traffic crash deaths, alcohol-attributable, age-standardized death rates, per 100,000 population | SA_0000001459_AA |
| Rotavirus vaccines completed dose (RotaC) immunization coverage among 1-year-olds (%) | ROTAC |
| Routine monitoring of people with dementia | GDO_q16x1 |
| Rubella - number of reported cases | WHS3_57 |
| SDG 3.9.2 WASH deaths | WSH_1 |
| SDG 6.3.1 Proportion of safely treated domestic wastewater flows (%) | WSH_DOMESTIC_WASTE_SAFELY_TREATED |
| Safety requirements | SUNBEDREG_SAFETY |
| Sales of beer in 1000s hectolitres | SA_0000001678 |
| Sales of spirits in 1000s hectolitres | SA_0000001685 |
| Sales of wine in 1000s hectolitres | SA_0000001684 |
| Satisfaction with assistive products and related services (%) | ASSISTIVETECH_SATISFACTIONSERVICES |
| Satisfaction with assistive products for different environments and activities (%) | ASSISTIVETECH_SATISFACTIONACTIVITIES |
| Screening and brief intervention for substance use in antenatal services | RSUD_540 |
| Screening and brief intervention for substance use in primary health care | RSUD_530 |
| Screening and brief interventions for substance use and substance use disorders | RSUD_78 |
| Seat-belt wearing rate (%) | RS_212 |
| Second-hand smoke attributable DALYs per 100'000 children under 5 years | SHS_11 |
| Second-hand smoke attributable deaths per 100'000 children under 5 years | SHS_9 |
| Second-hand smoke attributable DALYs ('000) | SHS_5 |
| Second-hand smoke attributable DALYs ('000) in children under 5 years | SHS_10 |
| Second-hand smoke attributable DALYs per 100'000 capita | SHS_7 |
| Second-hand smoke attributable deaths | SHS_4 |
| Second-hand smoke attributable deaths ('000) in children under 5 years | SHS_8 |
| Second-hand smoke attributable deaths per 100'000 capita | SHS_6 |
| Second-line drug susceptibility testing (DST) available | TB_sldst_avail |
| Sector for inpatient detoxification of alcohol use disorders | RSUD_29 |
| Sector for inpatient detoxification of drug use disorders | RSUD_34 |
| Sector for inpatient treatment of alcohol dependence | RSUD_30 |
| Sector for inpatient treatment of drug dependence | RSUD_35 |
| Sector for outpatient treatment of alcohol dependence | RSUD_31 |
| Sector for outpatient treatment of drug dependence | RSUD_36 |
| Sector for residential long-term rehabilitation of alcohol use disorders | RSUD_33 |
| Sector for residential long-term rehabilitation of drug use disorders | RSUD_38 |
| Sector for substitution maintenance therapy of opioid dependence | RSUD_37 |
| Sector for the treatment of alcohol-induced psychoses and other alcohol-induced psychiatric conditions | RSUD_32 |
| Sectors represented in national alcohol policy | SA_0000001694 |
| Sectors represented in national alcohol policy | SA_0000001694_ARCHIVED |
| See SDGIPVLT and SDGIPV12M | SDGIPV |
| Self-help groups | RSUD_390 |
| Self-help groups for substance use disorders | RSUD_87 |
| Server training | SA_0000001764 |
| Server training | SA_0000001764_ARCHIVED |
| Server training on a regular basis | SA_0000001703 |
| Service Capacity Index for Substance Use Disorders (SCI-SUD) | SUD_SERVICECAPACITYINDEX |
| Service coverage for people with mental health and neurological conditions | MENTAL_HEALTH_SERVICE_COVERAGE |
| Service delivery data collection for substance use | RSUD_830 |
| Service delivery data collection system for substance use disorders | RSUD_9 |
| Severe wasted numbers among children under 5 years of age (millions), model-based estimates | NUTSEVWASTINGNUM |
| Severe wasted prevalence among children under 5 years of age (% weight-for-height <-3 SD), survey-based estimates | NUTRITION_WH_3 |
| Severe wasted prevalence among children under 5 years of age (%), model-based estimates | NUTSEVWASTINGPREV |
| Sex workers with active syphilis (%) | PercposSW |
| Sex workers: Condom use (percent) | SW_CONDOMUSE_PERCENT |
| Sex workers: Population size estimate (number) | SW_PSE_NUM |
| Sex workers: Syphilis prevalence (percent) | SW_SYPHILISPREV_PERCENT |
| Sexual exploitation, abuse and harassment prevention and response training | WCO_SEAHPRTRAINING |
| Sexual exploitation, abuse and harassment prevention and response training by groups (%) | WCO_SEAHPRTRAINING_GROUPED_PER100 |
| Skilled health professionals density (per 10 000 population) | SDGSHP |
| Smear-positive tuberculosis case-detection rate (%) | MDG_0000000030 |
| Smear-positive tuberculosis treatment-success rate (%) | MDG_0000000031 |
| Smokeless tobacco packaging and labelling must display qualitative information on constituents and emissions on one or more of the principal display areas | W23_emissions_front_back_C |
| Smokeless tobacco packaging and labelling must display qualitative information on relevant constituents and emissions | W22_emissions_qual_C |
| Smokeless tobacco packaging and labelling must not display expiry dates | W24_exp_date_C |
| Smokeless tobacco packaging and labelling must not display quantitative information on emission yields (such as tar nicotine and carbon monoxide) including when used as part of a brand name or trademark | W21_emissions_quant_C |
| Smokeless tobacco packaging and labelling must not use descriptors depicting flavours | W20_flavours_C |
| Smokeless tobacco packaging and labelling must not use figurative or other signs including colors or numbers as substitutes for prohibited misleading terms and descriptors | W19_colours_numbers_C |
| Smoking cessation support is available in health clinics or other primary care facilities | TOBACCO_0000000363 |
| Smoking cessation support is available in hospitals | TOBACCO_0000000362 |
| Smoking cessation support is available in offices of health professionals | TOBACCO_0000000364 |
| Smoking cessation support is available in other settings | TOBACCO_0000000366 |
| Smoking cessation support is available in the community | TOBACCO_0000000365 |
| Sobriety checkpoints | SA_0000001727 |
| Sobriety checkpoints | SA_0000001727_ARCHIVED |
| Social costs of alcohol use in millions US$ | SA_0000001477 |
| Social costs of alcohol use in millions US$ | SA_0000001477_ARCHIVED |
| Social security expenditure on health as a percentage of general government expenditure on health | WHS7_134 |
| Social workers working in mental health sector (per 100,000) | MH_8 |
| Sources of assistive products (%) | ASSISTIVETECH_SOURCESOFAT |
| Special VAT (or sales tax) rate on non-alcoholic beverages (different from the standard VAT rate) | TAXBEV_VATSPECIAL_YN |
| Special VAT is lower or higher than standard VAT | TAXBEV_VATSPECIAL_LOHI |
| Special housing services for alcohol use disorders | RSUD_680 |
| Special housing services for drug use disorders | RSUD_690 |
| Special treatment programmes for gambling disorder | RSUD_650 |
| Specialist medical practitioners (number) | HWF_0004 |
| Specialized treatment facilities for alcohol use disorders | RSUD_370 |
| Specialized treatment facilities for drug use disorders | RSUD_380 |
| Specialized treatment facilities for substance use disorders | RSUD_360 |
| Specialized treatment services for drug use disoders and HIV/AIDS | RSUD_41 |
| Specialized treatment services for substance use disorders and TB | RSUD_42 |
| Specific absorption rate (SAR) (W/kg) | EMFSAR |
| Specific health warnings are mandated for other smoked tobacco packaging | TOBACCO_0000000388 |
| Sponsored events | E15_sponsored_events |
| Stand-alone mental health legislation | MH_3 |
| Stand-alone policy or plan for mental health | MH_25 |
| Standard drink defined | SA_0000001768 |
| Standard drink defined | SA_0000001768_ARCHIVED |
| Standard drink measures, in grams per unit | SA_0000001650 |
| Standard drink measures, in grams per unit | SA_0000001650_ARCHIVED |
| Standards and benchmarks for TB and vital registration system surveillance | TB_sb |
| Standards of care for health professionals | RSUD_82 |
| Standards of care for health professionals, human rights | RSUD_84 |
| Standards of care for health professionals, maintenance | RSUD_83 |
| Standards of care for professionals providing treatment for alcohol and drug use disorders | RSUD_750 |
| Standards of treatment and care for public specialized treatment facilities | RSUD_640 |
| Status of National coordination center establishment | AMR_GI_002 |
| Status of National plans to implement and strengthen antimicrobial surveillance | AMR_GI_003 |
| Status of alcohol sale | TAXBEV_ALCOHOLSALESTATUS |
| Status of bejel endemicity | NTD_BEJELSTATUS |
| Status of countries enrolled in GLASS | AMR_GI_001 |
| Status of elimination of trachoma as a public health problem | NTD_6 |
| Status of endemicity of Buruli ulcer | NTD_BU_END |
| Status of endemicity of Taenia solium | NTD_TSOL1 |
| Status of endemicity of cutaneous leishmaniasis | NTD_LEISHCEND |
| Status of endemicity of onchocerciasis | NTD_ONCHSTATUS |
| Status of endemicity of visceral leishmaniasis | NTD_LEISHVEND |
| Status of indigenous malaria cases | MALARIA_INDIG_STATUS |
| Status of pinta endemicity | NTD_PINTASTATUS |
| Status of yaws endemicity | NTD_YAWSEND |
| Stillbirth rate (per 1000 total births) | WHOSIS_000014 |
| Strategy implementation funding available for eHealth | GOE_Q011 |
| Strategy includes objectives as to how telehealth contributes to UHC | GOE_Q070 |
| Stunting numbers among children under 5 years of age (millions), model-based estimates | NUTSTUNTINGNUM |
| Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), model-based estimates | NUTSTUNTINGPREV |
| Stunting prevalence among children under 5 years of age (% height-for-age <-2 SD), survey-based estimates | NUTRITION_ANT_HAZ_NE2 |
| Stunting prevalence in children aged < 3 years (%) | stunt3 |
| Stunting prevalence in children aged < 5 years (%) | stunt5 |
| Subnational advertising, promotion and sponsorship bans - at least one jurisdiction has a comprehensive ban in place | E23_subnat_complete_bans_exist |
| Subnational bans on advertising, promotion and sponsorship - at least one jurisdiction has a comprehensive ban in place | E_comprehensive_subnat |
| Subnational bans on tobacco advertising, promotion and sponsorship | E22_subnational_exists |
| Subnational bans on tobacco advertising, promotion and sponsorship authority exists | E22_subnational_authority_exists |
| Subnational laws or regulations exist banning some or all types of tobacco advertising, promotion and sponsorship | E20_subnational_exists |
| Subnational smoking bans - at least one jurisdiction has a comprehensive ban in place | P_comprehensive_subnat |
| Subnational smoking bans - authority exists | P10_subnat_auth_exists |
| Substance use disorders service coverage, access to medicine progress | SCSUD_MEDACCESSPROGRESS |
| Substance use disorders service coverage, availability and quantity of specialized human workforce | SCSUD_HWFAVAILABILITY |
| Substance use disorders service coverage, availability of policy, action plan and legislation | SCSUD_GOVPAL |
| Substance use disorders service coverage, data on prevalence of substance use/ substance use disorders | SCSUD_DATAPREV |
| Substance use disorders service coverage, data on service provision | SCSUD_DATASERVPROV |
| Substance use disorders service coverage, data on service utilization | SCSUD_DATASERVUTIL |
| Substance use disorders service coverage, financing progress | SCSUD_FINANCINGPROGRESS |
| Substance use disorders service coverage, governance progress | SCSUD_GOVPROGRESS |
| Substance use disorders service coverage, health information system progress | SCSUD_HEALTHINFOPROGRESS |
| Substance use disorders service coverage, health workforce access to professional development and education | SCSUD_HWFDEV |
| Substance use disorders service coverage, health workforce progress | SCSUD_HWFPROGRESS |
| Substance use disorders service coverage, information on governmental expenditures | SCSUD_FINANCINGEXP |
| Substance use disorders service coverage, information on governmental support available | SCSUD_FINANCINGSUPPORT |
| Substance use disorders service coverage, medicine included in basic insurance package | SCSUD_MEDBIS |
| Substance use disorders service coverage, medicine included in drug formulary | SCSUD_MEDDF |
| Substance use disorders service coverage, medicine included into official manual/ national treatment guidelines | SCSUD_MEDNTG |
| Substance use disorders service coverage, medicine provided for free in public health care | SCSUD_MEDPUBLIC |
| Substance use disorders service coverage, medicine quantitative data on the number of prescriptions/sales is available | SCSUD_MEDNUM |
| Substance use disorders service coverage, medicine registered in the country | SCSUD_MEDREG |
| Substance use disorders service coverage, national guidelines | SCSUD_GOVGUIDELINES |
| Substance use disorders service coverage, non-structured services | SCSUD_NSS |
| Substance use disorders service coverage, non-structured services progress | SCSUD_NSSPROGRESS |
| Substance use disorders service coverage, pharmacological treatment services | SCSUD_PHARM |
| Substance use disorders service coverage, pharmacological treatment services progress | SCSUD_PHARMPROGRESS |
| Substance use disorders service coverage, psychosocial treatment services | SCSUD_PSYCH |
| Substance use disorders service coverage, psychosocial treatment services progress | SCSUD_PSYCHPROGRESS |
| Substance use disorders service coverage, rehabilitation programmes | SCSUD_REHAB |
| Substance use disorders service coverage, rehabilitation programmes progress | SCSUD_REHABPROGRESS |
| Substance use disorders service coverage, screening and brief interventions | SCSUD_SBI |
| Substance use disorders service coverage, screening and brief interventions progress | SCSUD_SBIPROGRESS |
| Substance use disorders service coverage, specialized treatment services | SCSUD_STS |
| Substance use disorders service coverage, specialized treatment services progress | SCSUD_STSPROGRESS |
| Substance use disorders service coverage, system of ongoing support for health workforce | SCSUD_HWFSUPPORT |
| Substance use policy at the national level | RSUD_12 |
| Substance use policy at the national level, level of integration | RSUD_13 |
| Sugar-content of beverage (g/100ml) | TAXBEV_SUGARCONTENT |
| Supervision requirements for buprenorphine administration | RSUD_62 |
| Supervision requirements for buprenorphine/naloxone administration | RSUD_63 |
| Supervision requirements for methadone administration | RSUD_61 |
| Surgeons (per 100 000) | UHC_HRHSURGEONDENSITY |
| Surveillance | IHR03 |
| Surveillance | IHRSPAR2_C05 |
| Surveillance (SPAR) | IHRSPAR_CAPACITY06 |
| Survey previous to the most recent school-based survey among adolescents was within the 5 years prior | M6_youth_periodic |
| Survey previous to the most recent survey among adults was within the 5 years prior | M3_adult_periodic |
| Surveys, research | SA_0000001654 |
| System for monitoring alcohol-related harm | SA_0000001705 |
| System of monitoring alcohol involvement in forensic pathology | RSUD_850 |
| System of monitoring drugs involvement in forensic pathology | RSUD_860 |
| TB new snuoth | TB_new_snuoth |
| TB patients with known HIV status (%) | TB_hivtest_pct |
| Targets for monitoring implementation of dementia national plan | GDO_q2x1x3 |
| Tax administration: Bans or limits on duty free imports by travellers | R_admin_duty_free_limited |
| Tax administration: If duty free imports are limited, duty free allowance (number of cigarette sticks) | R_admin_duty_free_allowance |
| Tax administration: Tax stamps applied on tobacco products | R_admin_tax_stamps |
| Tax incentives for production low/no alcohol content beer | SA_0000001816 |
| Tax incentives for production of other alcoholic beverages | SA_0000001817 |
| Tax structure: Excise tax proportion of price | R_excise_proportion |
| Tax structure: Greater reliance on specific tax in mixed excise regime | R_excise_specific_reliance |
| Tax structure: Minimum specific tax applied in ad valorem or mixed excise regime | R_excise_min_specific |
| Tax structure: Retail price used as base of ad valorem component in ad valorem or mixed excise regime (or retail price exclusive of VAT) | R_excise_retail_price_base |
| Tax structure: Type of excise tax applied | R_excise_type |
| Tax structure: Uniform excise tax | R_excise_uniform_varied |
| Taxation of ethanol production | SA_0000001814 |
| Taxes as a % of price: ad valorem excise | R_Ad_val |
| Taxes as a % of price: import duties | R_Imp_duty |
| Taxes as a % of price: other taxes | R_tax_other |
| Taxes as a % of price: specific excise | R_Sp_excise |
| Taxes as a % of price: total tax | R_Total_tax |
| Taxes as a % of price: value added tax | R_VAT |
| Team composition (%) | WCO_TEAMCOMPOSITION_PER100 |
| Team composition, number of staff | WCO_TEAMCOMPOSITION_NUM |
| Tertiary institutions provide students of health sciences with training on eHealth | GOE_Q018 |
| Tested TB patients HIV-positive (%) | TB_hivtest_pos_pct |
| Testing and counselling facilities, estimated number per 100 000 adult population | HIV_0000000008 |
| Testing and counselling facilities, reported number | HIV_0000000007 |
| Testing and counselling facilities, reporting period | HIV_0000000025 |
| The number of new and relapse cases of tuberculosis detected in a given year by age and sex | TB_Notification_agesex_num |
| The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage. | TB_rdst_num_prct |
| The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients. | TB_rdst_num |
| The quit line number must appear on cigarette packaging or labelling | W25_quitline_number_A |
| The quit line number must appear on other smoked tobacco packaging or labelling | W25_quitline_number_B |
| The quit line number must appear on smokeless tobacco packaging or labelling | W25_quitline_number_C |
| The sale of all smokeless tobacco products is completely banned | W27_smokeless_prod_ban |
| Thinness among children and adolescents, BMI-for-age < -2 standard deviations below the median (%) | NCD_BMI_MINUS2C |
| Timeframe for maintenance treatment of opioid dependence | RSUD_470 |
| Timeframe of opioid agonist treatment | RSUD_50 |
| Title of most recent adolescent survey | Youth_survey_title |
| To address patient safety and quality of care based on data quality, data transmission standards, or clinical competency criteria | GOE_Q169 |
| To define medical jurisdiction, liability or reimbursement of eHealth services such as telehealth | GOE_Q168 |
| To protect privacy of personally identifiable data of individuals irrespective of whether it is paper or digital format | GOE_Q170 |
| To protect the privacy of individuals' health-related data held in electronic format as an EHR | GOE_Q171 |
| Tobacco Enforce bans: E1 direct advertising | TOBACCO_MPOWER_E1_DIRECTADBANS |
| Tobacco Enforce bans: E2 indirect advertising | TOBACCO_MPOWER_E2_INDIRECTADBANS |
| Tobacco Enforce bans: E3 indirect advertising, additional bans | TOBACCO_MPOWER_E3_INDIRECTADBANSPLUS |
| Tobacco MPOWER Protect people: P1 smoke-free places (national legislation) | TOBACCO_MPOWER_P1_SMOKEFREEPLACES |
| Tobacco MPOWER Protect people: P2 smoke-free places, additional characteristics | TOBACCO_MPOWER_P2_SMOKEFREEPLACEDETAILS |
| Tobacco MPOWER overview: Monitor, Protect people, Offer help, Warn of dangers, Enforce bans, Raise taxes | TOBACCO_MPOWER_OVERVIEW |
| Tobacco MPOWER: National tobacco control programmes (NTCP) | TOBACCO_MPOWER_NTCP |
| Tobacco Monitor: population-based national surveys, smokeless tobacco or e-cigarettes | TOBACCO_MPOWER_M2_SMOKELESSECIGARETTES |
| Tobacco Monitor: population-based national surveys, smokeless tobacco or e-cigarettes, prevalence | TOBACCO_MPOWER_M2_PREVALENCE |
| Tobacco Monitor: population-based national surveys, tobacco use and smoking | TOBACCO_MPOWER_M1_TOBACCOUSESMOKING |
| Tobacco Monitor: population-based national surveys, tobacco use and smoking, prevalence | TOBACCO_MPOWER_M1_PREVALENCE |
| Tobacco Monitor: school-based national surveys, smokeless tobacco or e-cigarettes | TOBACCO_MPOWER_M4_SMOKELESSECIGARETTESSCHOOL |
| Tobacco Monitor: school-based national surveys, smokeless tobacco or e-cigarettes, prevalence | TOBACCO_MPOWER_M4_PREVALENCE |
| Tobacco Monitor: school-based national surveys, tobacco use, tobacco smoking, and cigarette smoking | TOBACCO_MPOWER_M3_TOBACCOUSESMOKINGSCHOOL |
| Tobacco Monitor: school-based national surveys, tobacco use, tobacco smoking, and cigarette smoking, prevalence | TOBACCO_MPOWER_M3_PREVALENCE |
| Tobacco Offer help: O1 Support for treatment of tobacco dependence / Availability of smoking cessation support | TOBACCO_MPOWER_O1_TREATMENTSUPPORT |
| Tobacco Offer help: O2 Availability of tobacco cessation medications | TOBACCO_MPOWER_O2_MEDICATIONAVAILABILITY |
| Tobacco Raise taxes: Reported use of earmarked tobacco taxes | TOBACCO_MPOWER_R_EARMARKED |
| Tobacco Raise taxes: Affordability | TOBACCO_MPOWER_R_AFFORDABILITY |
| Tobacco Raise taxes: Annual tax revenues from tobacco products, latest reporting period | TOBACCO_MPOWER_R_TAXREVENUELATEST |
| Tobacco Raise taxes: Annual tax revenues from tobacco products, previous reporting period | TOBACCO_MPOWER_R_TAXREVENUEPREVIOUS |
| Tobacco Raise taxes: Inflation-adjusted prices for most sold brand of cigarettes | TOBACCO_MPOWER_R_INFLATIONADJUSTEDPRICES |
| Tobacco Raise taxes: National taxes for tobacco and nicotine products | TOBACCO_MPOWER_R_TAX |
| Tobacco Raise taxes: Retail price for tobacco and nicotine products | TOBACCO_MPOWER_R_PRICE |
| Tobacco Raise taxes: Tax administration | TOBACCO_MPOWER_R_TAXADMINISTRATION |
| Tobacco Raise taxes: Tobacco tax structure | TOBACCO_MPOWER_R_TAXSTRUCTURE |
| Tobacco Warning: W1a cigarette packaging health warnings | TOBACCO_MPOWER_W1A_CIGARETTES |
| Tobacco Warning: W1b smoked tobacco packaging health warnings | TOBACCO_MPOWER_W1B_TOBACCOSMOKED |
| Tobacco Warning: W1c smokeless tobacco packaging health warnings | TOBACCO_MPOWER_W1C_TOBACCOSMOKELESS |
| Tobacco Warning: W2a cigarette packaging health warnings, other characteristics | TOBACCO_MPOWER_W2A_CIGARETTES |
| Tobacco Warning: W2b smoked tobacco packaging health warnings, other characteristics | TOBACCO_MPOWER_W2B_TOBACCOSMOKED |
| Tobacco Warning: W2c smokeless tobacco packaging health warnings, other characteristics | TOBACCO_MPOWER_W2C_TOBACCOSMOKELESS |
| Tobacco Warning: W3 anti-tobacco mass-media campaigns | TOBACCO_MPOWER_W3_MASSMEDIA |
| Tobacco excises increased over the survey period | R_excise_incr |
| Tobacco tax administration: Marking is covert | R_admin_covert_marking |
| Tobacco tax administration: Marking is overt | R_admin_overt_marking |
| Tobacco tax administration: Marking/unique identifier contains data for track and tracing purposes | R_admin_identifier_track_and_trace |
| Tobacco tax administration: Sales of duty (or excise) free cigarettes banned | R_admin_duty_free_banned |
| Tobacco tax administration: Tax stamps, fiscal marks, banderole or other types of marking are applied on cigarettes | R_admin_tax_stamps_cig |
| Tobacco tax administration: Tax stamps, fiscal marks, banderole or other types of marking are applied on other tobacco products | R_admin_tax_stamps_other |
| Tobacco tax administration: Unique identifier | R_admin_unique_identifier |
| Tobacco tax revenues - import duties | Rev_import |
| Tobacco tax revenues - other | Rev_other |
| Tobacco tax structure: A minimum price policy is implemented | R_min_price_policy |
| Tobacco tax structure: Price dispersion: Share of cheapest brand price in premium brand price (%) (the higher the % the smaller the gap) | R_afford_price_dispersion |
| Tobacco tax structure: Price gap decreased over the last two years (cheapest brand of cigarettes versus the premium brand) | R_afford_price_gap_decreased |
| Tobacco tax structure: Specific tax component automatically adjusted for inflation (or other) | R_afford_tax_auto_adjust |
| Total (recorded+unrecorded) alcohol per capita (15+) consumption | SA_0000001688_ARCHIVED |
| Total NCD Deaths | NCD_DTH_TOT |
| Total actual deceased donors (absolute number) | ORGANTOTALDECNUM |
| Total actual deceased donors (per million) | ORGANTOTALDECRATE |
| Total dementia hospital admissions (per 100,000) | GDO_q9x1_5 |
| Total density per 100 000 population: District/rural hospitals | DEVICES03 |
| Total density per 100 000 population: Health centres | DEVICES02 |
| Total density per 100 000 population: Health posts | DEVICES01 |
| Total density per 100 000 population: Hospitals | DEVICES00 |
| Total density per 100 000 population: Provincial hospitals | DEVICES04 |
| Total density per 100 000 population: Specialized hospitals | DEVICES05 |
| Total density per million females aged from 50 to 69 years old: Mammography units | DEVICES23 |
| Total density per million population: Computed tomography units | DEVICES09 |
| Total density per million population: Gamma camera or Nuclear medicine | DEVICES11 |
| Total density per million population: Linear Accelerator | DEVICES12 |
| Total density per million population: Magnetic Resonance Imaging | DEVICES08 |
| Total density per million population: Positron Emission tomography | DEVICES10 |
| Total density per million population: Radiotherapy units | DEVICES22 |
| Total density per million population: Telecobalt Unit | DEVICES21 |
| Total environment attributable DALYs per 100'000 children under 5 years | TOTENV_10 |
| Total environment attributable deaths per 100'000 children under 5 years | TOTENV_8 |
| Total environment attributable DALYs in children under 5 years | TOTENV_90 |
| Total environment attributable DALYs ('000) in children under 5 years | TOTENV_9 |
| Total environment attributable deaths ('000) in children under 5 years | TOTENV_7 |
| Total environment attributable deaths in children under 5 years | TOTENV_70 |
| Total expenditure on dementia basic research (local currency, self-report) | GDO_q18x2x3_1 |
| Total expenditure on dementia clinical/translational research (local currency, self-report) | GDO_q18x2x3_2 |
| Total expenditure on dementia implementation research (local currency, self-report) | GDO_q18x2x3_3 |
| Total expenditure on dementia research (local currency, self-report) | GDO_q18x2x1_1 |
| Total expenditure on dental healthcare in million (US$) | ORALHEALTH_DENTALHEALTHCARE_EXP_TOTAL |
| Total expenditure on health as a percentage of gross domestic product | WHS7_143 |
| Total fertility rate (per woman) | WHS9_95 |
| Total fertility rate (per woman) | tfr |
| Total net official development assistance to medical research and basic health sectors per capita (US$), by recipient country | SDGODA01 |
| Total net official development assistance to medical research and basic health sectors per capita (constant 2014 US$), by recipient | SDGODA |
| Total number country offices, by region | WCO_TOTALCO_NUM |
| Total number of live births | POP_TOTAL_BIRTHS_NUM |
| Total number of notified TB cases | TB_c_notified |
| Total number of published dementia research output | GDO_q20 |
| Total number of staff in country offices, by region | WCO_TOTALSTAFFCO_NUM |
| Total number of staff in country offices, by region (%) | WCO_TOTALSTAFFCO_PER100 |
| Total number of malaria cases (presumed + confirmed cases) | MALARIA_TOTAL_CASES |
| Total organs transplanted (absolute number) | ORGANTOTALNUM |
| Total organs transplanted (per million) | ORGANTOTALRATE |
| Total population pushed below the $1.90 a day poverty line by household health expenditures (%) | FINPROTECTION_IMP_NP_190_LEVEL_SH |
| Total population pushed below the $1.90 a day poverty line by household health expenditures (millions) | FINPROTECTION_IMP_NP_190_LEVEL_MILLION |
| Total population in thousands (oral health) | ORALHEALTH_DENOMINATOR_TTLPOP |
| Total population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global) | FINPROTECTION_IMP_NP_REL_LEVEL_SH |
| Total population pushed below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global) | FINPROTECTION_IMP_NP_REL_LEVEL_MILLION |
| Total population pushed below the $2.15 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_NP_215_LEVEL_SH |
| Total population pushed below the $2.15 a day poverty line by household health expenditures (millions, regional, global) | FINPROTECTION_IMP_NP_215_LEVEL_MILLION |
| Total population pushed below the $3.20 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_NP_310_LEVEL_SH |
| Total population pushed below the $3.20 a day poverty line by household health expenditures (millions) | FINPROTECTION_IMP_NP_310_LEVEL_MILLION |
| Total population pushed below the $3.65 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_NP_365_LEVEL_SH |
| Total population pushed below the $3.65 a day poverty line by household health expenditures (millions, regional, global) | FINPROTECTION_IMP_NP_365_LEVEL_MILLION |
| Total population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (%, regional, global) | FINPROTECTION_IMP_PREL_LEVEL_SH |
| Total population pushed further below a relative poverty line by household health expenditures - 60% of median daily per capita consumption or income (millions, regional, global) | FINPROTECTION_IMP_PREL_LEVEL_MILLION |
| Total population pushed further below the $1.90 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_P190_LEVEL_SH |
| Total population pushed further below the $1.90 a day poverty line by household health expenditures (millions, regional, global) | FINPROTECTION_IMP_P190_LEVEL_MILLION |
| Total population pushed further below the $2.15 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_P_215_LEVEL_SH |
| Total population pushed further below the $2.15 a day poverty line by household health expenditures (millions, regional, global) | FINPROTECTION_IMP_P_215_LEVEL_MILLION |
| Total population pushed further below the $3.20 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_P310_LEVEL_SH |
| Total population pushed further below the $3.20 a day poverty line by household health expenditures (millions, regional, global) | FINPROTECTION_IMP_P310_LEVEL_MILLION |
| Total population pushed further below the $3.65 a day poverty line by household health expenditures (%, regional, global) | FINPROTECTION_IMP_P_365_LEVEL_SH |
| Total population pushed further below the $3.65 a day poverty line by household health expenditures (millions, regional, global) | FINPROTECTION_IMP_P_365_LEVEL_MILLION |
| Total productivity losses due to 5 oral diseases in million (US$) | ORALHEALTH_PRODLOSS_ORALDISEASES |
| Total taxes on beverages (%) | TAXBEV_TOTALTAXES |
| Total tetanus - number of reported cases | WHS3_46 |
| Total use of antibacterials expressed as DDD per 1000 inhabitants per day | GLASSAMC_TC |
| Total workforce in mental health sector (per 100,000) | MH_21 |
| Traditional and Complementary Medicine Professionals (number) | HWF_0023 |
| Traditional, Complementary, and Integrative Medicine Current Health Expenditure by financing schemes | TRAD_MED_CHE_SCHEME |
| Traditional, Complementary, and Integrative Medicine Current Health Expenditure by health care providers | TRAD_MED_CHE_PROVIDER |
| Traditional, Complementary, and Integrative Medicine Healthworkforce Density (per 10,000 population) | TRAD_MED_HWF_DENSITY |
| Traditional, Complementary, and Integrative Medicine Healthworkforce Distribution | TRAD_MED_HWF_DIST |
| Traditional, Complementary, and Integrative Medicine Share of Current Health Expenditure | TRAD_MED_SHARE_CHE |
| Training in screening and brief interventions for alcohol problems | SA_0000001714 |
| Training requirements | SUNBEDREG_TRAINING |
| Transgender: Condom use (percent) | TG_CONDOMUSE_PERCENT |
| Transgender: Population size estimate (number) | TG_PSE_NUM |
| Transgender: Syphilis prevalence (percent) | TG_SYPHILISPREV_PERCENT |
| Travel distance to obtain assistive products (%) | ASSISTIVETECH_TRAVELDISTANCEAT |
| Treatment admissions (inpatient), alcohol dependence, per 100,000 | SA_0000001468 |
| Treatment admissions (inpatient), alcoholic psychosis, per 100,000 | SA_0000001469 |
| Treatment for tobacco dependence available in health clinics or other primary care facilities | O_Avail_hlthSPACEclin |
| Treatment for tobacco dependence available in health clinics or other primary care facilities | O_Avail_hlth_clin |
| Treatment for tobacco dependence available in hospitals | O_Avail_hosp |
| Treatment for tobacco dependence available in offices of health professionals | O_Avail_off_hlth_prof |
| Treatment for tobacco dependence available in other settings | O_Avail_other |
| Treatment for tobacco dependence available in the community | O_Avail_community |
| Treatment for tobacco dependence in health clinics or other primary care facilities cost covered | O_Ins_hlth_clin |
| Treatment for tobacco dependence in hospitals cost covered | O_Ins_hosp |
| Treatment for tobacco dependence in offices of health professionals cost covered | O_Ins_off_hlth_prof |
| Treatment for tobacco dependence in other settings cost covered | O_Ins_other |
| Treatment for tobacco dependence in the community cost covered | O_Ins_community |
| Treatment history unknown | TB_newret_oth |
| Treatment of acutely malnourished children | NUTRITION_WASTING_TREATMENT |
| Treatment programmes for children and adolescents with alcohol use disorders | RSUD_340 |
| Treatment programmes for children and adolescents with alcohol use disorders | RSUD_890 |
| Treatment programmes for children and adolescents with drug use disorders | RSUD_350 |
| Treatment programmes for children and adolescents with drug use disorders | RSUD_900 |
| Treatment programmes for women with alcohol use disorders | RSUD_660 |
| Treatment programmes for women with drug use disorders | RSUD_670 |
| Treatment setting for substance use disorders, most common | RSUD_40 |
| Treatment slots for alcohol and drug use disorders, outpatient, per 10 000 | RSUD_44 |
| Treatment success rate for new pulmonary smear-negative and extrapulmonary tuberculosis cases | TB_c_new_snep_tsr |
| Treatment success rate for patients treated for MDR-TB (%) | TB_c_mdr_tsr |
| Treatment success rate: HIV-positive TB cases | TB_c_tbhiv_tsr |
| Treatment success rate: XDR-TB cases | TB_c_xdr_tsr |
| Treatment success rate: new TB cases | TB_c_new_tsr |
| Treatment success rate: previously treated TB cases | TB_c_ret_tsr |
| Treatment system for substance use disorders | RSUD_39 |
| Treatment, services | SA_0000001653 |
| Tuberculosis - new and relapse cases | TB_c_newinc |
| Tuberculosis - new and relapse cases | TB_tot_newrel |
| Tuberculosis detection and treatment | UHC_TB_DT |
| Tuberculosis detection rate under DOTS (%) | MDG_0000000022 |
| Tuberculosis effective treatment coverage (%) | TB_effective_treatment_coverage |
| Tuberculosis treatment coverage | TB_1 |
| Tuberculosis treatment success under DOTS (%) | MDG_0000000024 |
| Tx - person-years lived above age x | LIFE_0000000034 |
| Type of excise tax applied on beverage | TAXBEV_EXCISE_TYPE |
| Type of national cervical cancer screening program | NCD_CCS_cervicalcancerpgmtype |
| Type of nomenclature system | DEVICES13 |
| Type of staff in country office, according to WCO typology (%) | WCO_TYPEOFSTAFF_CO_PER100 |
| Types of lists recommending health technology for high burden diseases | DEVICES07 |
| UHC Service Coverage Index (SDG 3.8.1) | UHC_INDEX_REPORTED |
| UHC Service Coverage sub-index on infectious diseases | UHC_SCI_INFECT |
| UHC Service Coverage sub-index on noncommunicable diseases | UHC_SCI_NCD |
| UHC Service Coverage sub-index on reproductive, maternal, newborn and child health | UHC_SCI_RMNCH |
| UHC Service Coverage sub-index on service capacity and access | UHC_SCI_CAPACITY |
| UV radiation | UV_1 |
| UV radiation attributable DALYs ('000) | UV_3 |
| UV radiation attributable DALYs per 100'000 capita | UV_5 |
| UV radiation attributable deaths | UV_2 |
| UV radiation attributable deaths per 100'000 capita | UV_4 |
| Under-five mortality rate (deaths per 1000 live births) | u5mr |
| Under-five mortality rate (probability of dying by age 5 per 1000 live births) | MDG_0000000007 |
| Underweight among adults, BMI < 18.5 kg/m2 (age-standardized estimate) (%) | NCD_BMI_18A |
| Underweight among adults, BMI < 18.5 kg/m2 (crude estimate) (%) | NCD_BMI_18C |
| Underweight numbers among children under 5 years of age (millions), model-based estimates | NUTUNDERWEIGHTNUM |
| Underweight prevalence among children under 5 years of age (% weight-for-age <-2 SD), survey-based estimates | NUTRITION_WA_2 |
| Underweight prevalence among children under 5 years of age (%), model-based estimates | NUTUNDERWEIGHTPREV |
| Underweight prevalence in children aged < 3 years (%) | uweight3 |
| Underweight prevalence in children aged < 5 years (%) | uweight5 |
| Uniform or tiered excise tax system applied on alcoholic beverage | TAXBEV_EXCISE_UNIFORMTIERED_ALCOHOLIC |
| Uniform or tiered excise tax system applied on non-alcoholic beverage | TAXBEV_EXCISE_UNIFORMTIERED_NONALCOHOLIC |
| Unintended pregnancy rate (model-estimated) | SRH_PREGNANCY_UNINTENDED_RATE |
| Unit in the Ministry of Health responsible for the management of medical devices | DEVICES16 |
| Unmet need for family planning, among girls aged 15-19 (%) | MDG_0000000006_AGE1519 |
| Use of earmarked excise tax on beverages | TAXBEV_EARMARKEDEXCISETAX |
| Use of nomenclature system | DEVICES14 |
| Value-added tax (VAT) on alcohol (%) | SA_0000001551 |
| Value-added tax (VAT) on alcohol (%) | SA_0000001551_ARCHIVED |
| Value-added/sales tax on beverages (%) | TAXBEV_VATSALES |
| Varenicline - cost covered | O_Varen_ins |
| Varenicline - legally sold | O_Varen_sold |
| Varenicline - legally sold | TOBACCO_0000000371 |
| Varenicline - place available | O_Varen_where |
| Varenicline - place available | TOBACCO_0000000372 |
| Vehicle standards | RS_242 |
| Vision and eyecare: Effective refractive error coverage (eREC) (%) | NCD_SENSORYFUNCTION_VISION_EREC |
| Voluntary treatment for people with alcohol use disorders in the criminal justice system | RSUD_210 |
| Voluntary treatment for people with drug use disorders in the criminal justice system | RSUD_220 |
| WCO staffing under each GPW13 strategic priority | WCO_STAFFING_GPW13_NUM |
| Warning about the dangers of tobacco | W_Group |
| Wasted numbers among children under 5 years of age (millions), model-based estimates | NUTWASTINGNUM |
| Wasted prevalence among children under 5 years of age (%), model-based estimates | NUTWASTINGPREV |
| Wasting among children under 5 years of age (weight-for-height <-2 SD), number (in thousands), survey-based estimates | NUTRITION_WH_2_NUM |
| Wasting prevalence among children under 5 years of age (% weight-for-height <-2 SD), survey-based estimates | NUTRITION_WH_2 |
| Wasting prevalence in children aged < 3 years (%) | wast3 |
| Wasting prevalence in children aged < 5 years (%) | wast5 |
| Water, sanitation and hygiene attributable DALYs per 100'000 children under 5 years | WSH_8 |
| Water, sanitation and hygiene attributable deaths per 100'000 children under 5 years | WSH_4 |
| Water, sanitation and hygiene attributable DALYs ('000) | WSH_5 |
| Water, sanitation and hygiene attributable DALYs ('000) in children under 5 years | WSH_6 |
| Water, sanitation and hygiene attributable DALYs per 100'000 capita | WSH_7 |
| Water, sanitation and hygiene attributable deaths ('000) in children under 5 years | WSH_2 |
| Water, sanitation and hygiene attributable deaths per 100'000 capita | WSH_3 |
| Which allows for the sharing of personal and health data between research entities | GOE_Q174 |
| Which allows individuals electronic access to their own health-related data when held in an EHR | GOE_Q175 |
| Which allows individuals to demand that their own data be corrected when held in an EHR if it is known to be inaccurate | GOE_Q176 |
| Which allows individuals to demand the deletion of health-related data from their EHR | GOE_Q177 |
| Which governs the sharing of digital data between health professionals in health services in other countries through the use of an EHR | GOE_Q173 |
| Which governs the sharing of digital data between health professionals in other health services in the same country through the use of an EHR | GOE_Q172 |
| Women accessing antenatal care (ANC) services who were tested for syphilis (%), reported | PerctestedANC |
| Women age 15-49 years who received a health check within 2 days after delivery of their most recent live birth in the last 2 years (%) | UNICEF_PNCMOTHER |
| Women of reproductive age (aged 15-49 years) who have their need for family planning satisfied with modern methods (%) | SDGFPALL |
| Women who have their need for family planning satisfied with modern methods (%) - modelled estimates | FAMILYPLANNINGUNPDUHC |
| Workforce availability for assistive technology | ASSISTIVETECH_Q06 |
| Workplace representatives nationally involved to prevent and address alcohol-related harm | SA_0000001763 |
| Workplace representatives nationally involved to prevent and address alcohol-related harm | SA_0000001763_ARCHIVED |
| YLLs attributable to ambient air pollution (age-standardized) | AIR_46 |
| Year of latest adult prevalence survey | M_svy_yr_adult |
| Year of latest youth prevalence survey (nonsmoked) | Yth_nonsmoked_svy_yr |
| Year of most recent adolescent survey | Youth_svy_yr |
| Year of national implementation of regulation | SUNBEDEXISTYEAR |
| Year of survey of adults - smokeless | M_smkless_svy_yr_adult |
| Year of survey of youth | M_svy_yr_youth |
| Year of survey of youth | TOBACCO_0000000505 |
| Year of survey of youth - smokeless | M_smkless_svy_yr_youth |
| Year the law was enacted (latest revision) | MH_26 |
| Years lived with disability caused by hazards, aged 5 years and above | HAZARD_YLD_GE5 |
| Years lived with disability caused by hazards, aged less than 5 years | HAZARD_YLD_LT5 |
| Years lived with disability caused by hazards, all ages | HAZARD_YLD_TOTAL |
| Years of healthy life lost due to disability (YLDs) | GHE_YLDNUM |
| Years of healthy life lost due to disability (YLDs) (per 100 000 population) | GHE_YLDRATE |
| Years of healthy life lost to disability (YLDs) (per 100 000 population) due to leptospirosis | LEPTO_YLD100K |
| Years of healthy life lost to disability (YLDs) due to leptospirosis | LEPTO_YLD |
| Years of life lost (YLLs) (per 100 000 population) due to leptospirosis | LEPTO_YLL100K |
| Years of life lost (YLLs) due to leptospirosis | LEPTO_YLL |
| Years of life lost caused by hazards, aged 5 years and above | HAZARD_YLL_GE5 |
| Years of life lost caused by hazards, aged less than 5 years | HAZARD_YLL_LT5 |
| Years of life lost caused by hazards, all ages | HAZARD_YLL_TOTAL |
| Years of life lost from mortality (YLLs) | GHE_YLLNUM |
| Years of life lost from mortality (YLLs) (per 100 000 population) | GHE_YLLRATE |
| Yellow fever - number of reported cases | WHS3_50 |
| Yellow fever vaccine (YFV) immunization coverage among 1-year olds (%) | VACCINECOVERAGE_YFV |
| Youth indicator 1 definition | M_def_1_text_youth |
| Youth indicator 1 rate | M_def_1_prev_youth |
| Youth indicator 2 definition | M_def_2_text_youth |
| Youth indicator 2 rate | M_def_2_prev_youth |
| Youth smokeless tobacco use indicator definition | M_smkless_def_text_youth |
| Youth smokeless tobacco use indicator rate | M_smkless_prev_youth |
| Youth survey age range | M_svy_age_youth |
| Youth survey age range - smokeless | M_smkless_age_range_youth |
| Youth violence: Extent of implementation of life-skills and social development programmes | VIOLENCE_EXTENTIMP_YOUTHLIFESKILLS |
| Zero vegetable or fruit consumption, 6-23 months | NUT_CF_ZVF |
| Zoonosis | IHR10 |
| Zoonotic Events and the Human-animal Interface | IHRSPAR_CAPACITY03 |
| Zoonotic diseases | IHRSPAR2_C12 |
| eLearning courses accredited by continuing medical education or professional licensing bodies | GOE_Q120 |
| eLearning is used in pre-service education to teach health sciences students | GOE_Q103 |
| eLearning programmes for in-service training of health professionals have been evaluated | GOE_Q122 |
| eLearning used for in-service training of health professionals | GOE_Q118 |
| ex - expectation of life at age x | LIFE_0000000035 |
| lack of evidence showing effectiveness of EHR | GOE_Q156 |
| lx - number of people left alive at age x | LIFE_0000000031 |
| mHealth programmes are sponsored by government | GOE_Q028 |
| nLx - person-years lived between ages x and x+n | LIFE_0000000033 |
| nMx - age-specific death rate between ages x and x+n | LIFE_0000000029 |
| ndx - number of people dying between ages x and x+n | LIFE_0000000032 |
| nqx - probability of dying between ages x and x+n | LIFE_0000000030 |
| strategy refers to the use of ICT to support UHC | GOE_Q002 |
| to be retired | GHE_DALY_NUMERIC |
| to be retired | GHE_DEATHS_NUMERIC |
| to be retired | GHE_YLD_NUMERIC |
| to be retired | GHE_YLL_NUMERIC |
| to be retired | bfearly |
| xxx | TB_treatment_coverage |
| ≥70% of total antibiotic use being from WHO AWaRe Access group antibiotics (70% Access target) | GLASSAMC_GPW13_T4B |